
<html lang="en"     class="pb-page"  data-request-id="9072f9cd-8d6e-4991-90a9-5b576c32aadf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b00632;website:website:acspubs;issue:issue:10.1021/jmcmar.2017.60.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography" /></meta><meta name="dc.Creator" content="Luca C.  Gobbi" /></meta><meta name="dc.Creator" content="Henner  Knust" /></meta><meta name="dc.Creator" content="Matthias  Körner" /></meta><meta name="dc.Creator" content="Michael  Honer" /></meta><meta name="dc.Creator" content="Christian  Czech" /></meta><meta name="dc.Creator" content="Sara  Belli" /></meta><meta name="dc.Creator" content="Dieter  Muri" /></meta><meta name="dc.Creator" content="Martin R.  Edelmann" /></meta><meta name="dc.Creator" content="Thomas  Hartung" /></meta><meta name="dc.Creator" content="Isabella  Erbsmehl" /></meta><meta name="dc.Creator" content="Sandra  Grall-Ulsemer" /></meta><meta name="dc.Creator" content="Andreas  Koblet" /></meta><meta name="dc.Creator" content="Marianne  Rueher" /></meta><meta name="dc.Creator" content="Sandra  Steiner" /></meta><meta name="dc.Creator" content="Hayden T.  Ravert" /></meta><meta name="dc.Creator" content="William B.  Mathews" /></meta><meta name="dc.Creator" content="Daniel P.  Holt" /></meta><meta name="dc.Creator" content="Hiroto  Kuwabara" /></meta><meta name="dc.Creator" content="Heather  Valentine" /></meta><meta name="dc.Creator" content="Robert F.  Dannals" /></meta><meta name="dc.Creator" content="Dean F.  Wong" /></meta><meta name="dc.Creator" content="Edilio  Borroni" /></meta><meta name="dc.Description" content="Aggregates of tau and beta amyloid (Aβ) plaques constitute the histopathological hallmarks of Alzheimer’s disease and are prominent targets for novel therapeutics as well as for biomarkers for diag..." /></meta><meta name="Description" content="Aggregates of tau and beta amyloid (Aβ) plaques constitute the histopathological hallmarks of Alzheimer’s disease and are prominent targets for novel therapeutics as well as for biomarkers for diag..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 12, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00632" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00632" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00632" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00632" /></link>
        
    
    

<title>Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00632" /></meta><meta property="og:title" content="Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0015.jpeg" /></meta><meta property="og:description" content="Aggregates of tau and beta amyloid (Aβ) plaques constitute the histopathological hallmarks of Alzheimer’s disease and are prominent targets for novel therapeutics as well as for biomarkers for diagnostic in vivo imaging. In recent years much attention has been devoted to the discovery and development of new PET tracers to image tau aggregates in the living human brain. Access to a selective PET tracer to image and quantify tau aggregates represents a unique tool to support the development of any novel therapeutic agent targeting pathological forms of tau. The objective of the study described herein was to identify such a novel radiotracer. As a result of this work, we discovered three novel PET tracers (2-(4-[11C]methoxyphenyl)imidazo[1,2-a]pyridin-7-amine 7 ([11C]RO6924963), N-[11C]methyl-2-(3-methylphenyl)imidazo[1,2-a]pyrimidin-7-amine 8 ([11C]RO6931643), and [18F]2-(6-fluoropyridin-3-yl)pyrrolo[2,3-b:4,5-c′]dipyridine 9 ([18F]RO6958948)) with high affinity for tau neurofibrillary tangles, excellent selectivity against Aβ plaques, and appropriate pharmacokinetic and metabolic properties in mice and non-human primates." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00632"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00632">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00632&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00632&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00632&amp;href=/doi/10.1021/acs.jmedchem.7b00632" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7350-7370</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00606" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00647" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca+C.++Gobbi">Luca C. Gobbi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0563-2491" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henner++Knust">Henner Knust</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++K%C3%B6rner">Matthias Körner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Honer">Michael Honer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Czech">Christian Czech</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sara++Belli">Sara Belli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dieter++Muri">Dieter Muri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+R.++Edelmann">Martin R. Edelmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Hartung">Thomas Hartung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabella++Erbsmehl">Isabella Erbsmehl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Grall-Ulsemer">Sandra Grall-Ulsemer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Koblet">Andreas Koblet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marianne++Rueher">Marianne Rueher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Steiner">Sandra Steiner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hayden+T.++Ravert">Hayden T. Ravert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+B.++Mathews">William B. Mathews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+P.++Holt">Daniel P. Holt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroto++Kuwabara">Hiroto Kuwabara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Valentine">Heather Valentine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+F.++Dannals">Robert F. Dannals</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean+F.++Wong">Dean F. Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edilio++Borroni">Edilio Borroni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div><div class="aff-info" id="aff2.0"><span class="aff-text"><sup>‡</sup>Department of Radiology, <sup>§</sup>Department of Psychiatry, and <sup>∥</sup>Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8ee2fbedefa0e9e1ecece7cefce1ede6eba0ede1e3"><span class="__cf_email__" data-cfemail="fb978e989ad59c94999992bb899498939ed5989496">[email protected]</span></a>. Phone: (+41) 61-688-80-34.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00632&amp;href=/doi/10.1021%2Facs.jmedchem.7b00632" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7350–7370</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 April 2017</li><li><span class="item_label"><b>Published</b> online</span>12 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 September 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00632" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00632</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7350%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLuca%2BC.%2BGobbi%252C%2BHenner%2BKnust%252C%2BMatthias%2BK%25C3%25B6rner%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D17%26contentID%3Dacs.jmedchem.7b00632%26title%3DIdentification%2Bof%2BThree%2BNovel%2BRadiotracers%2Bfor%2BImaging%2BAggregated%2BTau%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2Bwith%2BPositron%2BEmission%2BTomography%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7370%26publicationDate%3DSeptember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00632"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2745</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00632" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;C. Gobbi&quot;},{&quot;first_name&quot;:&quot;Henner&quot;,&quot;last_name&quot;:&quot;Knust&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Körner&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Honer&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Czech&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;Belli&quot;},{&quot;first_name&quot;:&quot;Dieter&quot;,&quot;last_name&quot;:&quot;Muri&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;R. Edelmann&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Hartung&quot;},{&quot;first_name&quot;:&quot;Isabella&quot;,&quot;last_name&quot;:&quot;Erbsmehl&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Grall-Ulsemer&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Koblet&quot;},{&quot;first_name&quot;:&quot;Marianne&quot;,&quot;last_name&quot;:&quot;Rueher&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Steiner&quot;},{&quot;first_name&quot;:&quot;Hayden&quot;,&quot;last_name&quot;:&quot;T. Ravert&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;B. Mathews&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;P. Holt&quot;},{&quot;first_name&quot;:&quot;Hiroto&quot;,&quot;last_name&quot;:&quot;Kuwabara&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Valentine&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;F. Dannals&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;F. Wong&quot;},{&quot;first_name&quot;:&quot;Edilio&quot;,&quot;last_name&quot;:&quot;Borroni&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7350-7370&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00632&quot;},&quot;abstract&quot;:&quot;Aggregates of tau and beta amyloid (Aβ) plaques constitute the histopathological hallmarks of Alzheimer’s disease and are prominent targets for novel therapeutics as well as for biomarkers for diagnostic in vivo imaging. In recent years much attention has been devoted to the discovery and development of new PET tracers to image tau aggregates in the living human brain. Access to a selective PET tracer to image and quantify tau aggregates represents a unique tool to support the development of any novel therapeutic agent targeting pathological forms of tau. The objective of the study described herein was to identify such a novel radiotracer. As a result of this work, we discovered three novel PET tracers (2-(4-[11C]methoxyphenyl)imidazo[1,2-a]pyridin-7-amine 7 ([11C]RO6924963), N-[11C]methyl-2-(3-methylphenyl)imidazo[1,2-a]pyrimidin-7-amine 8 ([11C]RO6931643), and [18F]2-(6-fluoropyridin-3-yl)pyrrolo[2,3-b:4,5-c′]dipyridine 9 ([18F]RO6958948)) with high affinity for tau neurofibrillary tangles, excellent select&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00632&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00632" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00632&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00632" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00632&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00632" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00632&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00632&amp;href=/doi/10.1021/acs.jmedchem.7b00632" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00632" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00632" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00632%26sid%3Dliteratum%253Aachs%26pmid%3D28654263%26genre%3Darticle%26aulast%3DGobbi%26date%3D2017%26atitle%3DIdentification%2Bof%2BThree%2BNovel%2BRadiotracers%2Bfor%2BImaging%2BAggregated%2BTau%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2Bwith%2BPositron%2BEmission%2BTomography%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D17%26spage%3D7350%26epage%3D7370%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/jmcmar.2017.60.issue-17/20170914/jmcmar.2017.60.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Aggregates of tau and beta amyloid (Aβ) plaques constitute the histopathological hallmarks of Alzheimer’s disease and are prominent targets for novel therapeutics as well as for biomarkers for diagnostic in vivo imaging. In recent years much attention has been devoted to the discovery and development of new PET tracers to image tau aggregates in the living human brain. Access to a selective PET tracer to image and quantify tau aggregates represents a unique tool to support the development of any novel therapeutic agent targeting pathological forms of tau. The objective of the study described herein was to identify such a novel radiotracer. As a result of this work, we discovered three novel PET tracers (2-(4-[<sup>11</sup>C]methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine <b>7</b> ([<sup>11</sup>C]RO6924963), <i>N</i>-[<sup>11</sup>C]methyl-2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine <b>8</b> ([<sup>11</sup>C]RO6931643), and [<sup>18</sup>F]2-(6-fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine <b>9</b> ([<sup>18</sup>F]RO6958948)) with high affinity for tau neurofibrillary tangles, excellent selectivity against Aβ plaques, and appropriate pharmacokinetic and metabolic properties in mice and non-human primates.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The microtubule-associated protein tau is highly expressed in neurons, where it has an important function in the assembly and stabilization of axonal microtubules. Six isoforms of tau exist in the adult human brain, originating from a common gene by alternative splicing and varying between 352 to 441 amino acids in length.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The native soluble forms of the tau protein exhibit predominantly a random coil conformation. By contrast, in certain types of neurological disorders, tau is encountered in protein aggregates possessing a cross β-sheet amyloid core structure.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Most prominent among these neurological disorders is Alzheimer’s disease (AD), which is characterized by the presence of tau aggregates in the brain in form of neurofibrillary tangles (NFTs) and neuropil threads (NTs).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The second protein aggregates present in AD consist of amyloid-β (Aβ) plaques, sharing a similar cross β-sheet fibrillary core structure. The spreading of tau pathology in AD is well documented and follows a predictable pattern, in terms of both timing and spatial localization.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">As of today, no cure exists for AD that represents the most common reason for dementia. The increasing prevalence of AD related to aging populations, in particular in Western countries, makes it a major reason for concern for society and a topic for intensive research.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Evidence is emerging in recent years for tau NFTs but not Aβ plaques to be indicators of clinical symptoms progression, despite the fact of Aβ pathology temporally preceding the one of tau.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, several novel therapeutic approaches to cure or at least modify the progression of AD are focusing on tau and on preventing the spreading of aggregated tau species or clearing of existing NFTs and NTs. The development of any such new therapy would greatly benefit from the existence of a sensitive biomarker able to monitor tau pathology in the living brain. In particular, this would allow for patient selection and stratification as well as collection of longitudinal data demonstrating the efficacy of any novel anti-tau therapeutic agent at limiting tau pathology. Moreover, such a biomarker would represent an invaluable diagnostic tool for monitoring AD.</div><div class="NLM_p">Recently, a number of positron emission tomography (PET) tracers targeting aggregated forms of tau have been identified.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Such radiotracers enable for the first time the quantitative monitoring of tau aggregates in the living human brain.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> For any novel tau PET tracer, selectivity over Aβ plaques is mandatory because of the mixed nature of pathology in AD. The first clinically evaluated radiotracer in this field was <b>1</b> ([<sup>18</sup>F]FDDNP), a ligand possessing high affinity for Aβ plaques and thus of limited use as tau aggregates biomarker (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> More recently several novel structures of selective tau tracers were reported, the most prominent being <b>2</b> (flortaucipir, formerly known as [<sup>18</sup>F]AV-1451 and [<sup>18</sup>F]T807),<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a><b>3</b> ([<sup>18</sup>F]T808),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a><b>4</b> ([<sup>18</sup>F]THK5351),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>5</b> ([<sup>11</sup>C]PBB3),<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> and <b>6 (</b>[<sup>18</sup>F]MK-6240).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of PET tracers for imaging of tau aggregates reported to have entered clinical evaluation studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">During running of an internal program to secure access to a selective tau PET tracer, the initial results on [<sup>18</sup>F]<b>2</b> and [<sup>18</sup>F]<b>3</b> were disclosed.<a onclick="showRef(event, 'ref12 ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref15">(12, 13, 15)</a> The two structures were deemed as promising starting points for a PET tracer discovery program. We herein wish to report on our work that has culminated in the identification of the three novel and selective tau radiotracers [<sup>11</sup>C]<b>7</b> ([<sup>11</sup>C]RO6924963),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> [<sup>11</sup>C]<b>8</b> ([<sup>11</sup>C]RO6931643),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and [<sup>18</sup>F]<b>9</b> ([<sup>18</sup>F]RO6958948).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Amyloid aggregates are known to possess different binding sites on the cross-β sheet fibrils surface.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> Caution is thus mandatory when interpreting the results of any competitive binding assay, as the addressed binding site depends on the reporter ligand that is used. Our strategy to find novel high affinity tau NFT ligands was to build a novel medium to high throughput assay based on the displacement of [<sup>3</sup>H]<b>3</b> from brain sections originating from AD donors. Ligand <b>3</b> has been described to possess high affinity of <i>K</i><sub>d</sub> = 22 nM for tau aggregates as encountered in AD.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> New chemical structures were derived from <b>3</b> and <b>2</b> following the hypothesis that related scaffolds would share a common binding site on the amyloid fibril surface. Early in the program we demonstrated <b>2</b> to indeed compete for binding with [<sup>3</sup>H]<b>3</b> (vide infra). For assessing selectivity of the most promising candidates against Aβ plaques, we relied on low throughput, direct binding assays with tritiated material. Of particular importance for rapidly progressing the project was the simplification of the tricyclic aromatic core of the molecules. In addition, incorporation of heteroatoms in the aromatic rings was investigated to reduce the lipophilicity, thus aiming at improving the specific to nonspecific binding ratio. The optimal range for the properties of a PET tracer for use in the central nervous system has been extensively reviewed in the past few years, and this information guided our design of novel molecules.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Nonlabeled Compounds</h3><div class="NLM_p">The synthesis of imidazo[1,2-<i>a</i>]pyridines typically started from 2-amino-4-chloropyridine (<b>10</b>) by reaction with an appropriate amine (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). While 2,4-diaminopyridine (<b>11</b>) was commercially available, reaction of <b>10</b> with methylamine produced <i>N</i>4-methyl-2,4-diaminopyridine (<b>12</b>). Condensation of <b>11</b> and <b>12</b> with α-bromoacetophenones <b>13</b>–<b>15</b> afforded imidazo[1,2-<i>a</i>]pyridines <b>7</b> and <b>16</b>–<b>18</b>. Direct N-alkylation of <b>16</b> to give the dimethylamino derivative <b>19</b> proceeded in poor yield (6%) under formation of a mixture with the monoalkylated compound <b>17</b>. No attempt was made to optimize this step. Mono-N-alkylation of <b>16</b> with a fluoroethyl group was best achieved in a three-step procedure via the Boc intermediates <b>20</b> and <b>21</b>, thus leading to the final product <b>22</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Imidazo[1,2-<i>a</i>]pyridines <b>7</b> and <b>16</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) For <b>12</b>, R<sub>1</sub> = NHMe: 40% aqueous MeNH<sub>2</sub>, 160 °C, 4 h, 75%. (b) For <b>7</b>, <b>18</b>: <b>14</b> or <b>15</b>, NaHCO<sub>3</sub>, MeOH or EtOH, reflux, 4–6 h, 22–35%. For <b>16</b>, <b>17</b>: <b>13</b>, acetone, 65 °C, 5 h, 44–90%. (c) NaH, DMF, 30 min, then MeI, rt, 18 h, 6%. (d) LiHMDS, THF, 0 °C, 25 min, then Boc<sub>2</sub>O, rt, 1.5 h, 66%. (e) NaH, DMF, rt, 15 min, then 1-bromo-2-fluoroethane, 50 °C, 1 h, 95%. (f) TFA, DCM, rt, 3 h, 93%.</p></p></figure><div class="NLM_p">Commercially available 4-chloropyrimidin-2-amine (<b>23</b>) or pyrimidine-2,4-diamine (<b>24</b>) (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) served as starting points for the synthesis of imidazo[1,2-<i>a</i>]pyrimidines. Where necessary, aromatic nucleophilic substitution of 4-chloropyrimidin-2-amine (<b>23</b>) was used in the first step to introduce the amine substituents in position R<sub>1</sub> to give intermediates <b>25</b>–<b>28</b>. Condensation of <b>24</b>–<b>28</b> with appropriately substituted α-bromoacetophenones in acetone afforded the final products <b>8</b> and <b>29</b>–<b>36</b>. Phenol <b>33</b> was further elaborated by alkylation to the fluoroethoxy derivative <b>37</b> or it is precursor for radiofluorination, tosylate <b>38</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Imidazo[1,2-<i>a</i>]pyrimidines <b>8</b> and <b>29</b>–<b>37</b> and Imidazo[1,2-<i>c</i>]pyrimidine <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) <b>25</b>: NH<sub>2</sub>Me·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 2 h, 40%. <b>26</b>: NHMe<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 1 h, 43%. <b>27</b>: NH<sub>2</sub><i>c</i>Pr, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 18 h, 55%. <b>28</b>: 4-(2-fluoroethyl)piperidine·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 12 h, 78%. (b) <b>8</b> and <b>29</b>–<b>36</b>: α-Br-acetophenones, acetone, 60–65 °C, 5–18 h, 35–94%. Or <b>36</b>: α-Br-acetophenone, pTsOH, acetone, 65 °C, 12 h, 25%. (c) 1-Bromo-2-fluoroethane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 1 h, 55%. (d) (TsOCH<sub>2</sub>)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 2 h, 41%. (e) α-Br-acetophenone, EtOH, 80 °C, 8 h, 13%.</p></p></figure><div class="NLM_p">Condensation of 4,6-diaminopyrimidine (<b>39</b>) and α-bromoacetophenone in EtOH at 80 °C afforded in one step the regioisomeric imidazo[1,2-<i>c</i>]pyrimidine <b>40</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">The initial synthesis of the tricyclic pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine core was achieved in two steps, beginning with a Suzuki cross-coupling of iodide <b>41</b> with boronic acid <b>42</b> leading to intermediate <b>43</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Ring closure of <b>43</b> by intramolecular nucleophilic substitution was accompanied by concomitant loss of the Boc protective group, thus resulting in tricyclic intermediate <b>44</b>. Reprotection with Boc anhydride to obtain <b>45</b> was beneficial for further transformations of this compound via Suzuki cross-coupling reaction toward both the α-fluoropyridine <b>47</b> and the corresponding nitro derivative <b>49</b>, which represents the radiofluorination precursor of [<sup>18</sup>F]<b>9</b>. Complete loss of the Boc protective group was observed during the Suzuki cross-coupling reaction leading to nitro derivative <b>49</b>, while the synthesis of <b>9</b> under identical conditions led to a mixture of free and <i>N</i>-Boc protected material, thus requiring an additional cleavage step. Full consumption of starting material <b>45</b> was observed in the cross-coupling reactions leading to <b>47</b> and <b>49</b>. The modest yields for these conversions were mainly originating from the formation of side products and from the poor solubility of the final compounds, which complicated their isolation.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridines <b>9</b> and <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [Pd(OAc)<sub>2</sub>], PPh<sub>3</sub>, Et<sub>3</sub>N, DMF, 100 °C, 3 h, ∼90% purity, 63%. (b) K<sub>2</sub>CO<sub>3</sub>, 18-crown-6, DMF, 100 °C, 3 h, 63%. (c) NaH, DMF, 0 °C to rt, then Boc<sub>2</sub>O, DMF, 0 °C to rt, 18 h, 73%. (d) [PdCl<sub>2</sub>(dppf)]·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 17–18 h. <b>47</b>: 10%. <b>49</b>: 13%. (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 18 h, 88%.</p></p></figure><div class="NLM_p">To explore structural variations of the tricyclic core of <b>9</b>, one of the nitrogen atoms was shifted in the scaffold (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Starting from 4-chloro-5-iodopyrimidine (<b>50</b>) and 3-bromoaniline (<b>51</b>), intermediate <b>52</b> was obtained by nucleophilic aromatic substitution (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The intramolecular Pd-catalyzed direct arylation gave the tricyclic core of compound <b>53</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> that was reacted under Suzuki cross-coupling conditions with boronic acid <b>54</b> to lead to the final product <b>55</b> in moderate yield. Protection of the pyrrole-NH was not required for this step.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 9<i>H</i>-Pyrimido[4,5-<i>b</i>]indole <b>55</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, reflux, 3 h, 70%. (b) [Pd(OAc)<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>], NaOAc, DMA, microwave 130 °C, 4 h, 11%. (c) [PdCl<sub>2</sub>(dppf)]·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave 100 °C, 1 h, 20%.</p></p></figure><div class="NLM_p">Further modification of <b>2</b> was investigated by replacing the 6-fluoro-4-pyridin-3-yl moiety with unsaturated fluorinated, cyclic amines (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Thus, 1-acetyl-3-bromopiperidin-4-one (<b>56</b>) and (3-bromophenyl)hydrazine hydrochloride (<b>57</b>) were reacted in the presence of BF<sub>3</sub>·Et<sub>2</sub>O, leading to the formation of an inseparable mixture of regioisomers having the bromo atom in position 7 (<b>58a</b>) or 9 (<b>58b</b>) of the 5<i>H</i>-pyrido[4,3-<i>b</i>]indole scaffold. N-Tosylation to form <b>59</b> allowed for the chromatographic isolation of the desired regioisomer. Buchwald amination of <b>59</b> with 4-fluoropiperidine (<b>60</b>) resulted in the tosyl protected 5<i>H</i>-pyrido[4,3-<i>b</i>]indole <b>61</b>. The desired final product <b>62</b> was obtained after cleavage of the tosyl group.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 5<i>H</i>-Pyrido[4,3-<i>b</i>]indole <b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BF<sub>3</sub>·Et<sub>2</sub>O, 120 °C, 16 h, 69% (mixture of regioisomers). (b) NaH, DMF, 0 °C to rt, 30 min, then TsCl, rt, 1 h, 21%. (c) [Pd<sub>2</sub>(dba)<sub>3</sub>]·CHCl<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, THF, 90 °C, 16 h, 76%. (d) NaOH, THF/H<sub>2</sub>O, 50 °C, 20 h, then NaOH, MeOH, reflux 6 h, 25%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vitro Optimization of Binding Affinity and Physicochemical Properties</h3><div class="NLM_p">In order to test the affinity of novel compounds toward protein tau aggregates possessing the polymorphic form relevant for AD pathology, we set up a novel assay based on the displacement of [<sup>3</sup>H]<b>3</b> from immunohistologically characterized fresh frozen human brain sections derived from AD cases. Tritiation of <b>3</b> is described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Supporting Information</a> and delivered the radioligand in 99% radiochemical purity and a specific activity of 1.49 TBq/mmol (40.3 Ci/mmol). Novel compounds were tested at a concentration of 10 nM (results in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As expected, both <b>2</b> and <b>3</b> demonstrated good affinity by displacing 41% and 40% of radioligand ([<sup>3</sup>H]<b>3</b>) binding, respectively. The affinity of <b>3</b> for tau aggregates was previously reported with <i>K</i><sub>d</sub> = 22 nM,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> thus in a comparable range as found with our new assay. In addition to the primary binding affinity assay, lipophilicity (log <i>D</i>) and passive cell membrane permeability (P<sub>eff</sub> in the PAMPA assay<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>) were determined for all compounds and used to guide the optimization program. We complemented the standard octanol/water partition coefficient log <i>D</i> results with the measurement of LIMBA log <i>D</i><sub>brain</sub> in the novel brain lipid membrane binding assay LIMBA.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a><b>2</b> was found to be rather lipophilic, with log <i>D</i><sub>octanol</sub> = 3.28, and possessed a moderate passive permeability <i>P</i><sub>eff</sub> = 1.8 × 10<sup>–6</sup> cm s<sup>–1</sup>. By contrast, <b>3</b> had a lower log <i>D</i><sub>octanol</sub> = 2.80 and a higher <i>P</i><sub>eff</sub> = 4.6 × 10<sup>–6</sup> cm s<sup>–1</sup>. The initial goals for optimization were an increase in affinity combined with a decrease in lipophilicity to augment the specific to nonspecific binding ratio in a PET experiment and obtain a PAMPA <i>P</i><sub>eff</sub> > 2 × 10<sup>–6</sup> cm s<sup>–1</sup> to provide high and fast brain uptake.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Results for the Determination of Affinity,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> Lipophilicity (log <i>D</i>), Brain Lipid Membrane Binding (LIMBA log <i>D</i><sub>brain</sub>), and Passive Membrane Permeability (PAMPA)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0013.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0014.gif" alt="" id="GRAPHIC-d197e1381-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Displacement of [<sup>3</sup>H]<b>3</b> (10 nM) from fresh frozen human brain sections derived from AD cases; test concentration = 10 nM.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Determined at pH = 7.4.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">No data determined on account of the poor affinity for tau aggregates.</p></div></div><div></div></div><div class="NLM_p">Initial attempts to simplify the tricyclic core of <b>3</b> by replacement with a bicyclic imidazo[1,2-<i>a</i>]pyrimidine, flanked by an aromatic ring in position 2, led to the observation that very simple structures possessing a small amino group in position 6 of the bicyclic heteroaromatic ring system retained moderate to good affinity (<b>29</b>–<b>31</b>) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly and to our surprise a direct analogue of <b>3</b>, compound <b>36</b>, had only very modest affinity (14% ligand displacement). These novel structures had an optimal log <i>D</i> (1.42, 2.13, and 2.33 for <b>29</b>, <b>30</b>, and <b>31</b>, respectively), possessed excellent passive membrane permeability in the PAMPA assay (<i>P</i><sub>eff</sub> ≥ 4.2 × 10<sup>–6</sup> cm s<sup>–1</sup>), and had low molecular weight in the range of 210–238 g/mol, indicative of a high ligand efficiency LE.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> On the basis of these favorable properties, a large optimization program was started on this novel structural class. Attempts to shift one of the nitrogen atoms in the bicyclic ring to a different position led to compound <b>40</b> that had a similar affinity compared to <b>29</b>. To our delight, removal of one of the ring nitrogen atoms of <b>29</b>, giving imidazo[1,2-<i>a</i>]pyridine <b>16</b>, further increased affinity (58% ligand displacement vs 40% for reference <b>3</b>). Methylation of the amino group of <b>16</b> resulted in <b>17</b> and <b>19</b> which displayed similar high affinity (60% and 59% ligand displacement, respectively). All these novel imidazo[1,2-<i>a</i>]pyridines possessed appropriate lipophilicity (log <i>D</i> ≤ 2.64) in combination with excellent passive membrane permeability (<i>P</i><sub>eff</sub> ≥ 4.3 × 10<sup>–6</sup> cm s<sup>–1</sup>).</div><div class="NLM_p">Further modification of the lead structures of <b>29</b> (imidazo[1,2-<i>a</i>]pyrimidine) and <b>16</b> (imidazo[1,2-<i>a</i>]pyridine) to introduce positions for carbon-11 or fluorine-18 labeling finally led to the identification of compounds <b>7</b>, <b>8</b>, <b>22</b>, <b>34</b>, and <b>37</b>. When compared to <b>3</b>, these five ligands possessed comparable or better affinity for tau aggregates in combination with lower lipophilicity and thus were predicted to display a more favorable specific to nonspecific binding ratio (SB/NSB). All these structures exhibited very good passive membrane permeability in the PAMPA assay.</div><div class="NLM_p">In parallel to the work around leads <b>16</b> and <b>29</b> derived from <b>3</b>, attempts were made to modify the structure and improve the properties of <b>2</b>. Replacement of the 6-fluoropyridin-4-yl ring of <b>2</b> with several aliphatic amines was found to be detrimental, as exemplified by the 4-fluoropiperidine derivative <b>62</b>. Introduction of an additional nitrogen atom in the tricyclic core of <b>2</b> failed to give the desired properties in the case of final compound <b>55</b> but was successful for the regioisomeric derivative <b>9</b>. 9<i>H</i>-Dipyrido[2,3-<i>b</i>;3′,4′-<i>d</i>]pyrrole <b>9</b> maintained the high affinity (44% ligand displacement) in combination with a slight reduction of the lipophilicity (log <i>D</i> = 3.22). Passive membrane permeability of <b>9</b> was found to be good (PAMPA <i>P</i><sub>eff</sub> = 3.8 × 10<sup>–6</sup> cm s<sup>–1</sup>).</div><div class="NLM_p">A modest linear correlation was found between the results for log <i>D</i> and LIMBA log <i>D</i><sub>brain</sub> (LIMBA log <i>D</i><sub>brain</sub> = 0.27 + (0.42 log <i>D</i>); <i>r</i><sup>2</sup> = 0.32). Interestingly LIMBA log <i>D</i><sub>brain</sub> predicted all compounds to possess low nonspecific binding (i.e., LIMBA log <i>D</i><sub>brain</sub> < 2.0). By contrast, prediction based on log <i>D</i> would have erroneously flagged several compounds with log <i>D</i> > 3 to display high nonspecific binding.<a onclick="showRef(event, 'ref29 ref30 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref34">(29, 30, 34)</a></div><div class="NLM_p last">During the course of the program, approximately 550 novel compounds originating from the structural classes discussed above were prepared and tested. In the light of the favorable in vitro properties and a reasonably good predicted chance to incorporate a <sup>11</sup>C or <sup>18</sup>F radionuclide, the six lead tracer molecules <b>7</b>–<b>9</b>, <b>22</b>, <b>34</b>, and <b>37</b> were selected for further profiling by in vitro autoradiography of <sup>3</sup>H-labeled material, in depth pharmacokinetic (PK) evaluation, and PET imaging in non-human primates.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Transport and in Vivo Pharmacokinetic Profile</h3><div class="NLM_p">The in vitro transport and in vivo drug pharmacokinetic profiles for the reference <b>3</b> and the six lead tracer candidates <b>7</b>–<b>9</b>, <b>22</b>, <b>34</b>, and <b>37</b> are summarized in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Pharmacokinetics in mice after single intravenous (iv) bolus administration were studied at a relatively low dose (∼1 mg/kg) to better reflect the microdosing conditions encountered in a human PET experiment, yet without compromising the quantification of the compound concentration in the biological samples. As reported in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, the tested compounds showed high systemic plasma clearance in mouse in vivo studies typically exceeding liver blood flow, and short terminal plasma half-lives ranging between 0.20 > <i>t</i><sub>1/2</sub> > 0.43 h, thus being appropriate for use with a carbon-11 (isotope decay <i>t</i><sub>1/2</sub> = 20 min) or fluorine-18 (<i>t</i><sub>1/2</sub> = 110 min) label. By use of physiologically based PK modeling that integrates drug physicochemical properties, animal/human in vitro input, and in vivo PK data from various species (data not shown), compounds <b>7</b>–<b>9</b> were expected to undergo high systemic clearance in humans. The same model predicted a short terminal half-life of ∼2 h and a large tissue distribution, all properties that were considered appropriate for a PET tracer.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Mouse Single-Dose PK Parameters in Plasma (iv Bolus Administration), in Vitro P-gp Efflux Ratios (ER), and Plasma Free Fractions (<i>f</i><sub>u_p</sub>) of Compounds <b>3</b>, <b>7</b>–<b>9</b>, <b>22</b>, <b>34</b>, and <b>37</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">P-gp ER</th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>f</i><sub>u_p</sub> [%]</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">iv dose [mg/kg]</th><th class="colsep0 rowsep0" align="center" char=".">terminal <i>t</i><sub>1/2</sub> [h]</th><th class="colsep0 rowsep0" align="center" char=".">total plasma Cl [mL min<sup>–1</sup> kg<sup>–1</sup>]</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> [L/kg]</th><th class="colsep0 rowsep0" align="center" char=".">brain/plasma total concn ratio (AUC<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>)</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">0.27</td><td class="colsep0 rowsep0" align="char" char=".">114</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">207</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">541</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.20</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">AUC: area under the concentration–time curve.</p></div></div></div><div class="NLM_p">Both in vitro transport and in vivo brain uptake studies in animals (methods in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Supporting Information</a>) confirmed the compounds not to be recognized by the efflux transporter P-glycoprotein (P-gp, mouse and human), to possess high passive cellular and PAMPA permeability and large distribution volume in vivo, and were therefore predicted to reach rapidly the brain in human.</div><div class="NLM_p last">Free fractions (<i>f</i><sub>u_p</sub>, method in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Supporting Information</a>) for the new tracer candidates in mouse and human plasma were high, in general >10%, in contrast to the reference compound <b>3</b>. High <i>f</i><sub>u_p</sub> was deemed to be of advantage in order to facilitate rapid in vivo clearance of the ligands from nonspecifically bound and free compartments, both contributing to confound the specific binding component in the PET images.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Furthermore, the high <i>f</i><sub>u_p</sub> values together with the lack of interaction with P-gp and high in vitro permeability were considered to be beneficial in promoting rapid brain uptake and large unbound fraction/low nonspecific binding in brain.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> In fact, most compounds possessed total brain to plasma AUC ratios (<i>B</i>/<i>P</i>) in rodents of >1, with the exception of <b>37</b>. A <i>B</i>/<i>P</i> of 0.5 for the latter compound was deemed to be still sufficient to progress <b>37</b> into further tests.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Tritiation of Lead Tracer Molecules</h3><div class="NLM_p">In order to allow for a detailed and high resolution in vitro autoradiographical characterization of the novel tracer candidates, the molecules were initially labeled with tritium. Five out of the six compounds were labeled by a hydrogen–tritium exchange reaction directed by the adjacent nitrogen-containing heterocycles. The well-known Crabtree’s catalyst ([Ir(COD)(PCy<sub>3</sub>)(Py)]PF<sub>6</sub>) was used in superstoichiometric amounts to promote the labeling and achieve high specific activity (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Thus, [<sup>3</sup>H]<b>7</b>, [<sup>3</sup>H]<b>9</b>, [<sup>3</sup>H]<b>22</b>, [<sup>3</sup>H]<b>34</b>, and [<sup>3</sup>H]<b>37</b> were obtained in specific activities ranging from 900 to 2000 GBq/mmol. The position of the label was assigned based on mechanistic considerations, knowing that C–H activation and isotope exchange require the proximity of a heteroatom for complexation of the Ir atom and preferably proceed via five-membered cyclometalated Ir<sup>III</sup> species.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Radioligand [<sup>3</sup>H]<b>8</b> was prepared in high specific activity (SA = 2600 GBq/mmol) by methylation of <b>32</b> with [<sup>3</sup>H]methylnosylate.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Representative Tritiations As Exemplified for the Preparation of [<sup>3</sup>H]<b>8</b>, [<sup>3</sup>H]<b>9</b>, and [<sup>3</sup>H]<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [<sup>3</sup>H]MeONs, Cs<sub>2</sub>CO<sub>3</sub>, toluene, rt, 24 h. (b) [<sup>3</sup>H]H<sub>2</sub>, [Ir(COD)(PCy<sub>3</sub>)(Py)]PF<sub>6</sub>, DCM/DMF, rt, 4 h.</p></p></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Autoradiography of Tritiated Compounds and Selectivity Testing by Antibody Colocalization Studies</h3><div class="NLM_p">All tritiated compounds were evaluated by in vitro autoradiography using native fresh-frozen brain sections originating from late-stage AD patients (with high tau load) and healthy control subjects (devoid of tau pathology) in order to evaluate (i) tracer binding to tau aggregates, (ii) nonspecific binding (NSB), and (iii) lack of binding to other targets, in particular to Aβ plaques. Analogous experiments performed on brain sections originating from two transgenic mouse tauopathy models, Tg4510 and TauPS2APP, revealed a lack of binding of the radioligands to the forms of tau present in these animals. Results for the reference [<sup>3</sup>H]<b>3</b> are included here for comparison, although extensive characterization and validation of this tool compound was done earlier in the project. The results are summarized in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. All radioligands were tested at a concentration of 3 nM. On first visual inspection of the macroscopic autoradiographies, all novel radioligands displayed a binding pattern in AD tissue sections similar to the reference [<sup>3</sup>H]<b>3</b>. This binding pattern in cortical tissue sections is characterized by a layered distribution and correlates with the distribution of tau aggregates (neurofibrillary tangles and neuropil threads) as visualized by immunohistochemical analysis with a tau-specific antibody (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Specificity of radioligand binding to tau aggregates and absence of significant off-target binding to any other CNS target were suggested by very low binding to cortical tissue sections from healthy control subjects (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, bottom row). Among the six candidates some differences in NSB levels in healthy control tissue were observed. [<sup>3</sup>H]<b>9</b> displayed the lowest NSB among all tracer candidates. Specific binding (SB) to tau aggregates was assessed by quantifying the difference in binding to tau-rich cortical gray matter (GM) in AD tissue versus tau-poor cortical tissue of healthy controls. Highest SB values of 9726 fmol/mg protein were identified for [<sup>3</sup>H]<b>7</b> followed by [<sup>3</sup>H]<b>9</b> and [<sup>3</sup>H]<b>8</b> (SB = 5905 and 5500 fmol/mg protein, respectively). Overall, SB correlated well with the affinity of the compounds as determined by the competition of [<sup>3</sup>H]<b>3</b> binding (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The binding of all six radioligand candidates in advanced AD (Braak V staging<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>) tissue sections was also characterized by low NSB in white matter (WM) yielding excellent signal-to-noise ratios (SNR) and image contrast in vitro. The SNR was quantitatively assessed by calculating GM over WM ratios of radioligand binding to AD Braak V cortical tissue sections. All compounds possessed favorable GM/WM ratios above or equal to 5, with the highest values found for [<sup>3</sup>H]<b>34</b> (GM/WM = 14) and [<sup>3</sup>H]<b>7</b> and [<sup>3</sup>H]<b>9</b> (GM/WM = 11).</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro autoradiography of the reference tracer [<sup>3</sup>H]<b>3</b> and all six test ligands (<b>7</b>–<b>9</b>, <b>22</b>, <b>34</b>, and <b>37</b>) in tritiated form using native cortical tissue sections from an AD Braak V patient (top row) and a healthy control subject (bottom row). The radioligand concentration was 3 nM for all compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Colocalization of tau mAb pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (A) and Aβ mAb BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (C) immunohistochemical staining with autoradiographical tracer binding (B) of [<sup>3</sup>H]<b>8</b>, as a representative example. Staining and binding experiments were performed on a single fresh-frozen tissue section from an AD Braak V cortical tissue block. The detail (D) shows the autoradiography superimposed with tau mAb (red) and Aβ mAb staining (green). The black radioactive binding signal colocalizes mainly with the tau mAb staining.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">High binding selectivity of the tritiated ligands for tau versus Aβ aggregates was demonstrated by colocalization experiments, assessed by autoradiography and immunohistochemistry on the same tissue section on both macroscopic and microscopic scale (<a class="ref internalNav" href="#fig3" aria-label="Figures 3">Figures 3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). For immunohistochemistry staining of NFTs and Aβ plaques the proprietary tau- and Aβ- specific antibodies pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were used. All compounds possessed excellent selectivity for aggregated tau without any evidence of binding to Aβ plaques. Representative images of one radioligand ([<sup>3</sup>H]<b>8</b>) are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Colocalization of tau mAb pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (A) and Aβ mAb BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (C) immunohistochemical staining with microautoradiographical tracer binding (B) of [<sup>3</sup>H]<b>8</b>, as a representative example. Staining and binding experiments were performed on a single fresh-frozen tissue section from an AD Braak V cortical tissue block. The detail (D) shows the microautoradiographical signal superimposed with tau mAb staining (red). The black silver grain deposits (representing radioligand binding) colocalize with tau mAb staining, while areas of Aβ mAb staining (dotted circle in B) do not colocalize with microautoradiographical signals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Radiochemical Synthesis of [<sup>11</sup>C]- and [<sup>18</sup>F]-Labeled Compounds</h3><div class="NLM_p">A radiosynthesis was established for five out of the six lead tracer candidates to introduce a fluorine-18 or a carbon-11 nuclide (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). In the case of compound <b>37</b>, offering in principle the possibility for labeling with any of the two radioisotopes, fluorine-18 was preferred on account of the longer decay half-life, facilitating the logistics of tracer use, and lower positron emission energy, leading to higher spatial resolution of PET images. A robust radiomethylation procedure for compound <b>22</b> could not be established in the short time frame of the project, and further work to progress this candidate was thus stopped.</div><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Carbon-11 and Fluorine-18 Tracers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [<sup>11</sup>C]MeI, NaH, DMF, 80 °C, 3 min; (b) [<sup>11</sup>C]MeI, 6 N NaOH, DMSO, 80 °C, 3 min; (c) [<sup>18</sup>F]KF, Kryptofix 2.2.2, DMSO, microwave 50 W, 4 min; (d) [<sup>18</sup>F]KF, Kryptofix 2.2.2, DMSO, microwave 50 W, 80 s.</p></p></figure><div class="NLM_p">The final product [<sup>11</sup>C]<b>7</b> was isolated in an average nondecay corrected yield of 26% (<i>n</i> = 3) in 33 min. The final product average specific radioactivity was 15 987 mCi/μmol (592 GBq/μmol) with a radiochemical purity of 97%. The average concentration of carrier <b>7</b> and precursor was 0.132 μg/mL and 0.009 μg/mL, respectively. Initial developmental radiosyntheses showed [<sup>11</sup>C]<b>7</b> was susceptible to radiolysis during the standard semipreparative HPLC and solid phase extraction (SPE) formulation. With a change of the HPLC solvent from an acetonitrile/triethylamine buffer to an ethanol/triethylamine buffer eluent system, the radiolysis during the semipreparative HPLC was reduced dramatically. Also, a significant reduction in radiolysis was observed by including ascorbic acid during the SPE isolation and formulation procedure. No significant radiolysis was observed during the validation 40 min stability tests.</div><div class="NLM_p">The final product [<sup>11</sup>C]<b>8</b> was isolated in an average nondecay corrected yield of 6.3% (<i>n</i> = 16) in 33 min. The final product had an average specific radioactivity of 14 080 mCi/μmol (521 GBq/μmol) and radiochemical purity of 95.5%. The average concentration of carrier product and precursor was 0.099 μg/mL and 0.009 μg/mL, respectively. As this radiotracer product was also susceptible to radiolysis, ascorbic acid was used in the formulation to eliminate this degradation.</div><div class="NLM_p">By use of the microwave radiofluorination module, [<sup>18</sup>F]<b>9</b> was isolated in an average nondecay corrected yield of 20.3% (<i>n</i> = 42) in 59 min. The final product had average specific radioactivity of 41 901 mCi/μmol (1550 GBq/μmol) and radiochemical purity of 100%. The average concentration of carrier and precursor was 0.199 μg/mL and 0.010 μg/mL, respectively. Since many PET radiotracer programs do not have access to microwave heating for radiofluorinations, we selected to test the synthesis of [<sup>18</sup>F]<b>9</b> using an easily programmed, flexible radiosynthesizer platform (Sofie ELIXYS). By use of the ELIXYS, [<sup>18</sup>F]<b>9</b> was isolated in an average nondecay corrected yield of 30.8% (<i>n</i> = 5) in 70 min. The final product had an average specific radioactivity of 141 720 mCi/μmol (5243 GBq/μmol) and radiochemical purity of 100%. The average concentration of carrier and precursor was 0.0342 μg/mL and 0.0314 μg/mL, respectively.</div><div class="NLM_p">[<sup>11</sup>C]<b>34</b> had an average nondecay corrected yield of 7.5% (<i>n</i> = 4) in 33 min with an average specific radioactivity of 16 848 mCi/μmol (610 GBq/μmol) and radiochemical purity of 97.7%. The average concentration of carrier and precursor was 0.059 μg/mL and 0.003 μg/mL, respectively. In the initial radiosynthesis of [<sup>11</sup>C]<b>34</b>, analytical HPLC showed the final product with less than 90% radiochemical purity. As was done with [<sup>11</sup>C]<b>8</b>, the addition of ascorbic acid in the product collection flask of the SPE formulation system increased the radiochemical and chemical purity of the final radiotracer product. Minimal change in radiochemical purity was observed in the validation 40 min stability test.</div><div class="NLM_p last">[<sup>18</sup>F]<b>37</b> was isolated in an average nondecay corrected yield of 25% (<i>n</i> = 2) in 40 min. The final product had an average specific radioactivity of 49 750 mCi/μmol (1841 GBq/μmol) and radiochemical purity of 96%. The average concentration of carrier was 0.057 μg/mL, and no residual precursor was observed.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> PET Imaging in Non-Human Primates</h3><div class="NLM_p">PET studies in tau-naive baboons demonstrated favorable pharmacokinetic properties for three out of five tracer candidates. [<sup>11</sup>C]<b>7</b>, [<sup>11</sup>C]<b>8</b>, and [<sup>18</sup>F]<b>9</b> were characterized by good uptake in the baboon brain with peak SUVs between 1.1 and 2.0 immediately after tracer injection and scan initiation and rapid clearance of radioactivity from the baboon brain with [<sup>18</sup>F]<b>9</b> showing the fastest washout (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). All three tracer candidates were characterized by a homogeneous distribution of the radioactivity in different brain regions, as expected in the absence of tau aggregates in the animals. Tracer candidate [<sup>11</sup>C]<b>34</b> displayed moderate brain uptake (peak SUV of 1.2), but the whole brain time–activity curve slightly increased at time points later than 20 min, suggesting the generation and accumulation of a blood–brain barrier penetrating radiometabolite which counteracts the washout of the parent compound. The time–activity curve for [<sup>18</sup>F]<b>37</b> showed minimal brain uptake, followed by a steady increase of radioactivity uptake in the brain, which clearly points to the generation of a lipophilic radiometabolite that penetrates the blood–brain barrier and slowly accumulates in the brain. The unfavorable kinetic profile of [<sup>11</sup>C]<b>34</b> and [<sup>18</sup>F]<b>37</b> led to the exclusion of these two tracer candidates from further development.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time–activity curves of the whole gray matter of candidate radioligands as determined in a baboon PET study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88352" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88352" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a lead optimization program has led to the identification of six promising PET tracer candidates for imaging of tau aggregates in AD. These novel structures possess high specificity and affinity for tau aggregates and an excellent selectivity against Aβ plaques. Further characterization of the compounds indicated the three tracers [<sup>11</sup>C]<b>7</b>, [<sup>11</sup>C]<b>8</b>, and [<sup>18</sup>F]<b>9</b> to be of particular interest. In addition to the highly favorable binding properties to pathological tau aggregates, these three radioligands possess appropriate pharmacokinetic properties and good brain uptake in rodents and non-human primates, followed by fast systemic clearance. On the basis of the favorable profile, the three radiotracers were progressed into clinical validation studies in Alzheimer’s disease patients (ClinicalTrials.gov identifier: NCT02187627). The results of this work will be communicated in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Chemical Synthesis of Cold Compounds</h3><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Methods</h4><div class="NLM_p last">Unless otherwise noted, all reagents and chemicals were obtained from commercial suppliers and used without further purification. Nonaqueous reactions were carried out under an inert atmosphere of Ar or N<sub>2</sub>. Microwave heating of reactions was carried out on a Biotage Initiator apparatus. Reactions were monitored by TLC (TLC plates F254, Merck) or LC–MS (liquid chromatography–mass spectrometry) analysis. Flash column chromatography was carried out using cartridges packed with silica gel (Isolute columns, Telos flash columns) on an ISCO machine or on glass columns on silica gel 60 (32–60 mesh, 60 Å). The purity of final compounds was determined by HPLC and was at least above 95%. LC–high-resolution MS spectra were recorded with an Agilent LC system consisting of an Agilent 1290 high-pressure system, a CTC PAL autosampler, and an Agilent 6520 QTOF. The separation was achieved on a Zorbax Eclipse Plus C18 1.7 μm, 2.1 mm × 50 mm column at 55 °C (A = 0.01% formic acid in water; B = 0.01% formic acid in acetonitrile) at a flow of 1 mL/min with the following gradient: 0 min, 5% B; 0.3 min, 5% B; 4.5 min, 99% B; 5 min, 99% B. <sup>1</sup>H NMR spectra were measured on a Bruker 300 MHz instrument, a Bruker 600 MHz instrument in a 5 mm TCI cryoprobe at 298 K, or a Bruker Avance 400 MHz. A TMS internal standard was used for experiments done in CDCl<sub>3</sub>. The deuterated DMSO-<i>d</i><sub>6</sub> solvent signal was used as the reference with 2.50 ppm.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-(4-Methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine (<b>7</b>)</h4><div class="NLM_p last">A vial was charged with pyridine-2,4-diamine (<b>11</b>) (400 mg, 3.67 mmol), 2-bromo-1-(4-methoxyphenyl)ethanone (<b>14</b>) (882 mg, 3.85 mmol), NaHCO<sub>3</sub> (329 mg, 3.92 mmol), and MeOH (3.5 mL). The reaction mixture was stirred at reflux for 4 h. After cooling to rt, the mixture was diluted with water and EtOAc, sonicated, and stirred at room temperature for 15 min. The solids were collected by filtration, then rinsed with H<sub>2</sub>O and EtOAc. The resulting pale yellow solid was dried under high vacuum to afford 2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine (<b>7</b>) hydrobromide. This material was suspended in 5 mL of saturated aq NaHCO<sub>3</sub>, sonicated, filtered, and washed with H<sub>2</sub>O. The residue was suspended in 5 mL of aq 2 M NaOH, sonicated, filtered, and rinsed with water. The resulting residue was put under high vacuum to afford 2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine (<b>7</b>) as a light brown solid (310 mg, 35%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 7.07 Hz, 1H), 7.83 (s, 1H), 7.77 (d, <i>J</i> = 8.68 Hz, 2H), 6.94 (d, <i>J</i> = 8.68 Hz, 2H), 6.31–6.36 (m, 2H), 5.60 (s, 2H), 3.77 (s, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub>O + H<sup>+</sup>, 240.1132; found, 240.1134; Diff 0.2 mDa.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-Methyl-2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>8</b>)</h4><div class="NLM_p last"><i>N</i>4-Methylpyrimidine-2,4-diamine (<b>25</b>) (900 mg, 7.25 mmol) and 2-bromo-1-<i>m</i>-tolylethanone (1.62 g, 7.61 mmol) were combined with acetone (14 mL) under Ar and stirred overnight at 65 °C. The reaction mixture was cooled to rt and extracted with DCM and saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was back-extracted four times with DCM adding each time a small amount of MeOH. The solid still present in the aqueous layer was filtered off. The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, combined with the filtered solid, and concentrated. The residue was absorbed on 12 g silica gel and loaded on a chromatography column for purification (50 g SiO<sub>2</sub>, DCM to DCM/MeOH, 0–5% MeOH gradient). The product was further purified by trituration with MeOH and EtOAc, then dried on the high vacuum to afford <i>N</i>-methyl-2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>8</b>) (1.18 g, 65% yield) as a light yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (d, <i>J</i> = 7.27 Hz, 1H), 7.79 (s, 1H), 7.68 (s, 1H), 7.63 (d, <i>J</i> = 7.87 Hz, 1H), 7.39 (q, <i>J</i> = 4.64 Hz, 1H), 7.27 (t, <i>J</i> = 7.60 Hz, 1H), 7.06 (d, <i>J</i> = 7.67 Hz, 1H), 6.26 (d, <i>J</i> = 7.47 Hz, 1H), 2.85 (d, <i>J</i> = 4.84 Hz, 3H), 2.34 (s, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>14</sub>N<sub>4</sub> + H<sup>+</sup>, 239.1291; found, 239.1295; Diff, 0.4 mDa.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-(6-Fluoropyridin-3-yl)-9<i>H</i>-dipyrido[2,3-<i>b</i>;3′,4′-<i>d</i>]pyrrole (<b>9</b>)</h4><div class="NLM_p last">A solution of 2-(6-fluoropyridin-3-yl)-dipyrido[2,3-<i>b</i>;3′,4′-<i>d</i>]pyrrole-9-carboxylic acid <i>tert</i>-butyl ester (<b>47</b>) (22 mg, 60 μmol) and TFA (33.3 μL, 432 μmol) in DCM (0.5 mL) was stirred at rt overnight. After cooling to 0 °C, Et<sub>3</sub>N (70 μL, 503 μmol) was added and all volatiles were removed. The crude material was purified by preparative HPLC (YMC Triart C18 100 mm × 30 mm, 5 μm; H<sub>2</sub>O, 0.1% Et<sub>3</sub>N/MeCN gradient) to afford 2-(6-fluoropyridin-3-yl)-9<i>H</i>-dipyrido[2,3-<i>b</i>;3′,4′-<i>d</i>]pyrrole (<b>9</b>) as off-white solid (14 mg, 88%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.43 (br s, 1H), 9.41 (s, 1H), 9.04 (d, <i>J</i> = 2.62 Hz, 1H), 8.76 (d, <i>J</i> = 8.06 Hz, 1H), 8.74 (dt, <i>J</i> = 2.50, 8.30 Hz, 1H), 8.52 (d, <i>J</i> = 5.64 Hz, 1H), 8.02 (d, <i>J</i> = 8.06 Hz, 1H), 7.51 (dd, <i>J</i> = 0.91, 5.64 Hz, 1H), 7.37 (dd, <i>J</i> = 2.72, 8.56 Hz, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>9</sub>FN<sub>4</sub> + H<sup>+</sup>, 265.0884; found, 265.0888; Diff, 0.4 mDa.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-<i>N</i>-Methylpyridine-2,4-diamine (<b>12</b>)</h4><div class="NLM_p last">2-Amino-4-chloropyridine (<b>10</b>) (15.0 g, 117 mmol) and methanamine, 40 wt % in H<sub>2</sub>O (67.4 g, 75 mL, 868 mmol), were combined in an autoclave and stirred 4 h at 160 °C. After cooling to rt, the solution was treated with Na<sub>2</sub>CO<sub>3</sub> (10 g) and was extracted 10 times with DCM (50 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. After evaporation of the solvent, the residue was taken up in EtOAc (50 mL) and was heated to 60 °C. Then heptane (10 mL) was added. After stirring at rt for 2 h, solids were collected by filtration and washed with EtOAc/Hept 9:1. More product was obtained after adding heptane to the filtrate. 4-<i>N</i>-Methylpyridine-2,4-diamine (<b>12</b>) was isolated as a light brown solid (10.8 g, 75%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.44 (d, <i>J</i> = 5.84 Hz, 1H), 6.02 (br d, <i>J</i> = 4.73 Hz, 1H), 5.79 (dd, <i>J</i> = 2.12, 5.84 Hz, 1H), 5.50 (d, <i>J</i> = 2.01 Hz, 1H), 5.31 (s, 2H), 2.61 (d, <i>J</i> = 4.94 Hz, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>6</sub>H<sub>9</sub>N<sub>3</sub> + H<sup>+</sup>, 124.0869; found, 124.0869; Diff, 0.0 mDa.</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Phenylimidazo[1,2-<i>a</i>]pyridin-7-ylamine (<b>16</b>)</h4><div class="NLM_p last">2,4-Diaminopyridine (<b>11</b>) (3.00 g, 27.5 mmol) was combined with acetone (150 mL) to give a colorless solution. 2-Bromo-1-phenylethanone (<b>13</b>) (8.21 g, 41.2 mmol) was added to give a white suspension. The reaction mixture was heated under Ar to 65 °C and stirred for 5.5 h. Solids were collected by filtration and washed with acetone (45 mL), then dissolved in H<sub>2</sub>O (150 mL) and treated with 25% aqueous NH<sub>4</sub>OH (135 mL). The resulting suspension was filtered and washed with H<sub>2</sub>O (45 mL). The product was dried overnight under high vacuum to yield 2-phenylimidazo[1,2-<i>a</i>]pyridin-7-ylamine (<b>16</b>) as an off-white powder (5.17 g, 90%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.12 (d, <i>J</i> = 7.96 Hz, 1H), 7.95 (s, 1H), 7.85 (d, <i>J</i> = 7.57 Hz, 2H), 7.37 (t, <i>J</i> = 7.44 Hz, 2H), 7.24 (t, <i>J</i> = 7.35 Hz, 1H), 6.34–6.37 (m, 2H), 5.64 (br s, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>11</sub>N<sub>3</sub> + H<sup>+</sup>, 210.1026; found, 210.1029; Diff, 0.3 mDa.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-Methyl-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>17</b>)</h4><div class="NLM_p last"><i>N</i>4-Methylpyridine-2,4-diamine (<b>12</b>) (153 mg, 1.24 mmol) and 2-bromo-1-phenylethanone (<b>13</b>) (247 mg, 1.24 mmol) were combined in a reaction flask, and acetone (2.5 mL) was added. The vessel was sealed and heated for 5 h at 70 °C. Solids were collected by filtration and washed with acetone. The product was purified by preparative HPLC (Gemini NX 3u, 50 mm × 4.6 mm; MeOH/5% Et<sub>3</sub>N in H<sub>2</sub>O from 20:80 to 98:2) to give <i>N</i>-methyl-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>17</b>) as white solid (125 mg, 44%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (d, <i>J</i> = 7.22 Hz, 1H), 7.95 (s, 1H), 7.86 (d, <i>J</i> = 7.85 Hz, 2H), 7.32–7.43 (m, 2H), 7.20–7.28 (m, 1H), 6.36 (dd, <i>J</i> = 2.22, 7.47 Hz, 1H), 6.23 (q, <i>J</i> = 4.84 Hz, 1H), 6.18 (d, <i>J</i> = 2.02 Hz, 1H), 2.72 (d, <i>J</i> = 4.84 Hz, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>13</sub>N<sub>3</sub> + H<sup>+</sup>, 224.1182; found, 224.1183; Diff, 0.1 mDa.</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(7-Aminoimidazo[1,2-<i>a</i>]pyridin-2-yl)phenol (<b>18</b>)</h4><div class="NLM_p last">A vial was charged with pyridine-2,4-diamine (<b>11</b>) (0.300 g, 2.75 mmol), 2-bromo-1-(4-hydroxyphenyl)ethanone (<b>15</b>) (615 mg, 2.86 mmol), and EtOH (4.0 mL). The vial was flushed with Ar, closed, and heated at 70 °C overnight. The reaction mixture was cooled to rt and concentrated. The residue was suspended in H<sub>2</sub>O and a small amount of EtOAc. 25% aqueous NH<sub>4</sub>OH was added until neutral pH was obtained. The suspension was filtered and washed with H<sub>2</sub>O and a small amount EtOAc and finally put under high vacuum. The residue was purified by HPLC (Gemini NX 3u 50 mm × 4.6 mm; MeOH/5% Et<sub>3</sub>N in H<sub>2</sub>O from 20:80 to 98:2). Finally, trituration with EtOAc containing a few drops of MeOH and drying on the high vacuum afforded 4-(7-aminoimidazo[1,2-<i>a</i>]pyridin-2-yl)phenol (<b>18</b>) as a light brown solid (134 mg, 22% yield). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.43 (s, 1H), 8.07–8.10 (m, 1H), 7.77 (s, 1H), 7.65 (d, <i>J</i> = 8.07 Hz, 2H), 6.77 (d, <i>J</i> = 8.08 Hz, 2H), 6.32–6.37 (m, 2H), 5.62 (br s, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>11</sub>N<sub>3</sub>O + H<sup>+</sup>, 226.0975; found, 226.0976; Diff, 0.1 mDa.</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>,<i>N</i>-Dimethyl-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>19</b>)</h4><div class="NLM_p last">To a solution under N<sub>2</sub> of 2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>16</b>) (500 mg, 2.39 mmol) in DMF (2 mL) was added NaH (60%, 172 mg, 4.30 mmol). After stirring at rt for 30 min, MeI (611 mg, 269 μL, 4.30 mmol) was added and the mixture was stirred in a closed flask for 18 h. The reaction mixture was concentrated and adsorbed on Isolute for purification by flash chromatography (Flashpack cartridge, 20 g amino modified SiO<sub>2</sub>; heptane/DCM 4:1 to DCM). <i>N</i>,<i>N</i>-Dimethyl-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>19</b>) was isolated as light brown solid (35 mg, 6%) next to <i>N</i>-methyl-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>17</b>) (42 mg, 8%) as brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (d, <i>J</i> = 7.47 Hz, 1H), 8.02 (s, 1H), 7.85–7.91 (m, 2H), 7.39 (t, <i>J</i> = 7.57 Hz, 2H), 7.25 (t, <i>J</i> = 7.27 Hz, 1H), 6.69 (dd, <i>J</i> = 2.52, 7.57 Hz, 1H), 6.44 (d, <i>J</i> = 2.42 Hz, 1H), 2.97 (s, 6H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>15</sub>N<sub>3</sub> + H<sup>+</sup>, 238.1339; found, 238.1343; Diff, 0.4 mDa.</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 2-Phenylimidazo[1,2-<i>a</i>]pyridin-7-ylcarbamate (<b>20</b>)</h4><div class="NLM_p last">2-Phenylimidazo[1,2-<i>a</i>]pyridin-7-amine hydrobromide (<b>16</b>·HBr) (720 mg, 2.36 mmol) was suspended in 5.0 mL of THF and cooled to 0 °C. LiHMDS (1 M solution in THF, 7.5 mL, 7.5 mmol) was added dropwise over a period of 25 min at 0 °C. Then Boc<sub>2</sub>O (566 mg, 2.59 mml) dissolved in 2.0 mL of THF was added over a period of 5 min. After the addition was complete, the ice bath was removed and the reaction mixture was stirred at rt for 1.5 h. The reaction mixture was quenched with 5 mL of water and extracted with DCM (30 mL) and saturated aqueous NH<sub>4</sub>Cl (15 mL). The aqueous layer was extracted with two more portions of DCM (30 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by chromatography (40 g SiO<sub>2</sub>; DCM to 5% MeOH in DCM). <i>tert</i>-Butyl 2-phenylimidazo[1,2-<i>a</i>]pyridin-7-ylcarbamate (<b>20</b>) (482 mg, 66%) was obtained as a light brown solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 1H), 8.37 (d, <i>J</i> = 7.47 Hz, 1H), 8.21 (s, 1H), 7.92 (d, <i>J</i> = 7.06 Hz, 2H), 7.66 (s, 1H), 7.41 (t, <i>J</i> = 7.54 Hz, 2H), 7.24–7.34 (m, 1H), 6.98 (dd, <i>J</i> = 2.02, 7.47 Hz, 1H), 1.51 (s, 9H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> + H<sup>+</sup>, 309.1477; found, 309.1486; Diff, 0.9 mDa.</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 2-Fluoroethyl(2-phenylimidazo[1,2-<i>a</i>]pyridin-7-yl)carbamate (<b>21</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 2-phenylimidazo[1,2-<i>a</i>]pyridin-7-ylcarbamate (<b>20</b>) (1.35 g, 4.36 mmol) was dissolved in 12 mL of DMF (12 mL). NaH (∼55% dispersion in mineral oil, 286 mg, 6.55 mmol) was added, and the reaction mixture was stirred at rt for 15 min. 1-Bromo-2-fluoroethane (833 mg, 0.49 mL, 6.56 mmol) was added dropwise, and the reaction mixture was stirred 1 h at 50 °C. The reaction mixture was cooled to rt, diluted with H<sub>2</sub>O (10 mL), and extracted with EtOAc (100 mL). The aqueous layer was back-extracted with EtOAc (100 mL). The organic layers were washed four times with H<sub>2</sub>O (10 mL) and once with brine (10 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by chromatography (120 g SiO<sub>2</sub>; DCM to DCM/5% MeOH). All fractions containing product were combined and concentrated. The residue was triturated with EtOAc to afford <i>tert</i>-butyl 2-fluoroethyl(2-phenylimidazo[1,2-<i>a</i>]pyridin-7-yl)carbamate (<b>21</b>) as an off-white solid (1.05 g, 68%). The filtrate was concentrated to afford an additional portion of <i>tert</i>-butyl 2-fluoroethyl(2-phenylimidazo[1,2-<i>a</i>]pyridin-7-yl)carbamate (<b>21</b>) (0.416 g, 27%) as a light brown solid. Total yield 95%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 7.27 Hz, 1H), 8.36 (s, 1H), 7.92–7.98 (m, 2H), 7.41–7.49 (m, 3H), 7.29–7.36 (m, 1H), 6.86 (dd, <i>J</i> = 2.22, 7.27 Hz, 1H), 4.58 (td, <i>J</i> = 5.00, 47.40 Hz, 2H), 3.98 (td, <i>J</i> = 4.60, 26.20 Hz, 2H), 1.42 (s, 9H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub> + H<sup>+</sup>, 356.1769; found, 356.1774; Diff, 0.5 mDa.</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-(2-Fluoroethyl)-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>22</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 2-fluoroethyl(2-phenylimidazo[1,2-<i>a</i>]pyridin-7-yl)carbamate (<b>21)</b> (1.38 g, 3.88 mmol) was dissolved in 8.0 mL of DCM. TFA (8.88 g, 6.0 mL, 77.9 mmol) was added dropwise, and the reaction mixture was stirred at rt for 3 h. The reaction mixture was concentrated. The residue (light brown solid) was extracted with DCM and saturated aqueous Na<sub>2</sub>CO<sub>3</sub>. The aqueous layer was back-extracted twice with DCM. The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was triturated with DCM to afford <i>N</i>-(2-fluoroethyl)-2-phenylimidazo[1,2-<i>a</i>]pyridin-7-amine (<b>22</b>) (918 mg, 93% yield) as an off-white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.14 (d, <i>J</i> = 7.47 Hz, 1H), 7.97 (s, 1H), 7.79–7.92 (m, 2H), 7.33–7.42 (m, 2H), 7.18–7.31 (m, 1H), 6.45 (dd, <i>J</i> = 2.40, 7.50 Hz, 1H), 6.39–6.45 (m, 1H), 6.34 (d, <i>J</i> = 1.82 Hz, 1H), 4.61 (td, <i>J</i> = 4.90, 47.60 Hz, 2H), 3.41 (qd, <i>J</i> = 5.05, 28.06 Hz, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>14</sub>F N<sub>3</sub> + H<sup>+</sup>, 256.1245; found, 256.1246; Diff, 0.1 mDa.</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>4-Methylpyrimidine-2,4-diamine (<b>25</b>)</h4><div class="NLM_p last">To a solution of 4-chloropyrimidin-2-amine (<b>23</b>) (2.00 g, 15.4 mmol) in NMP (12 mL) were added under an atmosphere of N<sub>2</sub> methanamine hydrochloride (1.04 g, 15.4 mmol) and K<sub>2</sub>CO<sub>3</sub> (4.27 g, 30.9 mmol). The reaction mixture was stirred at 120 °C for 2 h. Solvents were evaporated, and the crude yellow oil was purified by flash chromatography (50 g amino modified SiO<sub>2</sub>; DCM to DCM/MeOH/25% aqueous NH<sub>4</sub>OH 140:10:1). The resulting oil was triturated with <i>t</i>-BuOMe (40 mL) and dried on the high vacuum to yield <i>N</i>4-methylpyrimidine-2,4-diamine (<b>25</b>) as light yellow solid (0.76 g, 40%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.59 (br d, <i>J</i> = 5.05 Hz, 1H), 6.70 (br s, 1H), 5.83 (br s, 2H), 5.68 (d, <i>J</i> = 5.85 Hz, 1H), 2.66–2.75 (m, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>5</sub>H<sub>8</sub>N<sub>4</sub> + H<sup>+</sup>, 125.0822; found, 125.0821; Diff, −0.1 mDa.</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Amino-4-(dimethylamino)pyrimidine (<b>26</b>)</h4><div class="NLM_p last">4-Chloropyrimidin-2-amine (<b>23</b>) (3.24 g, 25.0 mmol), dimethylamine hydrochloride (2.24 g, 27.5 mmol), and K<sub>2</sub>CO<sub>3</sub> (10.4 g, 75.0 mmol) were combined with NMP (15 mL). The reaction mixture was stirred for 1 h at 120 °C before pouring it onto a mixture of aqueous 1 M NaOH and ice. After extraction with EtOAc (3 × 100 mL) the combined organic layers were concentrated. <i>t</i>-BuOMe (40 mL) was added to precipitate the product that was collected by filtration. Drying under vacuum afforded 2-amino-4-(dimethylamino)pyrimidine (<b>26</b>) as white powder (1.48 g, 43%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.85 (d, <i>J</i> = 6.25 Hz, 1H), 5.88 (d, <i>J</i> = 6.25 Hz, 1H), 4.61 (br s, 2H), 3.04 (s, 6H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>6</sub>H<sub>10</sub>N<sub>4</sub> + H<sup>+</sup>, 139.0978; found, 139.0977; Diff, −0.1 mDa.</div></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>4-Cyclopropylpyrimidine-2,4-diamine (<b>27</b>)</h4><div class="NLM_p last">To a suspension of 4-chloropyrimidin-2-amine (<b>23</b>) (300 mg, 2.32 mmol) and K<sub>2</sub>CO<sub>3</sub> (640 mg, 4.63 mmol) in DMF (3.0 mL) was added cyclopropylamine (1.21 g, 1.49 mL, 21.1 mmol), and the reaction mixture was stirred overnight at 100 °C. The reaction mixture was cooled to rt and extracted with EtOAc and H<sub>2</sub>O, and the aqueous layer was back-extracted with EtOAc. The organic layers were washed three times with H<sub>2</sub>O and once with brine. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Trituration of the residue with Et<sub>2</sub>O afforded <i>N</i>4-cyclopropylpyrimidine-2,4-diamine (<b>27</b>) as off-white solid (193 mg, 55%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 5.84 Hz, 1H), 6.12 (d, <i>J</i> = 5.84 Hz, 1H), 5.04 (br s, 1H), 4.63 (br s, 2H), 2.48–2.56 (m, 1H), 0.76–0.83 (m, 2H), 0.53–0.59 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>7</sub>H<sub>10</sub>N<sub>4</sub> + H<sup>+</sup>, 151.0978; found, 151.0977; Diff, −0.1 mDa.</div></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4-[4-(2-Fluoroethyl)piperidin-1-yl]pyrimidin-2-ylamine (<b>28</b>)</h4><div class="NLM_p last">A mixture of 4-chloropyrimidin-2-amine (<b>23</b>) (4.0 g, 31 mmol), 4-(2-fluoroethyl)piperidine hydrochloride (<b>63</b>) (5.7 g, 34 mmol), K<sub>2</sub>CO<sub>3</sub> (6.4 g, 46 mmol), and NMP (12 mL) was stirred in a sealed tube 12 h at 120 °C. After cooling the reaction mixture to rt, it was poured into aqueous 1 M NaOH (120 mL) and extracted with DCM (3 × 150 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by chromatography (SiO<sub>2</sub>; 4–6% MeOH in DCM) to afford 4-[4-(2-fluoroethyl)piperidin-1-yl]pyrimidin-2-ylamine (<b>28</b>) as light yellow sticky solid (5.4 g, 78%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.72 (d, <i>J</i> = 6.04 Hz, 1H), 6.02 (d, <i>J</i> = 6.15 Hz, 1H), 5.98 (s, 2H), 4.51 (td, <i>J</i> = 6.00, 48.20 Hz, 2H), 4.30 (br d, <i>J</i> = 11.99 Hz, 2H), 2.73–2.81 (m, 2H), 1.64–1.73 (m, 3H), 1.56–1.64 (m, 2H), 1.02–1.12 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>17</sub>FN<sub>4</sub> + H<sup>+</sup>, 225.1510; found, 225.1510; Diff, 0.0 mDa.</div></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>29</b>)</h4><div class="NLM_p last">Pyrimidine-2,4-diamine (<b>24</b>) (5.19 g, 47.1 mmol) and 2-bromo-1-phenylethanone (<b>13</b>) (14.1 g, 70.7 mmol) were combined with acetone (200 mL) to give a white suspension. The reaction mixture was heated to 60 °C and stirred for 5 h. The reaction mixture was filtered through sintered glass and the resulting solid washed with acetone. H<sub>2</sub>O (50 mL) and 25% aqueous NH<sub>4</sub>OH (75 mL) were added to the product. After filtration of the solid and washing with H<sub>2</sub>O, drying at 40 °C under high vacuum afforded 2-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>29</b>) as a white powder (9.22 g, 93%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36 (d, <i>J</i> = 7.25 Hz, 1H), 7.81–7.86 (m, 3H), 7.38 (t, <i>J</i> = 7.48 Hz, 2H), 7.25 (t, <i>J</i> = 7.36 Hz, 1H), 6.80 (br s, 2H), 6.26 (d, <i>J</i> = 7.25 Hz, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>10</sub>N<sub>4</sub> + H<sup>+</sup>, 211.0978; found, 211.0981; Diff, 0.3 mDa.</div></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-Methyl-2-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>30</b>)</h4><div class="NLM_p last">A yellow slurry of <i>N</i>4-methylpyrimidine-2,4-diamine (<b>25</b>) (50.0 mg, 403 μmol) and 2-bromo-1-phenylethanone (<b>13</b>) (120 mg, 604 μmol) in acetone (2.75 mL) was stirred at 65 °C overnight. The off-white suspension was filtered and washed with H<sub>2</sub>O (1 mL) and acetone (1 mL). The solid precipitate was suspended into H<sub>2</sub>O (1 mL) and 25% aqueous NH<sub>4</sub>OH (0.9 mL). The suspension was stirred for 10 min at rt, filtered again, and washed with H<sub>2</sub>O. High vacuum drying for 4 h finally yielded <i>N</i>-methyl-2-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>30</b>) as light red solid (41 mg, 45%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.31 (d, <i>J</i> = 7.25 Hz, 1H), 7.83–7.86 (m, 2H), 7.82 (s, 1H), 7.35–7.43 (m, 3H), 7.25 (tt, <i>J</i> = 1.21, 7.35 Hz, 1H), 6.27 (d, <i>J</i> = 7.25 Hz, 1H), 2.85 (d, <i>J</i> = 4.73 Hz, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub> + H<sup>+</sup>, 225.1135; found, 225.1137; Diff, 0.2 mDa.</div></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>,<i>N</i>-Dimethyl-2-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>31</b>)</h4><div class="NLM_p last">A suspension of <i>N</i>4,<i>N</i>4-dimethylpyrimidine-2,4-diamine (<b>26</b>) (100 mg, 724 μmol) and 2-bromo-1-phenylethanone (<b>13</b>) (216 mg, 1.09 mmol) in acetone (4 mL) was stirred at 65 °C overnight. The off-white suspension was filtered and washed with acetone (5 mL). The solid was suspended in H<sub>2</sub>O (3.1 mL) and 25% aqueous NH<sub>4</sub>OH (2.5 mL). The mixture was stirred for 10 min at rt, filtered again, and washed with H<sub>2</sub>O. After high vacuum drying <i>N</i>,<i>N</i>-dimethyl-2-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>31</b>) was obtained as light brown solid (97 mg, 56%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.01 (d, <i>J</i> = 7.56 Hz, 1H), 7.96–7.99 (m, 2H), 7.45 (s, 1H), 7.39 (t, <i>J</i> = 7.25 Hz, 2H), 7.28 (t, <i>J</i> = 7.23 Hz, 1H), 6.34 (d, <i>J</i> = 7.56 Hz, 1H), 3.21 (s, 6H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>14</sub>H<sub>14</sub>N<sub>4</sub> + H<sup>+</sup>, 239.1291; found, 239.1295; Diff, 0.4 mDa.</div></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(3-Methylphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>32</b>)</h4><div class="NLM_p last">A vial was charged with pyrimidine-2,4-diamine (<b>24</b>) (0.450 g, 4.09 mmol), 2-bromo-1-<i>m</i>-tolylethanone (958 mg, 4.5 mmol), and acetone (10 mL). The vial was flushed with Ar and closed. The reaction mixture was stirred at 65 °C overnight. The reaction mixture was cooled to rt, filtered, and rinsed with acetone. The residue was suspended in saturated aqueous NaHCO<sub>3</sub> (30 mL), stirred for 10 min, filtered, then rinsed with H<sub>2</sub>O and a small amount of EtOAc. The residue was absorbed on silica gel (10 g) and loaded on a chromatography column (50 g SiO<sub>2</sub>; DCM to DCM/MeOH 9:1). Fractions containing product were combined and concentrated. The residue was dissolved under heating in EtOH (40 mL). H<sub>2</sub>O (20 mL) was added dropwise, and the mixture was concentrated until a solid started to precipitate. The resulting suspension was allowed to cool to rt, filtered, rinsed with water and a minimal amount of EtOH. Drying under high vacuum afforded 2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>32</b>) as an off-white solid (562 mg, 61%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (d, <i>J</i> = 7.27 Hz, 1H), 7.80 (s, 1H), 7.67 (s, 1H), 7.62 (d, <i>J</i> = 7.87 Hz, 1H), 7.26 (t, <i>J</i> = 7.67 Hz, 1H), 7.06 (d, <i>J</i> = 7.47 Hz, 1H), 6.79 (s, 2H), 6.25 (d, <i>J</i> = 7.27 Hz, 1H), 2.29–2.39 (m, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub> + H<sup>+</sup>, 225.1135; found, 225.1138; Diff, 0.3 mDa.</div></div><div id="sec3_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-(7-(Methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>33</b>)</h4><div class="NLM_p last">A vial was charged with <i>N</i>4-methylpyrimidine-2,4-diamine (<b>25</b>) (700 mg, 5.36 mmol), 2-bromo-1-(4-hydroxyphenyl)ethanone (<b>15</b>) (1.21 g, 5.62 mmol), and acetone (9 mL). The vial was flushed with Ar and closed. The reaction mixture was stirred overnight at 65 °C. The reaction mixture was filtered, rinsing with acetone. The residue was suspended in a mixture of saturated aqueous NaHCO<sub>3</sub> (15 mL) and CH<sub>2</sub>Cl<sub>2</sub> (5 mL) and stirred for 40 min at rt. The mixture was filtered, rinsing consecutively with H<sub>2</sub>O, EtOAc, and DCM. The residue was dried under high vacuum and then again triturated with EtOAc (5 mL) containing 0.1% of MeOH. Solids were collected and rinsed with EtOAc and few drops of MeOH. Drying under high vacuum afforded 4-(7-(methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>33</b>) (1.27 g, 5.02 mmol, 94%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.59 (br s, 1H), 8.27 (d, <i>J</i> = 7.27 Hz, 1H), 7.63 (d, <i>J</i> = 8.68 Hz, 2H), 7.60 (s, 1H), 7.30 (br d, <i>J</i> = 4.64 Hz, 1H), 6.77 (d, <i>J</i> = 7.81 Hz, 2H), 6.22 (d, <i>J</i> = 7.27 Hz, 1H), 2.84 (d, <i>J</i> = 4.64 Hz, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>12</sub>N<sub>4</sub>O + H<sup>+</sup>, 241.1084; found, 241.1085; Diff, 0.1 mDa.</div></div><div id="sec3_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-Cyclopropyl-2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>34</b>)</h4><div class="NLM_p last">A vial was charged with <i>N</i>4-cyclopropylpyrimidine-2,4-diamine (<b>27</b>) (700 mg, 4.66 mmol), 2-bromo-1-(4-methoxyphenyl)ethanone (<b>14</b>) (1.12 g, 4.89 mmol), and acetone (1 mL). The vial was flushed with Ar and closed. The reaction mixture was stirred at 65 °C overnight. The reaction mixture was extracted with DCM and saturated aqueous NaHCO<sub>3</sub>. The aqueous layer was extracted twice with DCM. The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was triturated with EtOAc containing a few drops of MeOH to afford <i>N</i>-cyclopropyl-2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>34</b>) (546 mg, 42% yield) as a light yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (d, <i>J</i> = 7.27 Hz, 1H), 7.78 (d, <i>J</i> = 8.68 Hz, 2H), 7.72 (s, 1H), 7.53 (d, <i>J</i> = 3.03 Hz, 1H), 6.96 (d, <i>J</i> = 8.88 Hz, 2H), 6.26 (br d, <i>J</i> = 7.27 Hz, 1H), 3.78 (s, 3H), 2.68–2.81 (m, 1H), 0.67–0.84 (m, 2H), 0.41–0.54 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>N<sub>4</sub>O + H<sup>+</sup>, 281.1397; found, 281.1401; Diff, 0.4 mDa.</div></div><div id="sec3_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(7-(Cyclopropylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>35</b>)</h4><div class="NLM_p last">A vial was charged with <i>N</i>4-cyclopropylpyrimidine-2,4-diamine (<b>27</b>) (800 mg, 5.33 mmol), 2-bromo-1-(4-hydroxyphenyl)ethanone (<b>15</b>) (1.15 g, 5.33 mmol), and acetone (9.0 mL). The vial was flushed with Ar and capped. The reaction mixture was stirred overnight at 65 °C. The mixture was diluted with DCM (20 mL) and saturated aqueous NaHCO<sub>3</sub> (20 mL). The aqueous layer was extracted twice with DCM. Solids were collected by filtration, and then the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent was evaporated. The combined solid residues were triturated with EtOAc containing a few drops of MeOH to afford 4-(7-(cyclopropylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>35</b>) as a light yellow solid (501 mg, 35%).<sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.40 (s, 1H), 8.31 (d, <i>J</i> = 7.27 Hz, 1H), 7.62–7.69 (m, 3H), 7.49 (d, <i>J</i> = 3.23 Hz, 1H), 6.78 (d, <i>J</i> = 8.68 Hz, 2H), 6.24 (br d, <i>J</i> = 7.47 Hz, 1H), 2.68–2.80 (m, 1H), 0.70–0.79 (m, 2H), 0.44–0.51 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>O + H<sup>+</sup>, 267.1241; found, 267.1246; Diff, 0.5 mDa.</div></div><div id="sec3_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 7-[4-(2-Fluoroethyl)piperidin-1-yl]-2-phenylimidazo[1,2-<i>a</i>]pyrimidine (<b>36</b>)</h4><div class="NLM_p last">To a solution of 4-[4-(2-fluoroethyl)piperidin-1-yl]pyrimidin-2-ylamine (<b>28</b>) (250 mg, 1.11 mmol) in acetone (8 mL) at 25 °C under N<sub>2</sub> were added 2-bromo-1-phenylethanone (<b>13</b>) (332 mg, 1.67 mmol) and a catalytic amount of TsOH. The reaction mixture was heated to 65 °C for 12 h. Volatiles were evaporated under reduced pressure, and the residual mixture was extracted with DCM (3 times 150 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material thus obtained was purified by preparative HPLC (Reprosil Gold column, 250 mm × 20 mm; 5 μm/C18, reverse phase; MeOH/10 mM aqueous NH<sub>4</sub>OAc) to afford 7-[4-(2-fluoroethyl)piperidin-1-yl]-2-phenylimidazo[1,2-<i>a</i>]pyrimidine (<b>36</b>) as off white solid (90 mg, 25%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48 (d, <i>J</i> = 7.82 Hz, 1H), 7.86 (d, <i>J</i> = 7.83 Hz, 2H), 7.86 (s, 1H), 7.39 (t, <i>J</i> = 7.80 Hz, 2H), 7.26 (t, <i>J</i> = 7.30 Hz, 1H), 6.79 (d, <i>J</i> = 7.82 Hz, 1H), 4.53 (td, <i>J</i> = 5.90, 47.90 Hz, 2H), 4.37–4.47 (m, 2H), 2.87–3.02 (m, 2H), 1.68–1.81 (m, 3H), 1.56–1.68 (m, 2H), 1.06–1.27 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>21</sub>FN<sub>4</sub> + H<sup>+</sup>, 325.1823; found, 325.1829; Diff, 0.6 mDa.</div></div><div id="sec3_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(4-(2-Fluoroethoxy)phenyl)-<i>N</i>-methylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>37</b>)</h4><div class="NLM_p last">A vial was charged with 4-(7-(methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>33</b>) (870 mg, 3.44 mmol), Cs<sub>2</sub>CO<sub>3</sub> (2.24 g, 6.88 mmol), DMF (12 mL), and 1-bromo-2-fluoroethane (611 mg, 360 μL, 4.82 mmol). The reaction mixture was stirred 1 h at 70 °C. The reaction mixture was diluted with H<sub>2</sub>O and then extracted with EtOAc (100 mL). The aqueous phase was back-extracted with EtOAc (100 mL). The organic layers were washed two times with H<sub>2</sub>O (15 mL) and once with brine (15 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was triturated with EtOAc, rinsed with EtOAc/DCM, and dried under high vacuum. An additional purification step was done by trituration with MeOH. Drying on the high vacuum overnight afforded 2-(4-(2-fluoroethoxy)phenyl)-<i>N</i>-methylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>37</b>) (570 mg, 55%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (d, <i>J</i> = 7.27 Hz, 1H), 7.74–7.81 (m, 2H), 7.70 (s, 1H), 7.34 (br q, <i>J</i> = 4.80 Hz, 1H), 6.96–7.03 (m, 2H), 6.24 (d, <i>J</i> = 7.27 Hz, 1H), 4.64–4.87 (m, 2H), 4.17–4.36 (m, 2H), 2.84 (d, <i>J</i> = 4.64 Hz, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>15</sub>FN<sub>4</sub>O + H<sup>+</sup>, 287.1303; found, 287.1302; Diff, −0.1 mDa.</div></div><div id="sec3_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-[4-[7-(Methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl]phenoxy]ethyl 4-Methylbenzenesulfonate (<b>38</b>)</h4><div class="NLM_p last">A reaction vial was charged with 4-(7-(methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenol (<b>33</b>) (335 mg, 1.39 mmol), 2-(<i>p</i>-tolylsulfonyloxy)ethyl 4-methylbenzenesulfonate (723 mg, 1.95 mmol), Cs<sub>2</sub>CO<sub>3</sub> (909 mg, 2.79 mmol), and DMF (6.5 mL). The reaction mixture was stirred 2 h at 50 °C. The reaction mixture was cooled to rt, diluted with H<sub>2</sub>O (10 mL), and extracted with EtOAc (80 mL). The aqueous layer was back-extracted with EtOAc (80 mL). The organic layers were washed twice with H<sub>2</sub>O (10 mL) and once with brine (10 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residue was purified by chromatography (40 g SiO<sub>2</sub>; DCM to DCM/10% MeOH). All fractions containing product were combined and concentrated. The residue was triturated with MeOH and dried on the high vacuum to afford 2-(4-(7-(methylamino)imidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenoxy)ethyl 4-methylbenzenesulfonate (<b>38</b>) as a pale yellow solid (248 mg, 41%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.28 (d, <i>J</i> = 7.27 Hz, 1H), 7.81 (d, <i>J</i> = 8.28 Hz, 2H), 7.73 (d, <i>J</i> = 8.68 Hz, 2H), 7.70 (s, 1H), 7.48 (d, <i>J</i> = 8.07 Hz, 2H), 7.34 (br q, <i>J</i> = 4.84 Hz, 1H), 6.86 (d, <i>J</i> = 8.88 Hz, 2H), 6.24 (d, <i>J</i> = 7.27 Hz, 1H), 4.30–4.39 (m, 2H), 4.10–4.26 (m, 2H), 2.84 (d, <i>J</i> = 4.84 Hz, 3H), 2.42 (s, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>S + H<sup>+</sup>, 439.1435; found, 439.1440; Diff, 0.5 mDa.</div></div><div id="sec3_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Phenylimidazo[1,2-<i>c</i>]pyrimidin-7-ylamine (<b>40</b>)</h4><div class="NLM_p last">To a solution of pyrimidine-4,6-diamine (<b>39</b>) (200 mg, 1.81 mmol) in EtOH (10 mL) was added 2-bromo-1-phenylethanone (<b>13</b>) (542 mg, 2.72 mmol). The reaction mixture was heated at 80 °C for 8 h. After evaporation of the solvent the crude was purified by chromatography (amino modified SiO<sub>2</sub>; 3% MeOH/DCM). 2-Phenylimidazo[1,2-<i>c</i>]pyrimidin-7-ylamine (<b>40</b>) was isolated as light brown solid (50 mg, 13%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.96 (d, <i>J</i> = 1.21 Hz, 1H), 8.06 (s, 1H), 7.90 (dd, <i>J</i> = 1.06, 8.11 Hz, 2H), 7.41 (t, <i>J</i> = 7.70 Hz, 2H), 7.30 (t, <i>J</i> = 7.52 Hz, 1H), 6.19 (s, 1H), 6.12 (s, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>12</sub>H<sub>10</sub>N<sub>4</sub> + H<sup>+</sup>, 211.0978; found, 211.0983; Diff, 0.5 mDa.</div></div><div id="sec3_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl <i>N</i>-[3-(2,6-Dichloro-3-pyridyl)-4-pyridyl]carbamate (<b>43</b>)</h4><div class="NLM_p last">A preheated flask under Ar was charged with <i>tert</i>-butyl 3-iodopyridin-4-ylcarbamate (<b>41</b>) (4.56 g, 14.2 mmol), 2,6-dichloropyridin-3-ylboronic acid (<b>42</b>) (5.46 g, 28.4 mmol), [Pd(OAc)<sub>2</sub>] (320 mg, 1.42 mmol), and PPh<sub>3</sub> (371 mg, 1.41 mmol). Et<sub>3</sub>N (4.32 g, 5.94 mL, 42.7 mmol) in DMF (137 mL) was added, and the reaction mixture was stirred at 100 °C for 3 h. The solvent was evaporated almost completely. H<sub>2</sub>O was added, and the crude product suspension was extracted twice with EtOAc. The combined organic layers were washed with H<sub>2</sub>O (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated. Trituration of the crude product with DCM afforded 1.92 g of the desired product. The DCM phase was evaporated and purified by flash chromatography (SiO<sub>2</sub>; EtOAc to heptane) to yield in total 3.39 g (∼90% purity, 63% yield) of <i>tert</i>-butyl <i>N</i>-[3-(2,6-dichloro-3-pyridyl)-4-pyridyl]carbamate (<b>43</b>) as light yellow solid. This material was used as such in the following step. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.08 (s, 1H), 8.48 (d, <i>J</i> = 5.85 Hz, 1H), 8.28 (s, 1H), 7.84–7.90 (m, 2H), 7.66 (d, <i>J</i> = 8.07 Hz, 1H), 1.42 (s, 9H), LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> + H<sup>+</sup>, 340.0614; found, 340.0624; Diff, 1.0 mDa.</div></div><div id="sec3_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-Chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>44</b>)</h4><div class="NLM_p last">A suspension of <i>tert</i>-butyl <i>N</i>-[3-(2,6-dichloro-3-pyridyl)-4-pyridyl]carbamate (<b>43</b>) (264 mg, 776 μmol), K<sub>2</sub>CO<sub>3</sub> (215 mg, 1.55 mmol), and 18-crown-6 (226 mg, 854 μmol) in DMF (15.8 mL) was stirred at 100 °C under Ar for 3 h. H<sub>2</sub>O was added, and the product was extracted twice with EtOAc. The combined organic layers were washed twice with H<sub>2</sub>O, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated. Trituration of the crude product with a small amount of MeOH afforded 2-chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>44</b>) (105 mg, 63%) as light yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.47 (br s, 1H), 9.39 (s, 1H), 8.68 (d, <i>J</i> = 8.07 Hz, 1H), 8.52 (d, <i>J</i> = 5.65 Hz, 1H), 7.51 (d, <i>J</i> = 5.46 Hz, 1H), 7.41 (d, <i>J</i> = 8.07 Hz, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>6</sub>ClN<sub>3</sub> + H<sup>+</sup>, 204.0323; found, 204.0333; Diff, 1.0 mDa.</div></div><div id="sec3_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-Chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic Acid <i>tert</i>-Butyl Ester (<b>45</b>)</h4><div class="NLM_p last">A suspension of NaH (60%, 26.5 mg, 607 μmol) in dry DMF (1.5 mL) was cooled under Ar to 0 °C, and a solution of 2-chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>44</b>) (103 mg, 506 μmol) in dry DMF (3.0 mL) was added. Stirring was continued at 0 °C for 10 min, then at rt for 30 min. After cooling down to 0 °C and addition of di-<i>tert</i>-butyl dicarbonate (132 mg, 141 μL, 1.05 mmol) in dry DMF (0.75 mL) stirring was continued at rt overnight. H<sub>2</sub>O was added, and the reaction mixture was extracted twice with EtOAc. The combined organic layers were washed twice with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. 2-Chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic acid <i>tert</i>-butyl ester (<b>45</b>) was obtained after purification by flash chromatography (SiO<sub>2</sub>; DCM to MeOH) and drying on the high vacuum as off-white solid (113 mg, 73%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.48 (d, <i>J</i> = 0.81 Hz, 1H), 8.76 (d, <i>J</i> = 8.17 Hz, 1H), 8.69 (d, <i>J</i> = 5.69 Hz, 1H), 8.11 (dd, <i>J</i> = 0.91, 5.75 Hz, 1H), 7.64 (d, <i>J</i> = 8.07 Hz, 1H), 1.70 (s, 9H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub> + H<sup>+</sup>, 303.0775; found, 303.0778; Diff, 0.3 mDa.</div></div><div id="sec3_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(6-Fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic Acid <i>tert</i>-Butyl Ester (<b>47</b>)</h4><div class="NLM_p last">A reaction flask was charged under Ar with 2-chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic acid <i>tert</i>-butyl ester (<b>45</b>) (100 mg, 329 μmol), 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (<b>46</b>) (147 mg, 658 μmol), K<sub>2</sub>CO<sub>3</sub> (137 mg, 988 μmol), and [Pd(dppf)Cl<sub>2</sub>]·DCM (10.8 mg, 13.2 μmol), and the vessel was sealed. DMF (7 mL) was added via a syringe, and the reaction mixture was stirred at 90 °C for 17 h. Solids were removed by filtration. H<sub>2</sub>O was added to the filtrate, and the mixture was extracted twice with EtOAc. The combined organic layers were washed with H<sub>2</sub>O (3×), dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated. Trituration of the crude product with a small amount of MeOH afforded 2-(6-fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>9</b>) as a light red solid (23 mg, 80% purity, 21%). The mother liquor was evaporated and purified by flash chromatography (SiO<sub>2</sub>; DCM to MeOH) to afford 2-(6-fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic acid <i>tert</i>-butyl ester (<b>47</b>) as off-white solid (12 mg, 10%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.29 (d, <i>J</i> = 1.01 Hz, 1H), 9.01 (td, <i>J</i> = 0.80, 2.60 Hz, 1H), 8.71 (d, <i>J</i> = 5.84 Hz, 1H), 8.62 (ddd, <i>J</i> = 2.52, 7.66, 8.56 Hz, 1H), 8.44 (d, <i>J</i> = 8.06 Hz, 1H), 8.27 (dd, <i>J</i> = 1.01, 5.84 Hz, 1H), 7.84 (d, <i>J</i> = 8.26 Hz, 1H), 7.08 (ddd, <i>J</i> = 0.60, 3.02, 8.66 Hz, 1H), 1.81 (s, 9H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>17</sub>FN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>, 365.1408; found, 365.1436; Diff, 2.8 mDa.</div></div><div id="sec3_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(6-Nitropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>49</b>)</h4><div class="NLM_p last">2-Chloropyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine-9-carboxylic acid <i>tert</i>-butyl ester (<b>45</b>) (285 mg, 938 μmol), 2-nitropyridine-5-boronic acid pinacol ester (<b>48</b>) (469 mg, 1.88 mmol), [Pd(dppf)Cl<sub>2</sub>]·DCM (34.5 mg, 42.2 μmol), and K<sub>2</sub>CO<sub>3</sub> (389 mg, 2.81 mmol) were combined under Ar in a reaction flask. DMF (24 mL) was added, and the tube was sealed. The reaction mixture was stirred at 90 °C for 18 h. Filtration through Celite and subsequently through a small silica gel pad (neutral, mesh 32–63) was followed by rinsing with DMF and evaporation to dryness. The brown solid was dissolved in DMF (20 mL), and DMSO was added until an almost clear solution resulted. After filtration, the solvents were evaporated to almost dryness. Purification by preparative HPLC (YMC Triart C18 100 mm × 30 mm, 5 μm; H<sub>2</sub>O, 0.1% Et<sub>3</sub>N/MeCN gradient) provided 2-(6-nitropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>49</b>) as a yellow solid (37 mg, 13%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.55 (br s, 1H), 9.44–9.46 (m, 2H), 8.95 (dd, <i>J</i> = 2.01, 8.46 Hz, 1H), 8.84 (d, <i>J</i> = 8.06 Hz, 1H), 8.54 (d, <i>J</i> = 5.64 Hz, 1H), 8.48 (d, <i>J</i> = 8.46 Hz, 1H), 8.20 (d, <i>J</i> = 8.06 Hz, 1H), 7.53 (d, <i>J</i> = 5.54 Hz, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>9</sub>N<sub>5</sub>O<sub>2</sub> + H<sup>+</sup>, 292.0829; found, 292.0827; Diff, −0.2 mDa.</div></div><div id="sec3_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (3-Bromophenyl)(5-iodopyrimidin-4-yl)amine (<b>52</b>)</h4><div class="NLM_p last">To a solution of 4-chloro-5-iodopyrimidine (<b>50</b>) (2.0 g, 8.3 mmol) in EtOH (40 mL) was added at rt dropwise 3-bromoaniline (<b>51</b>) (0.95 mL, 8.32 mmol). The mixture was stirred under reflux for 3 h. Solvents were evaporated, and the crude material was triturated with hexane to get (3-bromophenyl)(5-iodopyrimidin-4-yl)amine (<b>52</b>) as light yellow solid (2.2 g, 70%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.98 (br s, 1H), 8.78 (s, 1H), 8.62 (s, 1H), 7.86 (t, <i>J</i> = 1.81 Hz, 1H), 7.60 (td, <i>J</i> = 1.70, 7.68 Hz, 1H), 7.31–7.37 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>7</sub>BrIN<sub>3</sub> + H<sup>+</sup>, 375.8941; found, 375.8940; Diff, −0.1 mDa.</div></div><div id="sec3_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 7-Bromo-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>53</b>)</h4><div class="NLM_p last">A solution of (3-bromophenyl)(5-iodopyrimidin-4-yl)amine (<b>52</b>) (400 mg, 1.06 mmol) in DMA (8 mL) was degassed with Ar for 10 min. Dry NaOAc (130 mg, 1.60 mmol) and [Pd(OAc)<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>] (79 mg, 0.11 mmol) were added. After repeated degassing with Ar (10 min) the vial was capped and irradiated in a microwave apparatus at 130 °C for 4 h. The reaction mixture filtered through Celite, and solvents were evaporated. Purification by chromatography over silica gel and further by trituration with DCM afforded 7-bromo-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>53</b>) (30 mg, 11%) as light yellow solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.47 (br s, 1H), 9.49 (s, 1H), 8.97 (s, 1H), 8.22 (d, <i>J</i> = 8.26 Hz, 1H), 7.73 (d, <i>J</i> = 1.71 Hz, 1H), 7.51 (dd, <i>J</i> = 1.76, 8.31 Hz, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>6</sub>BrN<sub>3</sub> + H<sup>+</sup>, 246.9745; found, 246.9753; Diff, 0.8 mDa.</div></div><div id="sec3_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 7-(6-Fluoropyridin-3-yl)-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>55</b>)</h4><div class="NLM_p last">To a solution of 7-bromo-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>53</b>) (20 mg, 0.081 mmol) and 6-fluoropyridin-3-ylboronic acid (<b>54</b>) (23 mg, 0.16 mmol) in DMF (2 mL) in a microwave vessel was added K<sub>2</sub>CO<sub>3</sub> (33 mg, 0.24 mmol). The vial was purged with Ar for 10 min, and then [Pd(dppf)Cl<sub>2</sub>]·DCM (1.3 mg, 0.0020 mmol) was added and the mixture was purged again with Ar for 10 min. After sealing of the vial, the mixture was irradiated in a microwave apparatus at 100 °C for 1 h. The reaction mixture was filtered through a Celite plug. The residue was washed with EtOAc (10 mL). The combined filtrates were washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvents were evaporated. Purification by chromatography (SiO<sub>2</sub>; 50–60% EtOAc/hexane) afforded 7-(6-fluoropyridin-3-yl)-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>55</b>) as light yellow solid (4.2 mg, 20%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.33 (ddd, <i>J</i> = 8.56, 2.92, 0.60 Hz, 1H), 7.69 (dd, <i>J</i> = 8.26, 1.61 Hz, 1H), 7.82 (d, <i>J</i> = 1.01 Hz, 1H), 8.40 (ddd, <i>J</i> = 8.20, 2.70 Hz, 1H), 8.38 (d, <i>J</i> = 8.06 Hz, 1H), 8.65 (dd, <i>J</i> = 1.61, 0.81 Hz, 1H), 8.96 (s, 1H), 9.50 (s, 1H), 12.50 (s, 1H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>15</sub>H<sub>9</sub>FN<sub>4</sub> + H<sup>+</sup>, 265.0884; found, 265.0885; Diff, 0.1 mDa.</div></div><div id="sec3_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 7-Bromo-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>59</b>)</h4><div class="NLM_p">Step a: A solution of 1-acetyl-3-bromopiperidin-4-one (<b>56</b>) (3.50 g, 11.7 mmol) and (3-bromophenyl)hydrazine hydrochloride (<b>57</b>) (2.99 g, 13.4 mmol) in BF<sub>3</sub>·Et<sub>2</sub>O (70 mL) was heated 16 h at 120 °C. Volatilities were evaporated, and the residue was diluted with H<sub>2</sub>O (15 mL), neutralized with saturated aqueous Na<sub>2</sub>CO<sub>3</sub>, and extracted with EtOAc (2 × 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated. Chromatography (SiO<sub>2</sub>; 2% MeOH in DCM) afforded an inseparable mixture of 7-bromo-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>58a</b>) and 9-bromo-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>58b</b>) (2.0 g, 69%). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>7</sub>BrN<sub>2</sub> + H<sup>+</sup>, 246.9866; found, 246.9866; Diff, 0.0 mDa.</div><div class="NLM_p last">Step b: The mixture of 7-bromo-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>58a</b>) and 9-bromo-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>58b</b>) (2.0 g, 8.1 mmol) was dissolved in DMF (50 mL), cooled to 0 °C, and NaH (60% 485 mg, 12.1 mmol) was added. The reaction mixture was stirred at 25 °C for 30 min, and then TsCl (2.46 g, 12.1 mmol) was added and the reaction mixture was stirred at rt for 1 h. H<sub>2</sub>O was added, and the product was extracted with EtOAc (2 × 30 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated. Chromatography (SiO<sub>2</sub>; EtOAc/hexane 2:3) afforded 7-bromo-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>59</b>) (700 mg, 21%) as light brown solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.45 (d, <i>J</i> = 0.91 Hz, 1H), 8.71 (d, <i>J</i> = 5.84 Hz, 1H), 8.37 (d, <i>J</i> = 1.51 Hz, 1H), 8.27 (d, <i>J</i> = 8.26 Hz, 1H), 8.17 (dd, <i>J</i> = 0.86, 5.79 Hz, 1H), 7.90 (d, <i>J</i> = 8.46 Hz, 2H), 7.73 (dd, <i>J</i> = 1.71, 8.26 Hz, 1H), 7.38 (d, <i>J</i> = 8.16 Hz, 2H), 2.28–2.33 (m, 3H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>13</sub>BrN<sub>2</sub>O<sub>2</sub>S + H<sup>+</sup>, 400.9954; found, 400.9959; Diff, 0.5 mDa.</div></div><div id="sec3_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 7-(4-Fluoropiperidin-1-yl)-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>61</b>)</h4><div class="NLM_p last">To a solution of 7-bromo-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>59</b>) (50 mg, 0.12 mmol) and 4-fluoropiperidine (<b>60</b>) (19 mg, 0.19 mmol) in THF (7 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (60 mg, 0.19 mmol) at rt. The mixture was purged 10 min with N<sub>2</sub> before addition of xanthphos (5.8 mg, 0.01 mmol) and [Pd<sub>2</sub>(dba)<sub>3</sub>]·CHCl<sub>3</sub> (18.3 mg, 0.02 mmol). The reaction mixture was purged 10 min with N<sub>2</sub>, and the vial was capped and heated to 90 °C for 16 h. The mixture was filtered through Celite, and the Celite pad was washed with EtOAc (10 mL). Solvents were evaporated and the residue was purified by chromatography (SiO<sub>2</sub>; EtOAc/hexane 2:3) to give 7-(4-fluoropiperidin-1-yl)-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>61</b>) as a light brown solid (40 mg, 76%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.22 (d, <i>J</i> = 0.91 Hz, 1H), 8.54 (d, <i>J</i> = 5.74 Hz, 1H), 8.10 (dd, <i>J</i> = 0.96, 5.69 Hz, 1H), 8.02 (d, <i>J</i> = 8.76 Hz, 1H), 7.83 (d, <i>J</i> = 8.02 Hz, 2H), 7.66 (d, <i>J</i> = 2.12 Hz, 1H), 7.35 (dd, <i>J</i> = 0.60, 8.00 Hz, 2H), 7.19 (dd, <i>J</i> = 2.22, 8.76 Hz, 1H), 4.84–4.99 (m, 1H), 3.48–3.56 (m, 2H), 3.33–3.37 (m, 2H), 2.28 (s, 3H), 1.99–2.09 (m, 2H), 1.82–1.89 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>2</sub>S + H<sup>+</sup>, 424.1489; found, 424.1490; Diff, 0.1 mDa.</div></div><div id="sec3_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 7-(4-Fluoropiperidin-1-yl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>62</b>)</h4><div class="NLM_p last">To a solution of 7-(4-fluoropiperidin-1-yl)-5-(toluene-4-sulfonyl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>61</b>) (40 mg, 0.095 mmol) in THF/H<sub>2</sub>O (1:1) (10 mL) was added NaOH (19 mg, 0.47 mmol). The reaction mixture was heated to 50 °C for 16 h. More NaOH (20 mg, 0.50 mmol) and MeOH (3 mL) were added, and stirring was continued at reflux for 6 h. The solvent was evaporated, and the residue was diluted with DCM (20 mL), then washed with H<sub>2</sub>O and brine. After drying over Na<sub>2</sub>SO<sub>4</sub> and evaporation of the solvent, the pale yellow solid was purified by column chromatography (SiO<sub>2</sub>; 0.5–1% MeOH/DCM). The product was further purified by trituration with two portions of Et<sub>2</sub>O (2 × 5 mL). 7-(4-Fluoropiperidin-1-yl)-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>62</b>) was isolated as off-white solid (6.5 mg, 25%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm) 11.37 (s, 1H), 9.13 (s, 1H), 8.29 (d, <i>J</i> = 5.54 Hz, 1H), 7.99 (d, <i>J</i> = 8.46 Hz, 1H), 7.35 (dd, <i>J</i> = 0.91, 5.54 Hz, 1H), 6.98 (s, 1H), 6.99 (d, <i>J</i> = 11.10 Hz, 1H), 4.81–4.94 (m, 1H), 3.41–3.47 (m, 2H), 3.20–3.25 (m, 2H), 1.98–2.07 (m, 2H), 1.81–1.88 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>FN<sub>3</sub> + H<sup>+</sup>, 270.1401; found, 270.1402; Diff, 0.1 mDa.</div></div><div id="sec3_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(2-Fluoroethyl)piperidine Hydrochloride (<b>63</b>)</h4><div class="NLM_p last">A suspension of <i>tert</i>-butyl 4-(2-fluoroethyl)piperidine-l-carboxylate<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> (1.21 g, 5.23 mmol) in HCl (4 M in dioxane, 5.23 mL, 20.9 mmol) was stirred at rt for 2 h. The solution was concentrated in vacuum and dried on high vacuum to yield 4-(2-fluoroethyl)piperidine hydrochloride (<b>63</b>) as white solid (906 mg, 100%). <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.84 (br s, 1H), 8.57 (br s, 1H), 4.50 (td, <i>J</i> = 5.80, 47.50 Hz, 2H), 3.19–3.25 (m, 2H), 2.79–2.87 (m, 2H), 1.78–1.84 (m, 2H), 1.66–1.73 (m, 1H), 1.57–1.66 (m, 2H), 1.29–1.40 (m, 2H). LC–HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>7</sub>H<sub>14</sub>FN + H<sup>+</sup>, 132.1183; found, 132.1182; Diff, −0.1 mDa.</div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <sup>3</sup>H-Radiosynthesis</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> General Methods</h4><div class="NLM_p last">Liquid scintillation counting for tritium compounds was accomplished using a HIDEX 300 SL and ULTIMATE GOLD cocktail (PerkinElmer Inc., Waltham, MA, USA). Precoated thin-layer chromatography sheets (TLC) were obtained from Merck KGaA (Darmstadt, Germany). Developed plates were visualized using automatic TLC linear analyzer (Berthold Technologies, Bad Wildbad, Germany). Radiochemical purity was measured using the β radioactivity HPLC detector RAMONA with internal solid scintillator (Raytest, Straubenhardt, Germany). Specific activity was determined by mass spectrometric isotopic peak intensity distribution, using 4000QTRAP system (AB Sciex GmbH, Zug, CH), flow injection mode with a CTC PAL, and an Agilent 1100 microLC pump without any separation.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(4-Methoxy[2,6-<sup>3</sup>H<sub>2</sub>]phenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine ([<sup>3</sup>H]<b>7</b>)</h4><div class="NLM_p last">In a 2 mL tritiation flask, 2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine (<b>7</b>) (2.0 mg, 8.4 μmol) and Crabtree’s catalyst (10.1 mg, 15.5 μmol) were dissolved in DCM (1.0 mL). The flask was attached to the tritium manifold (RC-TRITEC) and degassed by three freeze–thaw cycles. Tritium gas was introduced, and the light orange solution was vigorously stirred for 4 h in an atmosphere of tritium at 1050 mbar. The solution was cooled by liquid nitrogen, and the excess tritium gas in the reaction vessel was reabsorbed on a uranium-trap for waste-tritium. The solvent was lyophilized off, and labile tritium was removed by lyophilization with a 9:1 mixture of EtOH and H<sub>2</sub>O (3 × 1 mL) and toluene (2 × 1 mL). The remaining brownish oil was dissolved in DCM (25 mL) and transferred on a SCX-3 cation exchanger. Remaining catalyst was eluted with DCM (15 mL) and discarded, and the product was eluted with NH<sub>3</sub> in MeOH (1 N, 25 mL), collected separately, and concentrated under reduced pressure. The crude product was purified by preparative HPLC (XBridge C-18 Prep, 5 μm, 10 mm × 250 mm) using 0.1 M ammonium formate, pH 9/MeCN/water as eluent (gradient 1–13 min from 1:1:8 to 1:8:1, run time 15 min) at a flow rate of 6 mL/min. An amount of 833 MBq (22.5 mCi) was obtained of the title compound with a radiochemical purity of 99% and a specific activity of 1.02 TBq/mmol (27.6 Ci/mmol), as determined by MS spectrometry. The compound was stored as an ethanolic solution. The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS <i>m</i>/<i>z</i>: 240.2 [M + H]<sup>+</sup> (48%), 242.2 [M(<sup>3</sup>H) + H]<sup>+</sup> (10%), 244.2 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (40%), 246.2 [M(<sup>3</sup>H<sub>3</sub>) + H]<sup>+</sup> (2%).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(3-Methylphenyl)-<i>N</i>-([<sup>3</sup>H<sub>3</sub>]methyl)imidazo[1,2-<i>a</i>]pyrimidine-7-amine ([<sup>3</sup>H]<b>8</b>)</h4><div class="NLM_p last">A solution of [<sup>3</sup>H]methylnosylate in toluene (1 mL, 1.85 GBq, 0.66 μmol) was transferred to a 1.5 mL reactor and concentrated under a stream of argon. A solution of 2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidine-7-amine (<b>32</b>) (380 μg, 1.7 μmol) in THF (0.24 mL) and Cs<sub>2</sub>CO<sub>3</sub> (1400 mg, 4.3 μmol) were added, and the reaction mixture was concentrated to roughly 50 μL. After rinsing with THF (50 μL), the reactor was tightly closed, and the reaction mixture was stirred for 24 h. The reaction mixture was portionwise diluted with DCM (30 mL) and transferred to a 50 mL flask. The solvent and volatile byproducts were removed by vacuum transfer. The crude product was purified by preparative HPLC (XBridge C18, 5 μm, 10 mm × 250 mm) using 0.02 M H<sub>3</sub>PO<sub>4</sub>/MeCN/H<sub>2</sub>O as eluent (gradient 1–13 min from 1:1:8 to 1:8:1, run time 15 min) at a flow rate of 6 mL/min. An amount of 460 MBq (12.4 mCi) of the desired compound was obtained with a radiochemical purity of 94% and a specific activity of 2.6 TBq/mmol (70 Ci/mmol). The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS <i>m</i>/<i>z</i>: 238.9 [M + H]<sup>+</sup> (10%), 240.0 [M(<sup>3</sup>H) + H]<sup>+</sup> (12%), 242.9 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (9%), 244.9 [M(<sup>3</sup>H<sub>3</sub>) + H]<sup>+</sup> (70%).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 2-(6-Fluoro[2,4-<sup>3</sup>H<sub>2</sub>]pyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine ([<sup>3</sup>H]<b>9</b>)</h4><div class="NLM_p last">In a 2 mL tritiation flask, 2-(6-fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine (<b>9</b>) (2.0 mg, 7.6 μmol) and Crabtree’s catalyst (9.14 mg, 11.4 μmol) were dissolved in DCM (0.8 mL) and DMF (0.2 mL). The flask was attached to the tritium manifold 20 (RC-TRITEC) and degassed by three freeze–thaw cycles. Tritium gas was introduced, and the light orange solution was vigorously stirred for 4 h in an atmosphere of tritium at 450 mbar. The solution was cooled by liquid nitrogen and the excess tritium gas in the reaction vessel was reabsorbed on a uranium trap for waste-tritium. The solvent was lyophilized off, and labile tritium was removed by lyophilization with a 9:1 mixture of EtOH and H<sub>2</sub>O (3 × 1 mL) and toluene (2 × 1 mL). The remaining brownish oil was dissolved in EtOH (1.5 mL) and transferred on a SCX-2 cation exchanger. Remaining catalyst was eluted with MeOH (10 mL) and discarded, and the product was eluted with NH<sub>3</sub> in MeOH (3.5 N, 10 mL), collected separately, and concentrated under reduced pressure. The crude product was purified by preparative HPLC (XBridge Prep, 5 μm, 10 mm × 250 mm) using 0.05 M KH<sub>2</sub>PO<sub>4</sub> buffer, pH 7/MeCN/water as eluent (gradient 1–13 min from 1:1:8 to 1:8:1, run time 15 min) at a flow rate of 6 mL/min. An amount of 37 MBq (1 mCi) of the title compound was obtained with a radiochemical purity of 99% and a specific activity of 936 GBq/mmol (25.3 Ci/mmol), determined by MS spectrometry. The compound was stored as a pH 7 buffer/DMSO solution. The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS: <i>m</i>/<i>z</i> = 265.1 [M + H]<sup>+</sup> (34%), 267.1 [M(<sup>3</sup>H) + H]<sup>+</sup> (43%), 269.1 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (23%).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(2-Fluoroethyl)-2-[2,6-<sup>3</sup>H<sub>2</sub>]phenylimidazo[1,2-<i>a</i>]pyridin-7-amine ([<sup>3</sup>H]<b>22</b>)</h4><div class="NLM_p last">In a 2 mL tritiation flask, <i>N</i>-(2-fluoroethyl)-2-phenylimidazo[l,2-<i>a</i>]pyridin-7-amine (<b>22</b>) (2.0 mg, 7.8 μmol) and Crabtree’s catalyst (9.6 mg, 12 μmol) were dissolved in DCM (1.0 mL). The reaction and the purification were performed in analogy to compound <b>9</b> to provide 1.5 GBq (40 mCi) of the desired compound with a radiochemical purity of 96% and a specific activity of 1.96 TBq/mmol (52.9 Ci/mmol). The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS <i>m</i>/<i>z</i>: 255.9 [M + H]<sup>+</sup> (2%), 258.0 [M(<sup>3</sup>H) + H]<sup>+</sup> (14%), 260.0 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (81%), 261.9 [M(<sup>3</sup>H<sub>3</sub>) + H]<sup>+</sup> (3%).</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-Cyclopropyl-2-(4-methoxy[2,6-<sup>3</sup>H<sub>2</sub>]phenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine ([<sup>3</sup>H]<b>34</b>)</h4><div class="NLM_p last">In a 2 mL tritiation flask, <i>N</i>-cyclopropyl-2-(4-methoxyphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>34</b>) (3.0 mg, 10.7 μmol) and Crabtree’s catalyst (12.9 mg, 16.1 μmol) were dissolved in DCM (1.0 mL). The reaction was performed in analogy to compound <b>7</b>. After removal of the reaction vessel from the tritiation manifold, the remaining brownish oil was dissolved in DCM (45 mL) and EtOH (5 mL) and transferred to a volumetric flask. The light yellow solution was filtered over an SCX-3 cation exchanger and washed with DCM (20 mL). The filtrate was discarded, and the product was eluted with a solution of NH<sub>3</sub> in MeOH (7 N) and DCM (1:1, 20 mL), collected separately, and concentrated under reduced pressure. The crude product was purified by preparative HPLC (XBridge Prep, 5 μm, 10 mm × 250 mm) using 0.05 M triethylammonium acetate at pH 10/MeCN/water (gradient 1–13 min from 1:1:8 to 1:8:1, run time 15 min) as eluent at a flow rate of 6 mL/min. The collected fractions were diluted with H<sub>2</sub>O (10 mL) and extracted twice with DCM (2 × 15 mL). The organic layers were separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. An amount of 1.30 GBq (35.1 mCi) of the title compound was obtained with a radiochemical purity of 99% and a specific activity of 1.64 TBq/mmol (44.3 Ci/mmol), determined by MS spectrometry. The compound was stored as a methanolic solution (20 mL) with additional 5 μg/mL dithiothreitol to minimize radiolytic decomposition. The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS <i>m</i>/<i>z</i>: 280.9 [M + H]<sup>+</sup> (9%), 282.9 [M(<sup>3</sup>H) + H]<sup>+</sup> (27%), 284.9 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (64%).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(4-(2-Fluoroethoxy)[2,6-<sup>3</sup>H<sub>2</sub>]phenyl)-<i>N</i>-methylimidazo[1,2-<i>a</i>]pyrimidin-7-amine ([<sup>3</sup>H]<b>37</b>)</h4><div class="NLM_p last">In a 2 mL tritiation flask, 2-(4-(2-fluoroethoxy)phenyl)-<i>N</i>-methylimidazo[1,2-<i>a</i>]pyrimidin-7-amine (<b>37</b>) (2.0 mg, 6.8 μmol) and Crabtree’s catalyst (5.5 mg, 6.8 μmol) were dissolved in DCM (0.8 mL) and DMF (0.2 mL). The reaction and the purification were performed in analogy to compound <b>7</b> to provide 482 MBq (13 mCi) of the desired compound with a radiochemical purity of 98% and a specific activity of 2.00 TBq/mmol (54.1 Ci/mmol). The product was stored as a solution in ethanol (10 mL). The identity of the labeled compound was confirmed by MS and by co-injection of the cold reference standard with the radiolabeled material. MS <i>m</i>/<i>z</i>: 286.9 [M + H]<sup>+</sup> (3%), 289.0 [M(<sup>3</sup>H) + H]<sup>+</sup> (14%), 290.9 [M(<sup>3</sup>H<sub>2</sub>) + H]<sup>+</sup> (76%), 292.9 [M(<sup>3</sup>H<sub>3</sub>) + H]<sup>+</sup> (7%).</div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <sup>11</sup>C- and <sup>18</sup>F-Radiolabeling</h3><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> General Methods for Carbon-11 and Fluorine-18 Syntheses</h4><div class="NLM_p last">All chemicals and solvents were ACS or HPLC purity and purchased through Aldrich Chemical Co. or Fisher Scientific except where noted. All solid phase extraction cartridges were conditioned with 10 mL of absolute ethanol followed by 10 mL of HPLC water. The radiochemical and chemical quality control HPLC chromatograms were acquired using an Agilent 1260 Infinity system incorporating a quaternary pump, HiP ALS autosampler, and DAD UV detector with a Max-Light flow plus a Bioscan Flow-Count interface with a NaI radioactivity detector. Chromatographic data were analyzed using Agilent OpenLAB chromatography data system (revision A.04.02). The microwave radiosynthesis module (MRM) used is a custom-made semiautomated radiosynthesis device constructed and controlled as previously described.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> The ELIXYS (Sofie Biosciences, Inc., Culver City, CA) module is a commercially available automated multireactor radiosynthesizer.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-(4-[<sup>11</sup>C]Methoxyphenyl)imidazo[1,2-<i>a</i>]pyridin-7-amine ([<sup>11</sup>C]<b>7</b>)</h4><div class="NLM_p last">A standard gas carbon dioxide target of a General Electric (GE) Medical Systems (GEMS, Uppsala, Sweden) PETTrace cyclotron was filled with high purity nitrogen containing 0.5% oxygen. The target was irradiated with a proton beam at 60 μA for 25 min to produce approximately 2–3 Ci (74–111 GBq) of [<sup>11</sup>C]carbon dioxide. The radioactive gas was transferred to a GE FXMeI module that synthesizes <sup>11</sup>CH<sub>3</sub>I in approximately 10 min, after which the <sup>11</sup>CH<sub>3</sub>I was transferred by helium gas to an appropriate hot cell for radiosynthesis. The precursor, compound <b>18</b> (1 ± 0.3 mg, 4.4 μmol), was dissolved in 200 μL of dimethylformamide (DMF) and added to a vial containing sodium hydride (0.6–1.0 mg) that was subsequently sealed. Prior to the end of bombardment (EOB), the vial was placed in a lead-lined synthesis cell. After trapping of <sup>11</sup>CH<sub>3</sub>I, the vial was heated (80 °C) for 3 min. The reaction solution was diluted with 1 mL of aqueous triethylamine/phosphoric acid buffer (pH 7.2; TEA buffer) and injected onto the semipreparative HPLC column (XBridge C-18, 10 μm, 10 mm × 150 mm), eluting with 20:80 absolute ethanol/TEA buffer (pH 7.2) at 10 mL/min (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 1 in Supporting Information</a>) with the effluent monitored for radioactivity content and UV (254 nm). The product peak (<i>t</i><sub>R</sub> = 5.6 min, <i>k</i>′ = 4.9) was collected in 50 mL of water containing approximately 250 mg of ascorbic acid. The product solution was eluted onto a conditioned Oasis SepPak Plus (Waters Corp.), and the SepPak was washed with water HPLC water (10 mL containing approximately 50 mg of ascorbic acid). The radiotracer product was eluted from the SepPak with absolute ethanol (1 mL) followed by sterile saline (10 mL) through a 0.2 μm sterile Millipore FG filter (25 mm) into a sterile product vial preloaded with sterile saline (4 mL). Aliquots were removed from the final product vial for quality control analysis. Analytical HPLC was performed to determine radiochemical and chemical purity, specific activity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 2 in Supporting Information</a>), and chemical identity using an XBridge C-18 column (3.5 μm, 4.6 mm × 100 mm) eluted with 20:80 acetonitrile (MeCN)/TEA buffer (pH 7.2), eluted at 2 mL/min, and monitored at 254 nm.</div></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-[<sup>11</sup>C]Methyl-2-(3-methylphenyl)imidazo[1,2-<i>a</i>]pyrimidine-7-amine ([<sup>11</sup>C]<b>8</b>)</h4><div class="NLM_p last"><sup>11</sup>CH<sub>3</sub>I (described above) was transferred by helium gas to an appropriate hot cell for radiosynthesis. The precursor, compound <b>32</b> (0.5 ± 0.2 mg, 2.2 μmol), was dissolved in 200 μL of dimethylsulfoxide (DMSO), and 5 μL of 6 N NaOH was added. Prior to EOB, the vial was placed in a hot cell. After addition of <sup>11</sup>CH<sub>3</sub>I, the reaction solution is heated (80 °C) for 3 min. The reaction solution was diluted with 200 μL of aqueous triethylamine/phosphoric acid buffer (pH 7.2; TEA buffer) and injected onto the semipreparative HPLC column (XBridge C-18, 10 μm, 10 mm × 150 mm) eluted with 20:80 absolute ethanol/TEA buffer (pH 7.2) at 10 mL/min (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 3 in Supporting Information</a>) with the effluent monitored for radioactivity content and UV (254 nm). The product peak (<i>t</i><sub>R</sub> = 8.5 min, <i>k</i>′ = 7.7) was collected in 50 mL of water containing approximately 250 mg of ascorbic acid. The product solution was eluted onto a conditioned Oasis SepPak Plus (Waters Corp.), the SepPak was washed with water, HPLC water. The radiotracer product was eluted from the SepPak with absolute ethanol (1 mL) followed by sterile saline (10 mL) through a 0.2 μm sterile Millipore FG filter (25 mm) into a sterile product vial preloaded with sterile saline (4 mL). Aliquots were removed from the final bottle for quality control analysis. Analytical HPLC was performed to determine radiochemical and chemical purity, specific activity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 4 in Supporting Information</a>), and chemical identity using an XBridge C-18 column (3.5 μm, 4.6 mm × 100 mm) eluted with 25:75 acetonitrile (MeCN)/TEA buffer (pH 7.2), eluted at 2 mL/min, and monitored at 254 nm.</div></div><div id="sec3_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> [<sup>18</sup>F]2-(6-Fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine ([<sup>18</sup>F]<b>9</b>) Using the Microwave Radiofluorination Module</h4><div class="NLM_p">[<sup>18</sup>O]Water (Huayi Isotopes, Jiangsu, China, approximately 2 mL) was loaded into the niobium body, high yield [<sup>18</sup>F]fluoride target of a GEMS PETTrace cyclotron. The target was irradiated with a proton beam of 55 μA for 30 min to produce approximately 1.65 Ci (61 GBq) of aqueous [<sup>18</sup>F]fluoride by the <sup>18</sup>O(p,n)<sup>18</sup>F nuclear reaction.</div><div class="NLM_p">The microwave radiosynthesis module (MRM) was prepared with all reagents and equipment prior to EOB. At EOB, the [<sup>18</sup>F]fluoride was trapped to a Chromafix 30-PS-HCO<sub>3</sub> SPE cartridge (ABX GmbH, Germany) previously conditioned with 1 mL of high purity water (Fluka). Under computer control, the resin was eluted with 150 μL of a potassium carbonate (K<sub>2</sub>CO<sub>3</sub>)/Kryptofix 2.2.2 stock solution (10 mg of K<sub>2</sub>CO<sub>3</sub> and 48 mg of Kryptofix dissolved in 600 μL of 1:1 MeCN/water) into a 5 mL reaction vial sealed with a multiport cap. After rinsing with 250 μL of MeCN, the vial was heated to 110 °C with nitrogen gas flow for 150 s. Two separate additions of 250 μL of MeCN were heated with gas flow for 150 and 180 s, respectively.</div><div class="NLM_p last">After the drying sequence was complete, the 5 cc V-vial was transferred to the microwave cavity cooled with airflow. The precursor, compound <b>49</b> (0.5 mg ±0.2 mg, 1.7 μmol), in 400 μL of DMSO was added to the vial. The vial was microwave irradiated with 50 W for 240 s. The solution was diluted with 1 mL of HPLC water and 3 mL of TEA buffer (pH 7.2). The crude solution was injected onto a Xbridge C-18 column (10 μm, 10 mm × 150 mm) eluted with a solution of 15:85 MeCN/aqueous triethylamine buffer (pH 7.2) at flow rate of 15 mL/min (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 5 in Supporting Information</a>). The product peak (<i>t</i><sub>R</sub> = 20.7 min, <i>k</i>′ = 33) was collected in a reservoir of 50 mL of HPLC water. The collected fraction was pushed by nitrogen through a C-18 SepPak Plus, and the SepPak was then rinsed with HPLC water (10 mL). The radiotracer product was eluted from the cartridge with absolute ethanol (1 mL) followed by sterile saline (10 mL) through a 0.2 μm sterile Millipore FG filter (25 mm) into a sterile product vial preloaded with sterile saline (4 mL). Aliquots were removed from the final bottle for quality control analysis. Analytical HPLC was performed to determine radiochemical and chemical purity, specific activity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 6 in Supporting Information</a>), and chemical identity using an XBridge C-18 column (3.5 μm, 4.6 mm × 100 mm) eluted with 40:60 methanol/TEA buffer (pH 7.2), eluted at 1.5 mL/min, and monitored at 350 nm.</div></div><div id="sec3_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> [<sup>18</sup>F]2-(6-Fluoropyridin-3-yl)pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridine ([<sup>18</sup>F]<b>9</b>) Using Standard Thermal Heating (ELIXYS)</h4><div class="NLM_p">Aqueous [<sup>18</sup>F]fluoride was prepared as described above. After all chemicals and components were loaded onto the ELIXYS synthesis cassette, the [<sup>18</sup>F]fluoride ion was delivered to a 5 mL V-vial in a dose calibrator. The automated ELIXYS synthesis sequence was started with pushing the [<sup>18</sup>F]fluoride ion with nitrogen through a Chromafix 30-PS-HCO<sub>3</sub> SPE cartridge previously preconditioned by washing with 1 mL of high purity water. [<sup>18</sup>O]Water was collected for recycling. The resin cartridge was eluted with a solution of K<sub>2</sub>CO<sub>3</sub> (4.0 mg, 28.9 μmol) and Kryptofix (20.0 mg, 53.1 μmol) in 250 μL of 1:1 MeCN/water into the 5 mL reactor V-vial with glass stir bar in the ELIXYS reactor. The solution was dried at 110 °C under vacuum and nitrogen flow for 120 s with stirring. Two separate additions of MeCN (600 μL) were heated under vacuum and nitrogen flow for 180 and 150 s, respectively.</div><div class="NLM_p last">The vial was cooled to room temperature, and a solution of the precursor compound <b>49</b> (0.5 mg, 1.7 μmol) in DMSO (500 μL) was added to the reaction vessel containing the dried [<sup>18</sup>F]fluoride. The solution was heated with stirring at 160 °C for 10 min. HPLC water (3.5 mL) was added to the reaction mixture prior to HPLC purification, formulation, and quality control as described above.</div></div><div id="sec3_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> [<sup>11</sup>C]-<i>N</i>-Cyclopropyl-2-(4-[<sup>11</sup>C]methoxyphenyl)imidazo[1,2-<i>a</i>]pyrimidin-7-amine ([<sup>11</sup>C]<b>34</b>)</h4><div class="NLM_p last"><sup>11</sup>CH<sub>3</sub>I (described above) was transferred by helium gas to an appropriate hot cell for radiosynthesis. The precursor, compound <b>35</b> (1 ± 0.3 mg, 3.8 μmol), was dissolved in 200 μL of DMF and then added to sodium hydride (0.6–1.0 mg) and sealed. Prior to the EOB, the vial was placed in a hot cell. After addition of <sup>11</sup>CH<sub>3</sub>I, the reaction solution is heated (80 °C) for 3 min. The reaction solution was diluted with 200 μL of aqueous triethylamine/phosphoric acid buffer (pH 7.2; TEA buffer) and injected onto the semipreparative HPLC column (XBridge C-18, 10 μm, 10 mm × 150 mm) eluted with 25:75 absolute ethanol/TEA buffer (pH 7.2) at 10 mL/min (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 7 in Supporting Information</a>) with the effluent monitored for radioactivity content and UV (254 nm). The product peak (<i>t</i><sub>R</sub> = 6.9 min, <i>k</i>′ = 5.9) was collected in 50 mL of water containing approximately 250 mg of ascorbic acid. The product solution was eluted onto a conditioned Oasis SepPak Plus (Waters Corp.), and the SepPak was washed with water, HPLC water. The radiotracer product was eluted from the SepPak with absolute ethanol (1 mL) followed by sterile saline (10 mL) through a 0.2 μm sterile Millipore FG filter (25 mm) into a sterile product vial preloaded with sterile saline (4 mL). Aliquots were removed from the final bottle for quality control analysis. Analytical HPLC was performed to determine radiochemical and chemical purity, specific activity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 8 in Supporting Information</a>), and chemical identity using an XBridge C-18 column (3.5 μm, 4.6 mm × 100 mm) eluted with 25:75 acetonitrile (MeCN)/TEA buffer (pH 7.2), eluted at 2 mL/min, and monitored at 254 nm.</div></div><div id="sec3_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> [<sup>18</sup>F]2-(4-(2-Fluoroethoxy)phenyl)-<i>N</i>-methylimidazo[1,2-<i>a</i>]pyrimidin-7-amine ([<sup>18</sup>F]<b>37</b>) Using the Microwave Radiofluorination Module</h4><div class="NLM_p last">Aqueous [<sup>18</sup>F]fluoride was prepared and dried as described above. After the drying sequence was complete, the 5 cc V-vial was transferred to the microwave cavity and cooled with airflow. The precursor, compound <b>38</b> (2 mg ± 0.5 mg, 4.6 μmol), in 400 μL of DMSO was added to the vial. The vial was microwave irradiated with 50 W for 80 s. The solution was diluted with 1 mL of HPLC water and was injected onto a Xbridge C-18 column (10 μm, 10 mm × 150 mm) eluted with a solution of 30:70 methanol (MeOH)/aqueous triethylamine buffer (pH 7.2) at a flow rate of 15 mL/min (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 9 in Supporting Information</a>). The product peak (<i>t</i><sub>R</sub> = 11.58 min, <i>k</i>′ = 15.4) was collected in a reservoir of 50 mL of HPLC water containing 250 mg of ascorbic acid. The collected fraction was pushed by nitrogen through an Oasis SepPak Plus, and the SepPak was rinsed with HPLC water (10 mL). The radiotracer product was eluted from the SepPak with absolute ethanol (1 mL) followed by sterile saline (10 mL) through a 0.2 μm sterile Millipore FG filter (25 mm) into a sterile product vial preloaded with sterile saline (4 mL). Aliquots were removed from the final bottle for quality control analysis. Analytical HPLC was performed to determine radiochemical and chemical purity, specific activity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">Figure 10 in Supporting Information</a>), and chemical identity using an XBridge C-18 column (3.5 μm, 4.6 mm × 100 mm) eluted with 20:80 acetonitrile/TEA buffer (pH 7.2), eluted at 2 mL/min, and monitored at 254 nm.</div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> In Vitro Biological Testing</h3><div id="sec3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> General Considerations</h4><div class="NLM_p last">All final compounds were examined for known classes of assay interference compounds (pan assay interference compounds, PAINS)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and classified as negative.</div></div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> In Vitro Autoradiography</h4><div class="NLM_p last">Fresh frozen human brain tissue blocks were purchased from the Banner Sun Health Research Institute (Sun City, AZ, USA). Pathological diagnosis of AD was made according to standard NIA-Reagan Institute criteria based on neuropathological data. Tissue sections (10 μm) were cut in a cryostat (Leica CM3050) at −17 °C chamber temperature and −15 °C object temperature and thaw-mounted on microscope glass slides (HistoBond, Paul Marienfeld GmbH, Lauda-Königshofen, Germany). Brain sections were incubated for 30 min in 50 mM Tris-HCl buffer at room temperature. For affinity testing of novel compounds, 10 nM [<sup>3</sup>H]<b>3</b> were co-incubated with 10 nM of the novel unlabeled compound. For macroautoradiographical analysis of novel compounds, the tritiated version of the compound was incubated at 3 nM. For microautoradiographies a radioligand concentration of 30 nM was used. After incubation all sections were rinsed three times for 10 min in ice-cold Tris buffer and dipped three times in distilled water at 4 °C. Slide-mounted brain sections were dried for at least 3 h and exposed to a Fuji imaging plate (BAS-TR 2025, Fujifilm, Dielsdorf, Switzerland) with a [<sup>3</sup>H]microscale (RPA-510, GE Healthcare, Glattbrugg, Switzerland) for 5 days. The imaging plate was scanned with 25 μm resolution in a Fujifilm high-resolution plate scanner (BAS-5000, Bucher Biotec AG, Basel, Switzerland). For microautoradiographies, the sections were dipped in NTB emulsion (Kodak) and kept for >2 weeks at 4 °C in a dark box before being developed for 2 min in Kodak developer solution, fixed for 5 min in Kodak fixer solution, and finally analyzed under the light microscope. Visualization and quantification of macroautoradiographies were performed with the MCID image analysis program (version 7; InterFocus Imaging GmbH, Mering, Germany). Total amount of radioligand bound (TB) to the brain areas of interest was expressed as fmol of bound radioligand per mg of protein. For affinity testing of novel compounds, TB was determined in gray matter (GM) regions of late-stage AD tissue sections with high tau pathology, nonspecific binding (NSB) was determined in a tau-free white matter (WM) region of the same tissue section, and specific binding (SB) was calculated as follows: SB = TB – NSB. The displacement potency of novel unlabeled test compounds was calculated according to the formula 100 – (SB<sub>test compound</sub>/SB<sub>radioligand only</sub>) × 100. For quantitative assessment of novel tritiated compounds, NSB was determined by calculating radioligand binding in GM regions of healthy control tissue sections devoid of tau pathology. SB to tau aggregates was assessed by quantifying the difference in binding to tau-rich cortical GM in AD tissue (TB) versus cortical GM of healthy controls (NSB). Signal-to-noise ratios (SNR) were quantified by calculating GM/WM ratios of radioligand binding to late-stage AD cortical tissue sections.</div></div><div id="sec3_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Immunohistochemical Colocalization</h4><div class="NLM_p last">Macro- and microautoradiographies were analyzed by costaining of NFTs and Aβ plaques on the same tissue section using the tau- and Aβ-specific antibodies pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (5 mg/mL, 2 h at room temperature). For macroautoradiographies, antibody incubation was performed after exposure and scanning of the sections. For microautoradiographies, the sections were first incubated with the antibodies before dipping in NTB emulsion and exposure.</div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Baboon PET Imaging</h3><div class="NLM_p last">Male baboons (Papio anubis), with a body weight of 22–28 kg, were used for this study. The experimental protocol was approved by the American Care and Use Committee of Johns Hopkins University. The animals were initially sedated intramuscularly with ketamine hydrochloride with restraint dosages of 7.5–10 mg/kg to achieve a light stage of anesthesia and then maintained on continuous propofol intravenous infusion at 0.3–0.4 mg kg<sup>–1</sup> min<sup>–1</sup> (DIPRIVAN injectable emulsion) after intubation. All tracers were delivered intravenously over 1 min as a slow bolus. The dynamic PET scanning started immediately upon initiation of the tracer infusion and continued for 90 min in 3D list mode. The following ranges of radiochemical and mass doses were used for the PET studies: 350–780 MBq; 0.045–1.26 μg. Each animal was positioned in an ECAT HRRT brain PET scanner (high resolution research tomography, CPS Innovations, Inc., Knoxville, TN). A 6 min transmission scan with a 37 MBq <sup>137</sup>Cs point source was initially done for attenuation correction. PET images were acquired in full 3D mode and reconstructed with high resolution span-3 modality with the following frame schedule: four 15 s, four 0.5 min, three 1 min, two 2 min, five 4 min, 12 5 min frames (total of 30 frames in 90 min). The image reconstruction procedure consisted of histogramming of the list-mode data into specified dynamic sinograms. The statistical 3D reconstruction of each frame sinogram used six iterations of the OP-OSEM algorithm (16 subsets), followed by 2 mm Gaussian postsmoothing. The attenuation, dead time, and decay corrections were performed for generation of quantitative dynamic images (image volume of 256 (left-to-right) by 256 (nasion-to-inion) by 207 (neck-to-cranium) voxels, voxel size of 1.22 mm by 1.22 mm by 1.22 mm). The final spatial resolution is expected to be about 2.5 mm full-width at half-maximum in three directions.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> A catheter was placed in the femoral artery to obtain arterial blood samples at various time points. Sampling of arterial blood was performed every 6 s during the first minute of the experiment and thereafter at intervals of progressively increasing duration. A total of about 42 samples were collected in each dynamic PET scan. Blood samples were immediately centrifuged, and plasma samples were assayed for radioactivity content using a γ counter that was cross-calibrated against the PET. Plasma from selected samples was analyzed by HPLC for the presence of parent compound and its radiolabeled metabolites using a general method developed previously for PET radiotracers.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> On the basis of the measurements at 0, 5, 10, 20, 30, 60, and 90 min, post-tracer injection, the metabolite ratio of each tracer at each time of arterial blood sampling was calculated using a linear interpolation method.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Then, the total radioactivity at each measurement was distributed to authentic tracer and metabolites. The metabolite-corrected plasma activity–time curve was used as the input function for tissue tracer kinetic modeling. The individual frames from 10 min to the end of the scan were summed into one frame for purposes of MRI-to-PET coregistration and visual presentation of PET images. A standard volume of interest template<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> was spatially aligned to the summed PET image of the first baseline scan of each subject. Then, VOIs were transferred to individual PET spaces according to realignment parameters between the first baseline scan and successive baseline and blocking scans for each animal. Minimal editing was allowed for individual images. VOIs were applied to individual PET frames to obtain VOI time–radioactivity curves.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00632">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00632" class="ext-link">10.1021/acs.jmedchem.7b00632</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Radiochemical synthesis procedure for [<sup>3</sup>H]<b>3</b>, radioactivity and ultraviolet chromatograms of [<sup>11</sup>C]<b>7</b>, [<sup>11</sup>C]<b>8</b>, [<sup>18</sup>F]<b>9</b>, [<sup>11</sup>C]<b>34</b>, and [<sup>18</sup>F]<b>37</b>, experimental details on the determination of drug distribution coefficients in octanol (log <i>D</i>), of brain lipids/water distribution coefficient (LIMBA log <i>D</i><sub>brain</sub>), and of high throughput passive membrane permeability assay (PAMPA) values, protocols for the single dose pharmacokinetics studies in mouse, the determination of P-gp-mediated drug transport, and the determination of drug binding to plasma proteins (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf">jm7b00632_si_001.pdf (1.18 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_002.csv">jm7b00632_si_002.csv (1.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00632" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca C. Gobbi</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0563-2491" title="Orcid link">http://orcid.org/0000-0002-0563-2491</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#472b32242669202825252e073528242f226924282a"><span class="__cf_email__" data-cfemail="315d4452501f565e53535871435e5259541f525e5c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henner Knust</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Körner</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Honer</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Czech</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara Belli</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieter Muri</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin R. Edelmann</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Hartung</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabella Erbsmehl</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Grall-Ulsemer</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Koblet</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marianne Rueher</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Steiner</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hayden T. Ravert</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William B. Mathews</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel P. Holt</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroto Kuwabara</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Valentine</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert F. Dannals</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean F. Wong</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">‡Department of Radiology, §Department of Psychiatry, and ∥Department of
Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edilio Borroni</span> - <span class="hlFld-Affiliation affiliation">Pharma
Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d197e7057-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We sincerely thank Roland Humm and the scientists at Chembiotek for the synthesis of compounds. We acknowledge the excellent technical assistance in generating the biological data of Patricia Glaentzlin, Céline Sutter, Svenja Moes, and Jennifer Beck. We thank Christian Bartelmus for collecting HR-MS spectroscopical data and Bjoern Wagner for testing compounds in the LIMBA assay. Additionally we thank the staff of the Johns Hopkins PET Radiotracer Center for their radiochemistry expertise. This study was funded by F. Hoffmann-La Roche Ltd. contract to The Johns Hopkins University (JHU). JHU faculty receive salary support through a number of sponsored research sources including DFW NIH Career Award K24 DA000412, and none receive direct funding from Roche except via sponsored JHU contracts.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i85" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i85"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i86" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i86"> Abbreviations Used</h2><tr><td class="NLM_term"><i>B</i>/<i>P</i></td><td class="NLM_def"><p class="first last">brain to plasma AUC ratio</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u_p</sub></td><td class="NLM_def"><p class="first last">free fraction in plasma</p></td></tr><tr><td class="NLM_term">GM</td><td class="NLM_def"><p class="first last">gray matter</p></td></tr><tr><td class="NLM_term">Kryptofix 2.2.2</td><td class="NLM_def"><p class="first last">4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane</p></td></tr><tr><td class="NLM_term">LIMBA</td><td class="NLM_def"><p class="first last">lipid membrane binding assay</p></td></tr><tr><td class="NLM_term">mAb</td><td class="NLM_def"><p class="first last">monoclonal antibody</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibrillary tangle</p></td></tr><tr><td class="NLM_term">Ns</td><td class="NLM_def"><p class="first last">nosyl</p></td></tr><tr><td class="NLM_term">NSB</td><td class="NLM_def"><p class="first last">nonspecific binding</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">neutropil thread</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">passive cell membrane permeability assay</p></td></tr><tr><td class="NLM_term">SB</td><td class="NLM_def"><p class="first last">specific binding</p></td></tr><tr><td class="NLM_term">SPE</td><td class="NLM_def"><p class="first last">solid phase extraction</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">WM</td><td class="NLM_def"><p class="first last">white matter</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Buee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee-Scherrer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1016/S0165-0173(00)00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0165-0173%2800%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10967355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=95-130&author=L.+Bueeauthor=T.+Bussiereauthor=V.+Buee-Scherrerauthor=A.+Delacourteauthor=P.+R.+Hof&title=Tau+protein+isoforms%2C+phosphorylation+and+role+in+neurodegenerative+disorders&doi=10.1016%2FS0165-0173%2800%2900019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span></div><div class="casAuthors">Buee, L.; Bussiere, T.; Buee-Scherrer, V.; Delacourte, A.; Hof, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-130</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 425 refs.  Tau proteins belong to the family of microtubule-assocd. proteins.  They are mainly expressed in neurons where they play an important role in the assembly of tubulin monomers into microtubules to constitute the neuronal microtubules network.  Microtubules are involved in maintaining the cell shape and serve as tracks for axonal transport.  Tau proteins also establish some links between microtubules and other cytoskeletal elements or proteins.  Tau proteins are translated from a single gene located on chromosome 17.  Their expression is developmentally regulated by an alternative splicing mechanism and six different isoforms exist in the human adult brain.  Tau proteins are the major constituents of intra-neuronal and glial fibrillar lesions described in Alzheimer's disease and numerous neurodegenerative disorders referred to as 'tauopathies'.  Mol. anal. has revealed that an abnormal phosphorylation might be one of the important events in the process leading to their aggregation.  Moreover, a specific set of pathol. tau proteins exhibiting a typical biochem. pattern, and a different regional and laminar distribution could characterize each of these disorders.  Finally, a direct correlation has been established between the progressive involvement of the neocortical areas and the increasing severity of dementia, suggesting that pathol. tau proteins are reliable marker of the neurodegenerative process.  The recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KNCSKfZ8_7Vg90H21EOLACvtfcHk0lg7KYqRJ7LP_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D&md5=d51d14c9e8b56e9661db4ae4afc2c943</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DBuee-Scherrer%26aufirst%3DV.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DTau%2520protein%2520isoforms%252C%2520phosphorylation%2520and%2520role%2520in%2520neurodegenerative%2520disorders%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26spage%3D95%26epage%3D130%26doi%3D10.1016%2FS0165-0173%2800%2900019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6457</span><span class="refDoi"> DOI: 10.1021/bi052530j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi052530j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6446-6457&author=M.+Von+Bergenauthor=S.+Barghornauthor=S.+A.+Muellerauthor=M.+Pickhardtauthor=J.+Biernatauthor=E.-M.+Mandelkowauthor=P.+Daviesauthor=U.+Aebiauthor=E.+Mandelkow&title=The+core+of+tau-paired+helical+filaments+studied+by+scanning+transmission+electron+microscopy+and+limited+proteolysis&doi=10.1021%2Fbi052530j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbi052530j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi052530j%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DS.%2BA.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DAebi%26aufirst%3DU.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DThe%2520core%2520of%2520tau-paired%2520helical%2520filaments%2520studied%2520by%2520scanning%2520transmission%2520electron%2520microscopy%2520and%2520limited%2520proteolysis%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D6446%26epage%3D6457%26doi%3D10.1021%2Fbi052530j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eZkf-tlrSOouLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Alzheimer’s Association.</span><span> </span><span class="NLM_article-title">2015 Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.jalz.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25984581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=332-384&author=Alzheimer%E2%80%99s+Association.&title=2015+Alzheimer%E2%80%99s+disease+facts+and+figures&doi=10.1016%2Fj.jalz.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2015%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D332%26epage%3D384%26doi%3D10.1016%2Fj.jalz.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankratz, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2FS1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0lhH16llI_4eIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present, and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andr%C3%A9s&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present%2C+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future</span></div><div class="casAuthors">Ariza, Manuela; Kolb, Hartmuth C.; Moechars, Dieder; Rombouts, Frederik; Andres, Jose Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4365-4382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population.  The good correlation of the d. and neocortical spread of neurofibrillary tangles (NFTs) with clin. AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomog. (PET).  Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD.  In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clin. development of tau PET radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr59qS3XVaWtrVg90H21EOLACvtfcHk0lhZ0aEeUpBtZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D&md5=4d6974529735d3483482e5d7365440e0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Dani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span> </span><span class="NLM_article-title">Tau imaging in neurodegenerative diseases</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span><span class="refDoi"> DOI: 10.1007/s00259-015-3231-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1007%2Fs00259-015-3231-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26572762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyhs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=1139-1150&author=M.+Daniauthor=D.+J.+Brooksauthor=P.+Edison&title=Tau+imaging+in+neurodegenerative+diseases&doi=10.1007%2Fs00259-015-3231-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging in neurodegenerative diseases</span></div><div class="casAuthors">Dani, M.; Brooks, D. J.; Edison, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1139-1150</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aggregated tau protein is a major neuropathol. substrate central to the pathophysiol. of neurodegenerative diseases such as Alzheimer's disease (AD), frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration and chronic traumatic encephalopathy.  In AD, it has been shown that the d. of hyperphosphorylated tau tangles correlates closely with neuronal dysfunction and cell death, unlike β-amyloid.  Until now, diagnostic and pathol. information about tau deposition has only been available from invasive techniques such as brain biopsy or autopsy.  The recent development of selective in-vivo tau PET imaging ligands including [18F]THK523, [18F]THK5117, [18F]THK5105 and [18F]THK5351, [18F]AV1451(T807) and [11C]PBB3 has provided information about the role of tau in the early phases of neurodegenerative diseases, and provided support for diagnosis, prognosis, and imaging biomarkers to track disease progression.  Moreover, the spatial and longitudinal relationship of tau distribution compared with β - amyloid and other pathologies in these diseases can be mapped.  In this review, we discuss the role of aggregated tau in tauopathies, the challenges posed in developing selective tau ligands as biomarkers, the state of development in tau tracers, and the new clin. information that has been uncovered, as well as the opportunities for improving diagnosis and designing clin. trials in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdgnXgdVuVrVg90H21EOLACvtfcHk0lhZ0aEeUpBtZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyhs7bO&md5=b6ec60c403b40d433dc45e1686e76c0b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3231-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3231-2%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DTau%2520imaging%2520in%2520neurodegenerative%2520diseases%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26spage%3D1139%26epage%3D1150%26doi%3D10.1007%2Fs00259-015-3231-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottelbergs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupakhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleiren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fierens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenaerts, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariën, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te Riele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintmolders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span> </span><span class="NLM_article-title">Discovery of N-(pyridin-4-yl)-1,5-naphthyridin-2-amines as potential tau pathology PET tracers for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01173</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01173" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVansrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1272-1291&author=F.+J.+R.+Romboutsauthor=J.-I.+Andr%C3%A9sauthor=M.+Arizaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=A.+Bottelbergsauthor=L.+Chenauthor=V.+Chupakhinauthor=E.+Cleirenauthor=K.+Fierensauthor=A.+Fontanaauthor=X.+Langloisauthor=J.+E.+Leenaertsauthor=J.+Mari%C3%ABnauthor=C.+Mart%C3%ADnez+Lamencaauthor=R.+Salterauthor=M.+E.+Schmidtauthor=P.+Te+Rieleauthor=C.+Wintmoldersauthor=A.+A.+Trabancoauthor=W.+Zhangauthor=G.+Macdonaldauthor=D.+Moechars&title=Discovery+of+N-%28pyridin-4-yl%29-1%2C5-naphthyridin-2-amines+as+potential+tau+pathology+PET+tracers+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's Disease</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Andres, Jose-Ignacio; Ariza, Manuela; Alonso, Jose Manuel; Austin, Nigel; Bottelbergs, Astrid; Chen, Lu; Chupakhin, Vladimir; Cleiren, Erna; Fierens, Katleen; Fontana, Alberto; Langlois, Xavier; Leenaerts, Joseph E.; Marien, Jonas; Martinez Lamenca, Carolina; Salter, Rhys; Schmidt, Mark E.; Te Riele, Paula; Wintmolders, Cindy; Trabanco, Andres A.; Zhang, Wei; Macdonald, Gregor; Moechars, Dieder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1272-1291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mini-HTS on 4000 compds. selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quinolin-2-amine 10 as a novel potent binder to human AD aggregated tau with modest selectivity vs. aggregated β-amyloid (Aβ).  Initial medicinal chem. efforts identified key elements for potency and selectivity, as well as suitable positions for radiofluorination, leading to a first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicochem. properties.  Further optimization toward a more optimal pharmacokinetic profile led to the discovery of 1,5-naphthyridine 75, a potent and selective tau aggregate binder with potential as a tau PET tracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNbRcRYA-oCbVg90H21EOLACvtfcHk0lhZ0aEeUpBtZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVansrs%253D&md5=e32ac5db8fe1dffe3d616fc375db0f68</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01173%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBottelbergs%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChupakhin%26aufirst%3DV.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DFierens%26aufirst%3DK.%26aulast%3DFontana%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DLeenaerts%26aufirst%3DJ.%2BE.%26aulast%3DMari%25C3%25ABn%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez%2BLamenca%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DTe%2BRiele%26aufirst%3DP.%26aulast%3DWintmolders%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520N-%2528pyridin-4-yl%2529-1%252C5-naphthyridin-2-amines%2520as%2520potential%2520tau%2520pathology%2520PET%2520tracers%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1272%26epage%3D1291%26doi%3D10.1021%2Facs.jmedchem.6b01173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span><span class="refDoi"> DOI: 10.2967/jnumed.113.136069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.113.136069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers&doi=10.2967%2Fjnumed.113.136069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.136069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.136069%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874%26doi%3D10.2967%2Fjnumed.113.136069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Shin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">The merits of FDDNP-PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.3233/JAD-2011-0008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-2011-0008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21971458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=135-145&issue=Suppl.+3&author=J.+Shinauthor=V.+Kepeauthor=J.+R.+Barrioauthor=G.+W.+Small&title=The+merits+of+FDDNP-PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-0008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Merits of FDDNP-PET Imaging in Alzheimer's Disease</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Shin, Jonghan; Kepe, Vladimir; Barrio, Jorge R.; Small, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  2-(1-{6-[(2-[Fluorine-18]fluoroethyl)(methyl)amino]-2-naphthyl}-ethylidene)malononitrile (FDDNP) is the first positron emission tomog. (PET) mol. imaging probe to visualize Alzheimer's disease (AD) pathol. in living humans.  The most unique features of FDDNP are that (1) it is the only currently available radiotracer to image neurofibrillary tangles, beside amyloid aggregates, in living humans; and (2) it is also the only radiotracer to visualize AD pathol. in the hippocampal region of living humans.  In this article, we discuss FDDNP's unique ability to image tau pathol. in living humans.  Emphasizing tau pathol. imaging capability using FDDNP in AD, as well as other tauopathies, is timely and beneficial considering that (1) post mortem histopathol. studies using human specimens have consistently demonstrated that neurofibrillary tangles, compared with amyloid plaques, are better correlated with the disease severity and neuronal death; and (2) recently reported clin. trial failures of disease-modifying drugs in development, based on the amyloid-cascade hypothesis, suggest that some of the basic assumptions of AD causality warrant reassessment and redirection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmfShnsgqf7Vg90H21EOLACvtfcHk0lg7FRA6RDJ73A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J&md5=3f18072cd1d9516c234e493d2fc500ec</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-0008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-0008%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DThe%2520merits%2520of%2520FDDNP-PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26issue%3DSuppl.%25203%26spage%3D135%26epage%3D145%26doi%3D10.3233%2FJAD-2011-0008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Shoghi-Jadid, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1097/00019442-200201000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1097%2F00019442-200201000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11790632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FntF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=24-35&author=K.+Shoghi-Jadidauthor=G.+W.+Smallauthor=E.+D.+Agdeppaauthor=V.+Kepeauthor=L.+M.+Ercoliauthor=P.+Siddarthauthor=S.+Readauthor=N.+Satyamurthyauthor=A.+Petricauthor=S.-C.+Huangauthor=J.+R.+Barrio&title=Localization+of+neurofibrillary+tangles+and+beta-amyloid+plaques+in+the+brains+of+living+patients+with+Alzheimer+disease&doi=10.1097%2F00019442-200201000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease</span></div><div class="casAuthors">Shoghi-Jadid Kooresh; Small Gary W; Agdeppa Eric D; Kepe Vladimir; Ercoli Linda M; Siddarth Prabha; Read Stephen; Satyamurthy Nagichettiar; Petric Andrej; Huang Sung-Cheng; Barrio Jorge R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>
        ISSN:<span class="NLM_cas:issn">1064-7481</span>.
    </div><div class="casAbstract">The authors used 2-(1-(6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl)ethylidene)malononitrile ([18F]FDDNP), a hydrophobic radiofluorinated derivative of 2-(1-[6-(dimethylamino)-2-naphthyl]ethylidene)malononitrile (DDNP), in conjunction with positron emission tomography to determine the localization and load of neurofibrillary tangles (NFTs) and beta-amyloid senile plaques (APs) in the brains of living Alzheimer disease (AD) patients.  Previous work illustrated the in vitro binding characteristics of [18F]FDDNP to synthetic beta-amyloid(1-40) fibrils and to NFTs and APs in human AD brain specimens.  In the present study, greater accumulation and slower clearance was observed in AP- and NFT-dense brain areas and correlated with lower memory performance scores.  The relative residence time of the probe in brain regions affected by AD was significantly greater in patients with AD (n=9) than in control subjects (n=7; p=0.0007).  This noninvasive technique for monitoring AP and NFT development is expected to facilitate diagnostic assessment of patients with AD and assist in response-monitoring during experimental treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDj7JxSapyzs25P7XSLhESfW6udTcc2ebmOcAdW1oB2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FntF2ltw%253D%253D&md5=a6454002bae6d60ff1cef57a0fc85c55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00019442-200201000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00019442-200201000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DShoghi-Jadid%26aufirst%3DK.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DRead%26aufirst%3DS.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DLocalization%2520of%2520neurofibrillary%2520tangles%2520and%2520beta-amyloid%2520plaques%2520in%2520the%2520brains%2520of%2520living%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2002%26volume%3D10%26spage%3D24%26epage%3D35%26doi%3D10.1097%2F00019442-200201000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eaEwueXpny25Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0lg_R2PJ1a--Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.,  Sr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navitsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaerf, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1093/brain/aww334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1093%2Fbrain%2Faww334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=28077397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC1c7kslCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=748-763&author=M.+J.+Pontecorvoauthor=M.+D.+Devousauthor=M.+Navitskyauthor=M.+Luauthor=S.+Sallowayauthor=F.+W.+Schaerfauthor=D.+Jenningsauthor=A.+K.+Aroraauthor=A.+McGeehanauthor=N.+C.+Limauthor=H.+Xiongauthor=A.+D.+Joshiauthor=A.+Siderowfauthor=M.+A.+Mintun&title=Relationships+between+flortaucipir+PET+tau+binding+and+amyloid+burden%2C+clinical+diagnosis%2C+age+and+cognition&doi=10.1093%2Fbrain%2Faww334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition</span></div><div class="casAuthors">Pontecorvo Michael J; Devous Michael D Sr; Navitsky Michael; Lu Ming; Arora Anupa K; McGeehan Anne; Lim Nathaniel C; Xiong Hui; Joshi Abhinay D; Siderowf Andrew; Mintun Mark A; Salloway Stephen; Schaerf Frederick W; Jennings Danna</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">748-763</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The advent of tau-targeted positron emission tomography tracers such as flortaucipir (18F-AV-1451, also known as 18F-T807) have made it possible to investigate the sequence of development of tau and amyloid-β in relationship to age, and to the development of cognitive impairment due to Alzheimer's disease.  In this study, flortaucipir tau and florbetapir amyloid positron emission tomography were obtained for 217 subjects including 16 young and 58 older cognitively normal subjects, 95 subjects with mild cognitive impairment (Mini-Mental State Examination 24-30) and 48 subjects with clinically-defined possible or probable Alzheimer's disease (Mini-Mental State Examination >10).  Images were evaluated visually and quantitatively by regional and voxel-based cortical to cerebellar standard uptake value ratios.  For amyloid positron emission tomography positive (Aβ+) subjects, flortaucipir neocortical standard uptake value ratio was significantly higher with more advanced clinical stage (Alzheimer's disease > mild cognitive impairment > older cognitively normal) and was significantly elevated for Aβ+ mild cognitive impairment and Alzheimer's disease subjects relative to the respective Aβ- subjects.  In contrast, florbetapir Aβ- older cognitively normal subjects showed an increase in flortaucipir standard uptake value ratios in mesial temporal lobe regions (amygdala, hippocampus/choroid plexus region of interest) compared to younger cognitively normal subjects, but no increased standard uptake value ratios in neocortical regions.  Analysis of covariance with planned contrasts showed no differences in regional or composite posterior neocortical flortaucipir standard uptake value ratio as a function of diagnostic group among Aβ- older cognitively normal or clinically diagnosed Alzheimer's disease or mild cognitive impairment subjects.  The pattern of flortaucipir distribution among Aβ+ subjects was reminiscent of the cross-sectional distribution of tau reported in post-mortem pathology studies, in that the most commonly affected regions were the inferior and lateral temporal lobes, the same regions where the first signs of increased retention appeared in Aβ+ cognitively normal subjects.  However, there was large variability in extent/density of flortaucipir tau binding among Aβ+ subjects.  Although high neocortical flortaucipir retention was consistently associated with an Aβ+ florbetapir positron emission tomography scan, not all Aβ+ subjects had elevated flortaucipir standard uptake value ratios.  Finally, within the Aβ+ group, increasing levels of flortaucipir tau binding were associated with increased cognitive impairment, as assessed by Mini-Mental State Examination and Alzheimer's Disease Assessment Scale.  These results suggest development of tau beyond the mesial temporal lobe is associated with, and may be dependent on, amyloid accumulation.  Further, the results are consistent with the hypothesis that cortical tau is associated with cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIkDeaqfdY7MvLc4ARHEmzfW6udTcc2eb_ujHg6ssiDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7kslCjtA%253D%253D&md5=b83b958e22c18fbc5dd63b42e4fa9072</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faww334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faww334%26sid%3Dliteratum%253Aachs%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DNavitsky%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSchaerf%26aufirst%3DF.%2BW.%26aulast%3DJennings%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DA.%2BK.%26aulast%3DMcGeehan%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DN.%2BC.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DRelationships%2520between%2520flortaucipir%2520PET%2520tau%2520binding%2520and%2520amyloid%2520burden%252C%2520clinical%2520diagnosis%252C%2520age%2520and%2520cognition%26jtitle%3DBrain%26date%3D2017%26volume%3D140%26spage%3D748%26epage%3D763%26doi%3D10.1093%2Fbrain%2Faww334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+K.+Szardeningsauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2eb_ujHg6ssiDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies&doi=10.3233%2FJAD-2012-120712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang, Wei; Arteaga, Janna; Cashion, Daniel K.; Chen, Gang; Gangadharmath, Umesh; Gomez, Luis F.; Kasi, Dhanalakshmi; Lam, Chung; Liang, Qianwa; Liu, Changhui; Mocharla, Vani P.; Mu, Fanrong; Sinha, Anjana; Szardenings, A. Katrin; Wang, Eric; Walsh, Joseph C.; Xia, Chunfang; Yu, Chul; Zhao, Tieming; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-612</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathol. hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a no. of amyloid-β positron emission tomog. (PET) tracers currently in different stages of clin. development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compds. utilizing a unique screening process.  A competitive autoradiog. assay was set up to test compds. for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compd. [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclin. in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCPcTCD2ucRLVg90H21EOLACvtfcHk0liFAvYfukr-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI&md5=f9b40fa67928e2cbaa876fbaef62ff70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612%26doi%3D10.3233%2FJAD-2012-120712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26541774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Tago, Tetsuro; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Imaging of neurofibrillary pathol. in the brain helps in diagnosing dementia, tracking disease progression, and evaluating the therapeutic efficacy of antidementia drugs.  The radiotracers used in this imaging must be highly sensitive and specific for tau protein fibrils in the human brain.  We developed a novel tau PET tracer, 18F-THK5351, through compd. optimization of arylquinoline derivs.  Methods: The in vitro binding properties, pharmacokinetics, and safety of 18F-THK5351 were investigated, and a clin. study on Alzheimer disease (AD) patients was performed.  Results:18F-THK5351 demonstrated higher binding affinity for hippocampal homogenates from AD brains and faster dissocn. from white-matter tissue than did 18F-THK5117.  The THK5351 binding amt. correlated with the amt. of tau deposits in human brain samples.  Autoradiog. of brain sections revealed that THK5351 bound to neurofibrillary tangles selectively and with a higher signal-to-background ratio than did THK5117.  THK5351 exhibited favorable pharmacokinetics and no defluorination in mice.  In first-in-human PET studies in AD patients, 18F-THK5351 demonstrated faster kinetics, higher contrast, and lower retention in subcortical white matter than 18F-THK5117.  Conclusion:18F-THK5351 is a useful PET tracer for the early detection of neurofibrillary pathol. in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_bH5nh_KBLVg90H21EOLACvtfcHk0lgBKfWWkBaKCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D&md5=f488c442abb7ca31d5b66fbe60afd14e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.-R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.-K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0lgBKfWWkBaKCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wood, H.</span><span> </span><span class="NLM_article-title">Alzheimer disease: [<sup>11</sup>C]PBB3 - a new PET ligand that identifies tau pathology in the brains of patients with AD</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="refDoi"> DOI: 10.1038/nrneurol.2013.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrneurol.2013.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24145369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FosV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=599&author=H.+Wood&title=Alzheimer+disease%3A+%5B11C%5DPBB3+-+a+new+PET+ligand+that+identifies+tau+pathology+in+the+brains+of+patients+with+AD&doi=10.1038%2Fnrneurol.2013.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: [11C]PBB3--a new PET ligand that identifies tau pathology in the brains of patients with AD</span></div><div class="casAuthors">Wood Heather</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">599</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2eJd9xPq30d1QT_1O5WBYfW6udTcc2ebKIAao8TqjA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FosV2nsw%253D%253D&md5=ef3553346355cd9ef7c28d46fb0d8d01</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2013.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2013.216%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DH.%26atitle%3DAlzheimer%2520disease%253A%2520%255B11C%255DPBB3%2520-%2520a%2520new%2520PET%2520ligand%2520that%2520identifies%2520tau%2520pathology%2520in%2520the%2520brains%2520of%2520patients%2520with%2520AD%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D599%26doi%3D10.1038%2Fnrneurol.2013.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obrien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-(fluoro-<sup>18</sup>F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([<sup>18</sup>F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4778</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4778-4789&author=A.+M.+Waljiauthor=E.+D.+Hostetlerauthor=H.+Selnickauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=M.+Holahanauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=J.+Liauthor=J.+Balsellsauthor=J.+A.+Obrienauthor=S.+Melquistauthor=A.+Sorianoauthor=X.+Zhangauthor=A.+Ogawaauthor=S.+Xuauthor=E.+M.+Joshiauthor=J.+Della+Roccaauthor=F.+J.+Hessauthor=J.+Schachterauthor=D.+Heskauthor=D.+Schenkauthor=A.+Struykauthor=K.+Babaogluauthor=T.+G.+Lohithauthor=Y.+Wangauthor=K.+Yangauthor=J.+Fuauthor=J.+L.+Evelhochauthor=P.+J.+Coleman&title=Discovery+of+6-%28fluoro-18F%29-3-%281H-pyrrolo%5B2%2C3-c%5Dpyridin-1-yl%29isoquinolin-5-amine+%28%5B18F%5D-MK-6240%29%3A+a+positron+emission+tomography+%28PET%29+imaging+agent+for+quantification+of+neurofibrillary+tangles+%28NFTs%29&doi=10.1021%2Facs.jmedchem.6b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)</span></div><div class="casAuthors">Walji, Abbas M.; Hostetler, Eric D.; Selnick, Harold; Zeng, Zhizhen; Miller, Patricia; Bennacef, Idriss; Salinas, Cristian; Connolly, Brett; Gantert, Liza; Holahan, Marie; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Li, Jing; Balsells, Jaume; OBrien, Julie A.; Melquist, Stacey; Soriano, Aileen; Zhang, Xiaoping; Ogawa, Aimie; Xu, Serena; Joshi, Elizabeth; Della Rocca, Joseph; Hess, Fred J.; Schachter, Joel; Hesk, David; Schenk, David; Struyk, Arie; Babaoglu, Kerim; Lohith, Talakad G.; Wang, Yaode; Yang, Kun; Fu, Jianmin; Evelhoch, Jeffrey L.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4778-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathol. hallmark of several neurodegenerative diseases including Alzheimer's disease.  In vivo detection of NFTs using PET imaging represents a unique opportunity to develop a pharmacodynamic tool to accelerate the discovery of new disease modifying therapeutics targeting tau pathol.  Herein, we present the discovery of 6-(fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine, 6 ([18F]-MK-6240), as a novel PET tracer for detecting NFTs. 6 exhibits high specificity and selectivity for binding to NFTs, with suitable physicochem. properties and in vivo pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTkJBwXYLQ4LVg90H21EOLACvtfcHk0liJE7qeYC5S1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D&md5=7155752a95bc279765280108b794a758</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00166%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DObrien%26aufirst%3DJ.%2BA.%26aulast%3DMelquist%26aufirst%3DS.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DE.%2BM.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DStruyk%26aufirst%3DA.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25206-%2528fluoro-18F%2529-3-%25281H-pyrrolo%255B2%252C3-c%255Dpyridin-1-yl%2529isoquinolin-5-amine%2520%2528%255B18F%255D-MK-6240%2529%253A%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520agent%2520for%2520quantification%2520of%2520neurofibrillary%2520tangles%2520%2528NFTs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4778%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.6b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span> </span><span class="NLM_article-title">Preclinical characterization of [<sup>18</sup>F]-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span><span class="refDoi"> DOI: 10.2967/jnumed.115.171678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.115.171678" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1599-1606&author=E.+D.+Hostetlerauthor=A.+M.+Waljiauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=H.+Haleyauthor=M.+Holahanauthor=M.+Purcellauthor=K.+Riffelauthor=T.+G.+Lohithauthor=P.+Colemanauthor=A.+Sorianoauthor=A.+Ogawaauthor=S.+Xuauthor=X.+Zhangauthor=E.+Joshiauthor=J.+Della+Roccaauthor=D.+Heskauthor=D.+J.+Schenkauthor=J.+L.+Evelhoch&title=Preclinical+characterization+of+%5B18F%5D-MK-6240%2C+a+promising+PET+tracer+for+in+vivo+quantification+of+human+neurofibrillary+tangles&doi=10.2967%2Fjnumed.115.171678"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.171678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.171678%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHaley%26aufirst%3DH.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DColeman%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJoshi%26aufirst%3DE.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%2BJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DPreclinical%2520characterization%2520of%2520%255B18F%255D-MK-6240%252C%2520a%2520promising%2520PET%2520tracer%2520for%2520in%2520vivo%2520quantification%2520of%2520human%2520neurofibrillary%2520tangles%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1599%26epage%3D1606%26doi%3D10.2967%2Fjnumed.115.171678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[1,2-<i>a</i>]pyridin-7-amines as imaging tools</span>. WO2015044095 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+imidazo%5B1%2C2-a%5Dpyridin-7-amines+as+imaging+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520imidazo%255B1%252C2-a%255Dpyridin-7-amines%2520as%2520imaging%2520tools%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of 2-phenylimidazo[1,2-<i>a</i>]pyrimidines as imaging agents for diagnosis of Alzheimer’s disease</span>. WO2014187762 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+2-phenylimidazo%5B1%2C2-a%5Dpyrimidines+as+imaging+agents+for+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%25202-phenylimidazo%255B1%252C2-a%255Dpyrimidines%2520as%2520imaging%2520agents%2520for%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of diazacarbazole derivatives as tau PET ligands</span>. WO2015052105 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+diazacarbazole+derivatives+as+tau+PET+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520diazacarbazole%2520derivatives%2520as%2520tau%2520PET%2520ligands%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span><span class="refDoi"> DOI: 10.1371/journal.pbio.1001080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid&doi=10.1371%2Fjournal.pbio.1001080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0lgicZfqkyLY5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080%26doi%3D10.1371%2Fjournal.pbio.1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Childers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynn, D. G.</span><span> </span><span class="NLM_article-title">Templating molecular arrays in Amyloid’s cross-β grooves</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">10165</span><span class="NLM_x">–</span> <span class="NLM_lpage">10172</span><span class="refDoi"> DOI: 10.1021/ja902332s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902332s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=10165-10172&author=W.+S.+Childersauthor=A.+K.+Mehtaauthor=K.+Luauthor=D.+G.+Lynn&title=Templating+molecular+arrays+in+Amyloid%E2%80%99s+cross-%CE%B2+grooves&doi=10.1021%2Fja902332s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Templating Molecular Arrays in Amyloid's Cross-β Grooves</span></div><div class="casAuthors">Childers, W. Seth; Mehta, Anil K.; Lu, Kun; Lynn, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10165-10172</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid fibers, independent of primary amino acid sequence, share a common cross-β structure and bind the histochem. dye Congo Red (CR).  Despite extensive use of CR in amyloid diagnostics, remarkably little is known about the specific and characteristic binding interactions.  Fibril insoly., morphol. inhomogeneity, and multiple possible ligand binding sites all conspire to limit characterization.  Here, the authors have exploited the structure of cross-β nanotubes, which limit the no. of potential binding sites, to directly interrogate cross-β laminate grooves.  CR bound to cross-β nanotubes displays the hallmark apple-green interference color, a broad red-shifted low energy transition, and a Kd of 1.9±0.5 μM.  Oriented electron diffraction and linear dichroism defines the orientation of CR as parallel to the amyloid long axis and colinear with laminate grooves.  The broad red-shifted UV signature of CR bound to amyloid can be explained by semiempirical quantum calcns. that support the existence of a precise network of J- and H-CR aggregates, illuminating the ability of the amyloid to organize mols. into extended arrays that underlie the remarkable diagnostic potential of CR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPa_oIWRaGCrVg90H21EOLACvtfcHk0lgicZfqkyLY5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWktLs%253D&md5=246cba3b95997fa83e8b605a1e088bdf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja902332s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902332s%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BS.%26aulast%3DMehta%26aufirst%3DA.%2BK.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DLynn%26aufirst%3DD.%2BG.%26atitle%3DTemplating%2520molecular%2520arrays%2520in%2520Amyloid%25E2%2580%2599s%2520cross-%25CE%25B2%2520grooves%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D10165%26epage%3D10172%26doi%3D10.1021%2Fja902332s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Schuetz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soragni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span> </span><span class="NLM_article-title">The amyloid-congo red interface at atomic resolution</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5956</span><span class="NLM_x">–</span> <span class="NLM_lpage">5960</span><span class="refDoi"> DOI: 10.1002/anie.201008276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fanie.201008276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5956-5960&author=A.+K.+Schuetzauthor=A.+Soragniauthor=S.+Hornemannauthor=A.+Aguzziauthor=M.+Ernstauthor=A.+Boeckmannauthor=B.+H.+Meier&title=The+amyloid-congo+red+interface+at+atomic+resolution&doi=10.1002%2Fanie.201008276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201008276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201008276%26sid%3Dliteratum%253Aachs%26aulast%3DSchuetz%26aufirst%3DA.%2BK.%26aulast%3DSoragni%26aufirst%3DA.%26aulast%3DHornemann%26aufirst%3DS.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DErnst%26aufirst%3DM.%26aulast%3DBoeckmann%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26atitle%3DThe%2520amyloid-congo%2520red%2520interface%2520at%2520atomic%2520resolution%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D5956%26epage%3D5960%26doi%3D10.1002%2Fanie.201008276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lghevObQ4FfHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martarello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span> </span><span class="NLM_article-title">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.drudis.2014.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25173703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1936-1944&author=M.+Honerauthor=L.+Gobbiauthor=L.+Martarelloauthor=R.+A.+Comley&title=Radioligand+development+for+molecular+imaging+of+the+central+nervous+system+with+positron+emission+tomography&doi=10.1016%2Fj.drudis.2014.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span></div><div class="casAuthors">Honer, Michael; Gobbi, Luca; Martarello, Laurent; Comley, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1936-1944</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) is routinely used to support the development of drugs to treat neurol. and psychiatric disorders.  PET radioligands must not only be selective for the target of interest but must also possess a range of physicochem. and pharmacol. characteristics that allow them to be radiolabeled with short-lived positron-emitting isotopes, safely administered to humans, and for the degree of target binding to be quantified in vivo.  We review the ligand development process, including target selection, radioligand discovery (in vitro and preclin. evaluation), radiochem. and evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOrjEdZ64wLVg90H21EOLACvtfcHk0lghevObQ4FfHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE&md5=9ae3bb3030cdc3a701be1df568190371</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DMartarello%26aufirst%3DL.%26aulast%3DComley%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520development%2520for%2520molecular%2520imaging%2520of%2520the%2520central%2520nervous%2520system%2520with%2520positron%2520emission%2520tomography%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1936%26epage%3D1944%26doi%3D10.1016%2Fj.drudis.2014.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">Considerations in the development of reversibly binding PET radioligands for brain imaging</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span><span class="refDoi"> DOI: 10.2174/0929867323666160418114826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2174%2F0929867323666160418114826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=27087244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFGqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1818-1869&author=V.+W.+Pike&title=Considerations+in+the+development+of+reversibly+binding+PET+radioligands+for+brain+imaging&doi=10.2174%2F0929867323666160418114826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1818-1869</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The development of reversibly binding radioligands for imaging brain proteins in vivo, such as enzymes, neurotransmitter transporters, receptors and ion channels, with positron emission tomog. (PET) is keenly sought for biomedical studies of neuropsychiatric disorders and for drug discovery and development, but is recognized as being highly challenging at the medicinal chem. level.  This article aims to compile and discuss the main considerations to be taken into account by chemists embarking on programs of radioligand development for PET imaging of brain protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmdw3kTJmoxLVg90H21EOLACvtfcHk0lix6ezgE0r1-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFGqsrnI&md5=410265974a2a4569dea72376dcf6a8a1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160418114826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160418114826%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DConsiderations%2520in%2520the%2520development%2520of%2520reversibly%2520binding%2520PET%2520radioligands%2520for%2520brain%2520imaging%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1818%26epage%3D1869%26doi%3D10.2174%2F0929867323666160418114826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhang, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Synthesis of pyrimido[4,5-<i>b</i>]indoles and benzo[4,5]furo[2,3-<i>d</i>]pyrimidines via palladium-catalyzed intramolecular arylation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">8235</span><span class="NLM_x">–</span> <span class="NLM_lpage">8239</span><span class="refDoi"> DOI: 10.1016/S0040-4039(02)02036-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0040-4039%2802%2902036-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVylurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=8235-8239&author=Y.-M.+Zhangauthor=T.+Razlerauthor=P.+F.+Jackson&title=Synthesis+of+pyrimido%5B4%2C5-b%5Dindoles+and+benzo%5B4%2C5%5Dfuro%5B2%2C3-d%5Dpyrimidines+via+palladium-catalyzed+intramolecular+arylation&doi=10.1016%2FS0040-4039%2802%2902036-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines via palladium-catalyzed intramolecular arylation</span></div><div class="casAuthors">Zhang, Yue-Mei; Razler, Thomas; Jackson, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">8235-8239</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Various pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines were synthesized via a palladium-catalyzed intramol. arylation of pyrimidine substrates.  Thus, 4-aryloxy- or 4-anilino-5-iodopyrimidines, e.g. I, were treated with Pd(OAc)2(PPh3)2 and base in DMF to give the regioselective cyclized heterocycles, e.g. II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwaJ2_1zmIu7Vg90H21EOLACvtfcHk0lix6ezgE0r1-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVylurg%253D&md5=21958a59ec9365c318f188899fc3a049</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2902036-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252902036-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-M.%26aulast%3DRazler%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DSynthesis%2520of%2520pyrimido%255B4%252C5-b%255Dindoles%2520and%2520benzo%255B4%252C5%255Dfuro%255B2%252C3-d%255Dpyrimidines%2520via%2520palladium-catalyzed%2520intramolecular%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D8235%26epage%3D8239%26doi%3D10.1016%2FS0040-4039%2802%2902036-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lix6ezgE0r1-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Assmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaentzlin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span> </span><span class="NLM_article-title">Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1016/j.ejps.2015.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.ejps.2015.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26341407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGgs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=27-35&author=F.+Assmusauthor=A.+Seeligauthor=L.+Gobbiauthor=E.+Borroniauthor=P.+Glaentzlinauthor=H.+Fischer&title=Label-free+assay+for+the+assessment+of+nonspecific+binding+of+positron+emission+tomography+tracer+candidates&doi=10.1016%2Fj.ejps.2015.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates</span></div><div class="casAuthors">Assmus, Frauke; Seelig, Anna; Gobbi, Luca; Borroni, Edilio; Glaentzlin, Patricia; Fischer, Holger</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) is a valuable non-invasive technique for the visualization of drug tissue distribution and receptor occupancy at the target site in living animals and men.  Many potential PET tracers, however, fail due to an unfavorably high non-specific binding (NSB) to non-target proteins and phospholipid membranes which compromises the sensitivity of PET.  Hence, there is a high demand to assess the extent of NSB as early as possible in the PET tracer development process, preferentially before ligands are radiolabeled and elaborate imaging studies are performed.  The purpose of this study was to establish a novel Lipid Membrane Binding Assay (LIMBA) for assessing the tendency of potential tracers to bind non-specifically to brain tissue.  The assay works with unlabeled compds. and allows the medium-throughput measurement of brain tissue/water distribution coeffs., logDbrain (pH 7.4), at minimal expense of animal tissue.  To validate LIMBA, logDbrain (pH 7.4) values were measured and compared with NSB ests. derived from in vivo PET studies in human brain (n = 10 tracers, literature data), and in vitro autoradiog. studies in rat and mouse brain slices (n = 30 tritiated radioligands).  Good agreement between logDbrain (pH 7.4) and the vol. of distribution in brain of non-specifically bound tracer in PET was achieved, pertaining to compds. classified as non-substrates of P-glycoprotein (R2 ≥ 0.88).  The ability of LIMBA for the prediction of NSB was further supported by the strong correlation between logDbrain (pH 7.4) and NSB in brain autoradiog. (R2 ≥ 0.76), whereas octanol/water distribution coeffs., logDoct (pH 7.4) were less predictive.  In conclusion, LIMBA provides a fast and reliable tool for identifying compds. with unfavorably high NSB in brain tissue.  The data may be used in conjunction with other parameters like target affinity, d. and membrane permeability for the selection of most promising compds. to be further investigated in vivo as potential novel PET tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQSBHKYXu7F7Vg90H21EOLACvtfcHk0liE52PJCOrB9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGgs77O&md5=1b6fee87a0f08c9640b09cf3813c8362</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DAssmus%26aufirst%3DF.%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DGlaentzlin%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26atitle%3DLabel-free%2520assay%2520for%2520the%2520assessment%2520of%2520nonspecific%2520binding%2520of%2520positron%2520emission%2520tomography%2520tracer%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D79%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.ejps.2015.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Belli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Sánchez, R.</span><span> </span><span class="NLM_article-title">Estimation of drug binding to brain tissue: methodology and in vivo application of a distribution assay in brain polar lipids</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4529</span><span class="NLM_x">–</span> <span class="NLM_lpage">4541</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSlsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4529-4541&author=S.+Belliauthor=F.+Assmusauthor=B.+Wagnerauthor=M.+Honerauthor=H.+Fischerauthor=F.+Schulerauthor=R.+Alvarez-S%C3%A1nchez&title=Estimation+of+drug+binding+to+brain+tissue%3A+methodology+and+in+vivo+application+of+a+distribution+assay+in+brain+polar+lipids&doi=10.1021%2Facs.molpharmaceut.5b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Drug Binding to Brain Tissue: Methodology and in Vivo Application of a Distribution Assay in Brain Polar Lipids</span></div><div class="casAuthors">Belli, Sara; Assmus, Frauke; Wagner, Bjoern; Honer, Michael; Fischer, Holger; Schuler, Franz; Alvarez-Sanchez, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4529-4541</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The unbound drug concn.-effect relationship in brain is a key aspect in CNS drug discovery and development.  In this work, we describe an in vitro high-throughput distribution assay between an aq. buffer and a microemulsion of porcine brain polar lipids (BPL).  The derived distribution coeff. LogDBPL was applied to the prediction of unbound drug concns. in brain (Cu,b) and nonspecific binding to brain tissue.  The in vivo relevance of the new assay was assessed for a large set of proprietary drug candidates and CNS drugs by (1) comparing obsd. compd. concns. in rat CSF with Cu,b calcd. using the LogDBPL assay in combination with total drug brain concns., (2) comparing Cu,b derived from LogDBPL and total drug brain concns. to Cu,b estd. using in vitro P-glycoprotein efflux ratio data and unbound drug plasma levels, and (3) comparing tissue nonspecific binding data from human brain autoradiog. studies for 17 PET tracer candidates to distribution in BPL.  In summary, the LogDBPL assay provides a predicted drug fraction unbound in brain tissue that is nearly identical to brain homogenate equil. dialysis with an estn. of in vivo Cu,b that is superior to LogD in octanol.  LogDBPL complements the approach for predicting Cu,b based on in vitro P-glycoprotein efflux ratio and in vivo unbound plasma concn. and stands as a fast and cost-effective tool for nonspecific brain binding optimization of PET ligand candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHszf6IElNwbVg90H21EOLACvtfcHk0liE52PJCOrB9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSlsLfL&md5=085bdd5622cd74cd11ee4050e3637416</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00717%26sid%3Dliteratum%253Aachs%26aulast%3DBelli%26aufirst%3DS.%26aulast%3DAssmus%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DAlvarez-S%25C3%25A1nchez%26aufirst%3DR.%26atitle%3DEstimation%2520of%2520drug%2520binding%2520to%2520brain%2520tissue%253A%2520methodology%2520and%2520in%2520vivo%2520application%2520of%2520a%2520distribution%2520assay%2520in%2520brain%2520polar%2520lipids%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4529%26epage%3D4541%26doi%3D10.1021%2Facs.molpharmaceut.5b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0ljHkdRsHPYGOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0ljHkdRsHPYGOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1124/dmd.104.001222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+DeBartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice&doi=10.1124%2Fdmd.104.001222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0ljHkdRsHPYGOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDeBartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181%26doi%3D10.1124%2Fdmd.104.001222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Sánchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, S.</span><span> </span><span class="NLM_article-title">PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation</span> <span class="citation_source-journal">Biochem. Pharmacol. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.bcp.2013.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlKrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1684-1699&author=A.+Carusoauthor=R.+Alvarez-S%C3%A1nchezauthor=A.+Hillebrechtauthor=A.+Poirierauthor=F.+Schulerauthor=T.+Lav%C3%A9author=C.+Funkauthor=S.+Belli&title=PK%2FPD+assessment+in+CNS+drug+discovery%3A+Prediction+of+CSF+concentration+in+rodents+for+P-glycoprotein+substrates+and+application+to+in+vivo+potency+estimation&doi=10.1016%2Fj.bcp.2013.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation</span></div><div class="casAuthors">Caruso, Antonello; Alvarez-Sanchez, Ruben; Hillebrecht, Alexander; Poirier, Agnes; Schuler, Franz; Lave, Thierry; Funk, Christoph; Belli, Sara</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1684-1699</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The unbound drug concn. in brain parenchyma is considered to be the relevant driver for interaction with central nervous system (CNS) biol. targets.  Drug levels in cerebrospinal fluid (C_CSF) are frequently used surrogates for the unbound concns. in brain.  For drugs actively transported across the blood-brain barrier (BBB), C_CSF differs from unbound plasma concn. (Cu_p) to an extent that is commonly unknown.  In this study, the relationship between CSF-to-unbound plasma drug partitioning in rats and the mouse Pgp (Mdr1a) efflux ratio (ER) obtained from in vitro transcellular studies has been investigated for a set of 61 CNS compds. exhibiting substantial diversity in chem. structure and physico-chem. properties.  In order to understand the in vitro-in vivo extrapolation of Pgp efflux, a mechanistic model was derived relating in vivo CNS distribution kinetics to in vitro active transport.  The model was applied to predict C_CSF from Cu_p and ER data for 19 proprietary Roche CNS drug candidates.  The calcd. CSF concns. were correlated with CNS pharmacodynamic responses obsd. in rodent models.  The correlation between in vitro and in vivo potency for different pharmacol. endpoints indicated that the predicted C_CSF is a valuable surrogate of the concn. at the target site.  Overall, C_CSF proved superior description of PK/PD data than unbound plasma or total brain concn. for Mdr1a substrates.  Predicted C_CSF can be used as a default approach to understand the PK/PD relationships in CNS efficacy models and can support the extrapolation of efficacious brain exposure for new drug candidates from rodent to man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruK6k0mONiBbVg90H21EOLACvtfcHk0lhOT53SzlsRHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlKrs70%253D&md5=76fec0e52a881f894ed01836bba27db6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DAlvarez-S%25C3%25A1nchez%26aufirst%3DR.%26aulast%3DHillebrecht%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DBelli%26aufirst%3DS.%26atitle%3DPK%252FPD%2520assessment%2520in%2520CNS%2520drug%2520discovery%253A%2520Prediction%2520of%2520CSF%2520concentration%2520in%2520rodents%2520for%2520P-glycoprotein%2520substrates%2520and%2520application%2520to%2520in%2520vivo%2520potency%2520estimation%26jtitle%3DBiochem.%2520Pharmacol.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2013%26volume%3D85%26spage%3D1684%26epage%3D1699%26doi%3D10.1016%2Fj.bcp.2013.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaltz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muri, D.</span><span> </span><span class="NLM_article-title">Iridium-catalyzed H/D exchange: ligand complexes with improved efficiency and scope</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">11496</span><span class="NLM_x">–</span> <span class="NLM_lpage">11504</span><span class="refDoi"> DOI: 10.1002/chem.201402078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fchem.201402078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25043104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=11496-11504&author=M.+Parmentierauthor=T.+Hartungauthor=A.+Pfaltzauthor=D.+Muri&title=Iridium-catalyzed+H%2FD+exchange%3A+ligand+complexes+with+improved+efficiency+and+scope&doi=10.1002%2Fchem.201402078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium-catalyzed H/D exchange: Ligand complexes with improved efficiency and scope</span></div><div class="casAuthors">Parmentier, Michael; Hartung, Thomas; Pfaltz, Andreas; Muri, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11496-11504</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ir complexes with N,P-ligands, highly active catalysts for asym. double bond redn., were tested for their hydrogen isotope exchange (HIE) capabilities.  Electron-rich ligands, contg. dicyclohexylphosphines or phosphinites, were identified as excellent ligands for efficient D incorporation.  Substrates with strong directing groups, i.e., pyridines, ketones, and amides, as well as weak ligating units, such as nitro, sulfone, and sulfonamide, could be labeled efficiently.  With the addn. of B(C6F5)3 to the reaction mixt., also highly deactivating nitrile substituents were well tolerated in the reaction.  Based on the excellent results obtained with the chiral ThrePhox ligand, a structurally simpler, achiral ligand was developed.  The Ir complex contg. this ligand, proved to be a powerful catalyst for HIE reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDCnTLLu2rx7Vg90H21EOLACvtfcHk0lhOT53SzlsRHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtbfN&md5=7217e035dd35d013a169f64c608ad6c6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fchem.201402078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201402078%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DPfaltz%26aufirst%3DA.%26aulast%3DMuri%26aufirst%3DD.%26atitle%3DIridium-catalyzed%2520H%252FD%2520exchange%253A%2520ligand%2520complexes%2520with%2520improved%2520efficiency%2520and%2520scope%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D11496%26epage%3D11504%26doi%3D10.1002%2Fchem.201402078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Collin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göpfert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oroszlan-Szovik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span> </span><span class="NLM_article-title">Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2846</span><span class="refDoi"> DOI: 10.1093/brain/awu213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1093%2Fbrain%2Fawu213" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=2834-2846&author=L.+Collinauthor=B.+Bohrmannauthor=U.+G%C3%B6pfertauthor=K.+Oroszlan-Szovikauthor=L.+Ozmenauthor=F.+Gr%C3%BCninger&title=Neuronal+uptake+of+tau%2FpS422+antibody+and+reduced+progression+of+tau+pathology+in+a+mouse+model+of+Alzheimer%E2%80%98s+disease&doi=10.1093%2Fbrain%2Fawu213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu213%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DG%25C3%25B6pfert%26aufirst%3DU.%26aulast%3DOroszlan-Szovik%26aufirst%3DK.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26atitle%3DNeuronal%2520uptake%2520of%2520tau%252FpS422%2520antibody%2520and%2520reduced%2520progression%2520of%2520tau%2520pathology%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2598s%2520disease%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D2834%26epage%3D2846%26doi%3D10.1093%2Fbrain%2Fawu213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Rüfenacht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güntert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span> </span><span class="NLM_article-title">Quantification of the Aβ peptide in Alzheimer’s plaques by laser dissection microscopy combined with mass spectrometry</span> <span class="citation_source-journal">J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1002/jms.739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjms.739" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=193-201&author=P.+R%C3%BCfenachtauthor=A.+G%C3%BCntertauthor=B.+Bohrmannauthor=A.+Ducretauthor=H.+D%C3%B6beli&title=Quantification+of+the+A%CE%B2+peptide+in+Alzheimer%E2%80%99s+plaques+by+laser+dissection+microscopy+combined+with+mass+spectrometry&doi=10.1002%2Fjms.739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjms.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjms.739%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCfenacht%26aufirst%3DP.%26aulast%3DG%25C3%25BCntert%26aufirst%3DA.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DDucret%26aufirst%3DA.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26atitle%3DQuantification%2520of%2520the%2520A%25CE%25B2%2520peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520plaques%2520by%2520laser%2520dissection%2520microscopy%2520combined%2520with%2520mass%2520spectrometry%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2005%26volume%3D40%26spage%3D193%26epage%3D201%26doi%3D10.1002%2Fjms.739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ambler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wathey, B.</span><span> </span><span class="NLM_article-title">Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60G</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00172-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0960-894X%2899%2900172-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1317-1322&author=J.+Amblerauthor=L.+Brownauthor=X.-L.+Cockcroftauthor=M.+Gr%C3%BCtterauthor=J.+Haylerauthor=D.+Janusauthor=D.+Jonesauthor=P.+Kaneauthor=K.+Menearauthor=J.+Priestleauthor=G.+Smithauthor=M.+Talbotauthor=C.+V.+Walkerauthor=B.+Wathey&title=Optimisation+of+the+P2+pharmacophore+in+a+series+of+thrombin+inhibitors%3A+ion-dipole+interactions+with+lysine+60G&doi=10.1016%2FS0960-894X%2899%2900172-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900172-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900172-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmbler%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%26aulast%3DHayler%26aufirst%3DJ.%26aulast%3DJanus%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKane%26aufirst%3DP.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DPriestle%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DTalbot%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DC.%2BV.%26aulast%3DWathey%26aufirst%3DB.%26atitle%3DOptimisation%2520of%2520the%2520P2%2520pharmacophore%2520in%2520a%2520series%2520of%2520thrombin%2520inhibitors%253A%2520ion-dipole%2520interactions%2520with%2520lysine%252060G%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1317%26epage%3D1322%26doi%3D10.1016%2FS0960-894X%2899%2900172-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">A microwave radiosynthesis of the 4-[<sup>18</sup>F]-fluorobenzyltriphenylphosphonium ion</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1002/jlcr.3241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjlcr.3241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25329827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=695-698&author=H.+T.+Ravertauthor=D.+P.+Holtauthor=R.+F.+Dannals&title=A+microwave+radiosynthesis+of+the+4-%5B18F%5D-fluorobenzyltriphenylphosphonium+ion&doi=10.1002%2Fjlcr.3241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A microwave radiosynthesis of the 4-[18F]-fluorobenzyltriphenylphosphonium ion</span></div><div class="casAuthors">Ravert, Hayden T.; Holt, Daniel P.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">695-698</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The 4-[18F]-fluorobenzyltriphenylphosphonium cation was synthesized by a series of microwave reactions from no carrier added [18F]-fluoride.  The microwave procedure reduced the quantity of reagents used and synthesis time when compared with the original synthesis.  In addn., problematic solid phase extn., sodium borohydride redn. by column and inconsistent yields with excessive ppt. formation during the bromination step were eliminated.  The 4-[18F]-fluorobenzyltriphenylphosphonium cation was produced radiochem. pure in 8.3% yield with a specific radioactivity of 534.5 ± 371.4 GBq/μmole at end of synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzK5ukWRUerVg90H21EOLACvtfcHk0lgnx_NLx4gbFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksL3L&md5=5a91df498aff829a16c645635c91b694</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3241%26sid%3Dliteratum%253Aachs%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DA%2520microwave%2520radiosynthesis%2520of%2520the%25204-%255B18F%255D-fluorobenzyltriphenylphosphonium%2520ion%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D695%26epage%3D698%26doi%3D10.1002%2Fjlcr.3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">Synthesis and quality control of [<sup>18</sup>F]T807 for tau PET imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1002/jlcr.3425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjlcr.3425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=27427174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFynsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=411-415&author=D.+P.+Holtauthor=H.+T.+Ravertauthor=R.+F.+Dannals&title=Synthesis+and+quality+control+of+%5B18F%5DT807+for+tau+PET+imaging&doi=10.1002%2Fjlcr.3425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and quality control of [18F]T807 for tau PET imaging</span></div><div class="casAuthors">Holt, Daniel P.; Ravert, Hayden T.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The detailed synthesis and quality control of [18F]T807, radiotracer for tau protein aggregate imaging, are described.  The radiotracer synthesis was accomplished in an av. of 48 min with an av. specific activity at end-of-synthesis of over 4.4 TBq/μmole (120 Ci/μmole) and an av. radiochem. yield of 32%.  Compliance with all std. US Pharmacopeia (chapter 823) acceptance tests was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQIDxNpZoHcrVg90H21EOLACvtfcHk0liGEDv5a-WuWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFynsbvK&md5=d328495eeb9fd3421373523558a1f331</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3425%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520and%2520quality%2520control%2520of%2520%255B18F%255DT807%2520for%2520tau%2520PET%2520imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2016%26volume%3D59%26spage%3D411%26epage%3D415%26doi%3D10.1002%2Fjlcr.3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lazari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhoud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraglia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dam, R. M.</span><span> </span><span class="NLM_article-title">Fully automated production of diverse <sup>18</sup>F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification</span> <span class="citation_source-journal">J. Nucl. Med. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.2967/jnmt.114.140392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnmt.114.140392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25033883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC2cbjt1GmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=203-210&author=M.+Lazariauthor=J.+Collinsauthor=B.+Shenauthor=M.+Farhoudauthor=D.+Yehauthor=B.+Maragliaauthor=F.+T.+Chinauthor=D.+A.+Nathansonauthor=M.+Mooreauthor=R.+M.+van+Dam&title=Fully+automated+production+of+diverse+18F-labeled+PET+tracers+on+the+ELIXYS+multireactor+radiosynthesizer+without+hardware+modification&doi=10.2967%2Fjnmt.114.140392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification</span></div><div class="casAuthors">Lazari Mark; van Dam R Michael; Collins Jeffrey; Shen Bin; Chin Frederick T; Farhoud Mohammed; Yeh Daniel; Nathanson David A; Maraglia Brandon; Moore Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine technology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Fully automated radiosynthesizers are continuing to be developed to meet the growing need for the reliable production of PET tracers made under current good manufacturing practice guidelines.  There is a current trend toward supporting kitlike disposable cassettes that come preconfigured for particular tracers, thus eliminating the need for cleaning protocols between syntheses and enabling quick transitions to synthesizing other tracers.  Though ideal for production, these systems are often limited for the development of novel tracers because of pressure, temperature, and chemical compatibility considerations.  This study demonstrated the versatile use of the ELIXYS fully automated radiosynthesizer to adapt and produce 8 different (18)F-labeled PET tracers of varying complexity.  METHODS:  Three-reactor syntheses of 2-deoxy-2-(18)F-fluoro-β-d-arabinofuranosylcytosine (d-(18)F-FAC), 2-deoxy-2-(18)F-fluoro-5-methyl-β-l-arabinofuranosyluracil (l-(18)F-FMAU), and 2-deoxy-2-(18)F-fluoro-5-ethyl-β-d-arabinofuranosyluracil (d-(18)F-FEAU) along with the 1-reactor syntheses of d-(18)F-FEAU, (18)F-FDG, 3-deoxy-3-(18)F-fluoro-l-thymidine ((18)F-FLT), (18)F-fallypride, 9-(4-(18)F-fluoro-3-hydroxymethylbutyl)-guanine ((18)F-FHBG), and N-succinimidyl-4-(18)F-fluorobenzoate ((18)F-SFB), were all produced using ELIXYS without the need for any hardware modifications or reconfiguration.  Synthesis protocols were adapted and slightly modified from those in the literature but were not fully optimized.  Furthermore, (18)F-FLT, (18)F-FDG, and (18)F-fallypride were produced sequentially on the same day and used for preclinical imaging of A431 tumor-bearing severe combined immunodeficient mice and wild-type BALB/c mice.  To assess future translation to the clinical setting, several batches of tracers were subjected to a full set of quality control tests.  RESULTS:  All tracers were produced with radiochemical yields comparable to those in the literature. (18)F-FLT, (18)F-FDG, and (18)F-fallypride were successfully used to image the mice, with results consistent with those reported in the literature.  All tracers that were subjected to clinical quality control tests passed.  CONCLUSION:  The ELIXYS radiosynthesizer facilitates rapid tracer development and is capable of producing multiple (18)F-labeled PET tracers suitable for clinical applications using the same hardware setup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSynwpW7YKkXftos8R3JUhXfW6udTcc2eZIImTGFmM2Brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbjt1GmsQ%253D%253D&md5=a12a8567a5d0c3305de139266f929e64</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2967%2Fjnmt.114.140392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnmt.114.140392%26sid%3Dliteratum%253Aachs%26aulast%3DLazari%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DFarhoud%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DD.%26aulast%3DMaraglia%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DF.%2BT.%26aulast%3DNathanson%26aufirst%3DD.%2BA.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26atitle%3DFully%2520automated%2520production%2520of%2520diverse%252018F-labeled%2520PET%2520tracers%2520on%2520the%2520ELIXYS%2520multireactor%2520radiosynthesizer%2520without%2520hardware%2520modification%26jtitle%3DJ.%2520Nucl.%2520Med.%2520Technol.%26date%3D2014%26volume%3D42%26spage%3D203%26epage%3D210%26doi%3D10.2967%2Fjnmt.114.140392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liGEDv5a-WuWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camborde, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newport, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span> </span><span class="NLM_article-title">The influence of measurement uncertainties on the evaluation of the distribution volume ratio and binding potential in rat studies on a microPET R4: a phantom study</span> <span class="citation_source-journal">Phys. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2859</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span><span class="refDoi"> DOI: 10.1088/0031-9155/50/12/009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1088%2F0031-9155%2F50%2F12%2F009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=15930607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BD2M3os1Wmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2005&pages=2859-2869&author=V.+Sossiauthor=M.-L.+Cambordeauthor=G.+Tropiniauthor=D.+Newportauthor=A.+Rahmimauthor=D.+J.+Doudetauthor=T.+J.+Ruth&title=The+influence+of+measurement+uncertainties+on+the+evaluation+of+the+distribution+volume+ratio+and+binding+potential+in+rat+studies+on+a+microPET+R4%3A+a+phantom+study&doi=10.1088%2F0031-9155%2F50%2F12%2F009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of measurement uncertainties on the evaluation of the distribution volume ratio and binding potential in rat studies on a microPET R4: a phantom study</span></div><div class="casAuthors">Sossi Vesna; Camborde Marie-Laure; Tropini Giorgia; Newport Danny; Rahmim Arman; Doudet Doris J; Ruth Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Physics in medicine and biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2859-69</span>
        ISSN:<span class="NLM_cas:issn">0031-9155</span>.
    </div><div class="casAbstract">In small animal positron emission tomography (PET) imaging, the injectable radiotracer dose is often limited by the tracer mass which, together with the tracer kinetics and scanner sensitivity, dictates the statistical quality of the time activity curves (TACs) used to extract biological parameters.  We investigated the effect of measurement uncertainty on the determination of the distribution volume ratio (DVR) and binding potential (BP) as estimated using the tissue input Logan (DVR(L), BP(L)) and the ratio (DVRr, BPr) methods for two tracers, with the Concorde microPET R4 camera.  Parameters' coefficients of variation (COV) were estimated from a combination of rat and phantom data.  For 11C-dihydrotetrabenazine, the COV was 11% for the BP(L) and 13.4% for the BPr when using TACs obtained from individual regions of interest (ROIs) and segmented attenuation correction.  The COVs were reduced to 7.5% (BP(L)) and 8.6% (BPr) when the striatal and cerebellar TACs were estimated as averages of 3 and 2 ROIs respectively.  Results obtained for 11C-methylphenidate (MP) yielded approximately 30% higher COVs.  With measured attenuation correction, the COVs were on average 100% higher.  The presented method can be used to examine the contribution of a variety of imaging conditions to the uncertainty of biologically meaningful parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1I2Gy_ZBe_LjnyZkbE8yXfW6udTcc2eZsZGfGyh8fwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3os1Wmug%253D%253D&md5=7d1302ffb08f61bba8e363e980f64e06</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1088%2F0031-9155%2F50%2F12%2F009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F0031-9155%252F50%252F12%252F009%26sid%3Dliteratum%253Aachs%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DCamborde%26aufirst%3DM.-L.%26aulast%3DTropini%26aufirst%3DG.%26aulast%3DNewport%26aufirst%3DD.%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DDoudet%26aufirst%3DD.%2BJ.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520influence%2520of%2520measurement%2520uncertainties%2520on%2520the%2520evaluation%2520of%2520the%2520distribution%2520volume%2520ratio%2520and%2520binding%2520potential%2520in%2520rat%2520studies%2520on%2520a%2520microPET%2520R4%253A%2520a%2520phantom%2520study%26jtitle%3DPhys.%2520Med.%2520Biol.%26date%3D2005%26volume%3D50%26spage%3D2859%26epage%3D2869%26doi%3D10.1088%2F0031-9155%2F50%2F12%2F009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Column-switching HPLC for the analysis of plasma in PET imaging studies</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1016/S0969-8051(00)00125-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0969-8051%2800%2900125-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11056380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVWlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=627-630&author=J.+Hiltonauthor=F.+Yokoiauthor=R.+F.+Dannalsauthor=H.+T.+Ravertauthor=Z.+Szaboauthor=D.+F.+Wong&title=Column-switching+HPLC+for+the+analysis+of+plasma+in+PET+imaging+studies&doi=10.1016%2FS0969-8051%2800%2900125-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Column-switching HPLC for the analysis of plasma in PET imaging studies</span></div><div class="casAuthors">Hilton, John; Yokoi, Fuji; Dannals, Robert F.; Ravert, Hayden T.; Szabo, Zsolt; Wong, Dean F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-630</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A column-switch high performance liq. chromatog. method for the anal. of 4 mL of plasma is described with six examples of chromatog. of [11C]-labeled positron-emission tomog. imaging agents.  Complete extn. of all but the most polar metabolites by the reverse phase capture column is achieved by disruption of plasma protein binding by 8 M urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC_vdT2H7syLVg90H21EOLACvtfcHk0lgQ1QPeQX1Ctg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVWlurs%253D&md5=9e1f15e3bbe689845e351d38e24a1288</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900125-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900125-6%26sid%3Dliteratum%253Aachs%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DSzabo%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DColumn-switching%2520HPLC%2520for%2520the%2520analysis%2520of%2520plasma%2520in%2520PET%2520imaging%2520studies%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2000%26volume%3D27%26spage%3D627%26epage%3D630%26doi%3D10.1016%2FS0969-8051%2800%2900125-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Gillings, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falborg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marthi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Kinetics of the metabolism of four PET radioligands in living minipigs</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/S0969-8051(00)00187-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0969-8051%2800%2900187-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11182570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1yjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=97-104&author=N.+M.+Gillingsauthor=D.+Benderauthor=L.+Falborgauthor=K.+Marthiauthor=O.+L.+Munkauthor=P.+Cumming&title=Kinetics+of+the+metabolism+of+four+PET+radioligands+in+living+minipigs&doi=10.1016%2FS0969-8051%2800%2900187-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the metabolism of four PET radioligands in living minipigs</span></div><div class="casAuthors">Gillings, N. M.; Bender, D.; Falborg, L.; Marthi, K.; Munk, O. L.; Cumming, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Most radioligands are substantially metabolized in peripheral organs during the course of positron emission tomog. (PET) recordings.  Accurate detn. of plasma concns. of unmetabolized radioligands is often important for quantification of data from PET studies.  The fractions of untransformed radioligand and radioactive metabolites in plasma exts. must then be measured.  Temporal changes in these fractions are influenced by the rate const. of appearance of total radioactive metabolites in plasma (apparent rate const. of metab. in plasma, k0) and the net rate const. of elimination of all radioactive metabolites from plasma (k-1).  In order to clarify the relationship between radioligand fractions and rate consts., plasma samples collected from Gottingen minipigs during PET recordings using four different binding site ligands were analyzed by radio high performance liq. chromatog.  The calcd. plasma concns. of parent compds. and their radioactive metabolites were used to calc. k0 and k-1 for 11C-labeled NNC 112, NS 2214, PK 11195 and raclopride in minipigs using a novel application of the tissue-slope intercept plot.  In general, the apparent rate const. of metab. in plasma was found to be greater in the minipig than in man.  The reported kinetic anal. enables the apparent metab. of PET radioligands in plasma to be quantified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsETsfL5MYObVg90H21EOLACvtfcHk0lgX17btH8QM8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1yjsLk%253D&md5=4eff34b5a54444942954b538b2d0e18d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900187-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900187-6%26sid%3Dliteratum%253Aachs%26aulast%3DGillings%26aufirst%3DN.%2BM.%26aulast%3DBender%26aufirst%3DD.%26aulast%3DFalborg%26aufirst%3DL.%26aulast%3DMarthi%26aufirst%3DK.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DKinetics%2520of%2520the%2520metabolism%2520of%2520four%2520PET%2520radioligands%2520in%2520living%2520minipigs%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D97%26epage%3D104%26doi%3D10.1016%2FS0969-8051%2800%2900187-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span> </span><span class="NLM_article-title">PET imaging of nicotinic acetylcholine receptors in baboons with <sup>18</sup>F-AZAN, a radioligand with improved brain kinetics</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.2967/jnumed.111.092338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.111.092338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=121-129&author=H.+Kuwabaraauthor=D.+F.+Wongauthor=Y.+Gaoauthor=H.+Valentineauthor=D.+P.+Holtauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=A.+G.+Horti&title=PET+imaging+of+nicotinic+acetylcholine+receptors+in+baboons+with+18F-AZAN%2C+a+radioligand+with+improved+brain+kinetics&doi=10.2967%2Fjnumed.111.092338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.092338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.092338%26sid%3Dliteratum%253Aachs%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DValentine%26aufirst%3DH.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DPET%2520imaging%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520baboons%2520with%252018F-AZAN%252C%2520a%2520radioligand%2520with%2520improved%2520brain%2520kinetics%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D121%26epage%3D129%26doi%3D10.2967%2Fjnumed.111.092338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kaixiang Zhou, Fan Yang, Yuying Li, Yimin Chen, Xiaojun Zhang, Jinming Zhang, Junfeng Wang, Jiapei Dai, Lisheng Cai, <span class="NLM_string-name hlFld-ContribAuthor">Mengchao Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021,</strong> <em>18 </em>
                                    (3)
                                     , 1176-1195. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c01078" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c01078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BFluorine-18%252BLabeled%252B2-Phenylquinoxaline%252BDerivatives%252Bas%252BPotential%252BTau%252BImaging%252BAgents%26aulast%3DZhou%26aufirst%3DKaixiang%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01112020%26date%3D28122020%26date%3D27122020%26date%3D21012021%26volume%3D18%26issue%3D3%26spage%3D1176%26epage%3D1195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nerella Sridhar Goud, Ahana Bhattacharya, Raman Kumar Joshi, Chandana Nagaraj, Rose Dawn Bharath, <span class="NLM_string-name hlFld-ContribAuthor">Pardeep Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1223-1259. <a href="https://doi.org/10.1021/acs.jmedchem.0c01053" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCarbon-11%25253A%252BRadiochemistry%252Band%252BTarget-Based%252BPET%252BMolecular%252BImaging%252BApplications%252Bin%252BOncology%25252C%252BCardiology%25252C%252Band%252BNeurology%26aulast%3DGoud%26aufirst%3DNerella%2BSridhar%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19062020%26date%3D26012021%26volume%3D64%26issue%3D3%26spage%3D1223%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Watanabe, Yuta Tarumizu, Sho Kaide, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, <span class="NLM_string-name hlFld-ContribAuthor">Masahiro Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity and Brain Kinetics Relationships of 18F-Labeled Benzimidazopyridine Derivatives as Tau PET Tracers. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 262-266. <a href="https://doi.org/10.1021/acsmedchemlett.0c00641" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00641%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252Band%252BBrain%252BKinetics%252BRelationships%252Bof%252B18F-Labeled%252BBenzimidazopyridine%252BDerivatives%252Bas%252BTau%252BPET%252BTracers%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D07122020%26date%3D04012021%26date%3D11012021%26volume%3D12%26issue%3D2%26spage%3D262%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Watanabe, Haruka Tatsumi, Sho Kaide, Yoichi Shimizu, Shimpei Iikuni, <span class="NLM_string-name hlFld-ContribAuthor">Masahiro Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 120-126. <a href="https://doi.org/10.1021/acsmedchemlett.9b00456" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00456%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BRadioiodinated%252B6%25252C5%25252C6-Tricyclic%252BCompounds%252Bfor%252Bthe%252BDevelopment%252Bof%252BTau%252BImaging%252BProbes%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01102019%26date%3D06012020%26date%3D09012020%26volume%3D11%26issue%3D2%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicholas A. White, Kyle Clagg, Lauren E. Sirois, Kyle A. Mack, Mohammad A. Al-Sayah, William A. Nack, Paul D. O’Shea, Haiming Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Francis Gosselin</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphoramidates as Steering Elements for Highly Selective Access to Complementary Imidazo[1,2-a]pyrimidine Isomers. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (23)
                                     , 9527-9531. <a href="https://doi.org/10.1021/acs.orglett.9b03702" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b03702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b03702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b03702%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPhosphoramidates%252Bas%252BSteering%252BElements%252Bfor%252BHighly%252BSelective%252BAccess%252Bto%252BComplementary%252BImidazo%25255B1%25252C2-a%25255Dpyrimidine%252BIsomers%26aulast%3DWhite%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18102019%26date%3D18112019%26volume%3D21%26issue%3D23%26spage%3D9527%26epage%3D9531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederik J. R. Rombouts, Lieven Declercq, José-Ignacio Andrés, Astrid Bottelbergs, Lu Chen, Laura Iturrino, Joseph E. Leenaerts, Jonas Mariën, Fengbin Song, Cindy Wintmolders, Stijn Wuyts, Chunfang A. Xia, Paula te Riele, Guy Bormans, Rik Vandenberghe, Hartmuth Kolb, <span class="NLM_string-name hlFld-ContribAuthor">Diederik Moechars</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2974-2987. <a href="https://doi.org/10.1021/acs.jmedchem.8b01759" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01759%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%25255B18F%25255DFluoro-5-methylpyridin-2-yl%252529isoquinolin-6-amine%252B%252528JNJ-64326067%252529%25252C%252Ba%252BNew%252BPromising%252BTau%252BPositron%252BEmission%252BTomography%252BImaging%252BTracer%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12112018%26date%3D19032019%26date%3D27022019%26volume%3D62%26issue%3D6%26spage%3D2974%26epage%3D2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sho Kaide, Masahiro Ono, Hiroyuki Watanabe, Ayane Kitada, Masashi Yoshimura, Yoichi Shimizu, Masafumi Ihara, <span class="NLM_string-name hlFld-ContribAuthor">Hideo Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 478-483. <a href="https://doi.org/10.1021/acsmedchemlett.8b00092" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00092%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BRadioiodinated%252BBenzoimidazopyridine%252BDerivatives%252Bfor%252BDetection%252Bof%252BTau%252BPathology%26aulast%3DKaide%26aufirst%3DSho%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22022018%26date%3D29032018%26date%3D10042018%26volume%3D9%26issue%3D5%26spage%3D478%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gérard N  Bischof</span>, <span class="hlFld-ContribAuthor ">Alessandra  Dodich</span>, <span class="hlFld-ContribAuthor ">Marina  Boccardi</span>, <span class="hlFld-ContribAuthor ">Thilo  van Eimeren</span>, <span class="hlFld-ContribAuthor ">Cristina  Festari</span>, <span class="hlFld-ContribAuthor ">Henryk  Barthel</span>, <span class="hlFld-ContribAuthor ">Oskar  Hansson</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>, <span class="hlFld-ContribAuthor ">Rik  Ossenkoppele</span>, <span class="hlFld-ContribAuthor ">Osama  Sabri</span>, <span class="hlFld-ContribAuthor ">B Frisoni G  Giovanni</span>, <span class="hlFld-ContribAuthor ">Valentina  Garibotto</span>, <span class="hlFld-ContribAuthor ">Alexander  Drzezga</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2021,</strong> <em>48 </em>
                                    (7)
                                     , 2110-2120. <a href="https://doi.org/10.1007/s00259-020-05156-4" title="DOI URL">https://doi.org/10.1007/s00259-020-05156-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-05156-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-05156-4%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DClinical%252Bvalidity%252Bof%252Bsecond-generation%252Btau%252BPET%252Btracers%252Bas%252Bbiomarkers%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bin%252Bthe%252Bcontext%252Bof%252Ba%252Bstructured%252B5-phase%252Bdevelopment%252Bframework%26aulast%3DBischof%26aufirst%3DG%25C3%25A9rard%2BN%26date%3D2021%26date%3D2021%26volume%3D48%26issue%3D7%26spage%3D2110%26epage%3D2120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aren  van Waarde</span>, <span class="hlFld-ContribAuthor ">Sofia  Marcolini</span>, <span class="hlFld-ContribAuthor ">Peter Paul  de Deyn</span>, <span class="hlFld-ContribAuthor ">Rudi A.J.O.  Dierckx</span>. </span><span class="cited-content_cbyCitation_article-title">PET Agents in Dementia: An Overview. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2021,</strong> <em>51 </em>
                                    (3)
                                     , 196-229. <a href="https://doi.org/10.1053/j.semnuclmed.2020.12.008" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2020.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2020.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2020.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DPET%252BAgents%252Bin%252BDementia%25253A%252BAn%252BOverview%26aulast%3Dvan%2BWaarde%26aufirst%3DAren%26date%3D2021%26volume%3D51%26issue%3D3%26spage%3D196%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Zhou</span>, <span class="hlFld-ContribAuthor ">Marc  Benoit</span>, <span class="hlFld-ContribAuthor ">Md Golam  Sharoar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in pre-clinical diagnosis of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Metabolic Brain Disease</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1007/s11011-021-00733-4" title="DOI URL">https://doi.org/10.1007/s11011-021-00733-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11011-021-00733-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11011-021-00733-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMetabolic%2520Brain%2520Disease%26atitle%3DRecent%252Badvances%252Bin%252Bpre-clinical%252Bdiagnosis%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhou%26aufirst%3DJohn%26date%3D2021%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyunjung  Kim</span>, <span class="hlFld-ContribAuthor ">Yearn Seong  Choe</span>. </span><span class="cited-content_cbyCitation_article-title">High‐yield synthesis of a tau PET radioligand and its nonradioactive ligand using an alternative protection and deprotection strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 150-158. <a href="https://doi.org/10.1002/jlcr.3894" title="DOI URL">https://doi.org/10.1002/jlcr.3894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DHigh%2525E2%252580%252590yield%252Bsynthesis%252Bof%252Ba%252Btau%252BPET%252Bradioligand%252Band%252Bits%252Bnonradioactive%252Bligand%252Busing%252Ban%252Balternative%252Bprotection%252Band%252Bdeprotection%252Bstrategy%26aulast%3DKim%26aufirst%3DHyunjung%26date%3D2021%26date%3D2020%26volume%3D64%26issue%3D4%26spage%3D150%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailendra Mohan  Tripathi</span>, <span class="hlFld-ContribAuthor ">Alison D.  Murray</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Dementia: The Emerging Role of Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">The Neuroscientist</span><span> <strong>2021,</strong> <em>29 </em>, 107385842199703. <a href="https://doi.org/10.1177/1073858421997035" title="DOI URL">https://doi.org/10.1177/1073858421997035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1073858421997035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1073858421997035%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Neuroscientist%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDementia%25253A%252BThe%252BEmerging%252BRole%252Bof%252BPositron%252BEmission%252BTomography%26aulast%3DTripathi%26aufirst%3DShailendra%2BMohan%26date%3D2021%26date%3D2021%26volume%3D29%26spage%3D107385842199703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subramanian  Tamil Selvan</span>, <span class="hlFld-ContribAuthor ">Roopa  Ravichandar</span>, <span class="hlFld-ContribAuthor ">Krishna  Kanta Ghosh</span>, <span class="hlFld-ContribAuthor ">Anand  Mohan</span>, <span class="hlFld-ContribAuthor ">Pachaiyappan  Mahalakshmi</span>, <span class="hlFld-ContribAuthor ">Balázs  Gulyás</span>, <span class="hlFld-ContribAuthor ">Parasuraman  Padmanabhan</span>. </span><span class="cited-content_cbyCitation_article-title">Coordination chemistry of ligands: Insights into the design of amyloid beta/tau-PET imaging probes and nanoparticles-based therapies for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2021,</strong> <em>430 </em>, 213659. <a href="https://doi.org/10.1016/j.ccr.2020.213659" title="DOI URL">https://doi.org/10.1016/j.ccr.2020.213659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2020.213659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2020.213659%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DCoordination%252Bchemistry%252Bof%252Bligands%25253A%252BInsights%252Binto%252Bthe%252Bdesign%252Bof%252Bamyloid%252Bbeta%25252Ftau-PET%252Bimaging%252Bprobes%252Band%252Bnanoparticles-based%252Btherapies%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DTamil%2BSelvan%26aufirst%3DSubramanian%26date%3D2021%26volume%3D430%26spage%3D213659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor L.  Villemagne</span>, <span class="hlFld-ContribAuthor ">Frederik  Barkhof</span>, <span class="hlFld-ContribAuthor ">Valentina  Garibotto</span>, <span class="hlFld-ContribAuthor ">Susan M.  Landau</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>, <span class="hlFld-ContribAuthor ">Bart N. M.  van Berckel</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging Approaches in Dementia. </span><span class="cited-content_cbyCitation_journal-name">Radiology</span><span> <strong>2021,</strong> <em>298 </em>
                                    (3)
                                     , 517-530. <a href="https://doi.org/10.1148/radiol.2020200028" title="DOI URL">https://doi.org/10.1148/radiol.2020200028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1148/radiol.2020200028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1148%2Fradiol.2020200028%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiology%26atitle%3DMolecular%252BImaging%252BApproaches%252Bin%252BDementia%26aulast%3DVillemagne%26aufirst%3DVictor%2BL.%26date%3D2021%26volume%3D298%26issue%3D3%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradith  Lerdsirisuk</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Yoshimi  Hayakawa</span>, <span class="hlFld-ContribAuthor ">Yuki  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yoichi  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Ren  Iwata</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>93 </em>, 11-18. <a href="https://doi.org/10.1016/j.nucmedbio.2020.10.002" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B2-pyrrolopyridinylquinoline%252Bderivatives%252Bas%252Bselective%252Btau%252BPET%252Btracers%252Bfor%252Bthe%252Bdiagnosis%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLerdsirisuk%26aufirst%3DPradith%26date%3D2021%26volume%3D93%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sushil K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Yoshiki  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Naruhiko  Sahara</span>. </span><span class="cited-content_cbyCitation_article-title">Pick’s Tau Fibril Shows Multiple Distinct PET Probe Binding Sites: Insights from Computational Modelling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (1)
                                     , 349. <a href="https://doi.org/10.3390/ijms22010349" title="DOI URL">https://doi.org/10.3390/ijms22010349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22010349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22010349%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPick%2525E2%252580%252599s%252BTau%252BFibril%252BShows%252BMultiple%252BDistinct%252BPET%252BProbe%252BBinding%252BSites%25253A%252BInsights%252Bfrom%252BComputational%252BModelling%26aulast%3DMishra%26aufirst%3DSushil%2BK.%26date%3D2021%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather  Wilson</span>, <span class="hlFld-ContribAuthor ">Marios  Politis</span>, <span class="hlFld-ContribAuthor ">Eugenii A.  Rabiner</span>, <span class="hlFld-ContribAuthor ">Lefkos T.  Middleton</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2581. <a href="https://doi.org/10.3390/cells9122581" title="DOI URL">https://doi.org/10.3390/cells9122581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9122581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9122581%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DNovel%252BPET%252BBiomarkers%252Bto%252BDisentangle%252BMolecular%252BPathways%252Bacross%252BAge-Related%252BNeurodegenerative%252BDiseases%26aulast%3DWilson%26aufirst%3DHeather%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter N. E.  Young</span>, <span class="hlFld-ContribAuthor ">Mar  Estarellas</span>, <span class="hlFld-ContribAuthor ">Emma  Coomans</span>, <span class="hlFld-ContribAuthor ">Meera  Srikrishna</span>, <span class="hlFld-ContribAuthor ">Helen  Beaumont</span>, <span class="hlFld-ContribAuthor ">Anne  Maass</span>, <span class="hlFld-ContribAuthor ">Ashwin V.  Venkataraman</span>, <span class="hlFld-ContribAuthor ">Rikki  Lissaman</span>, <span class="hlFld-ContribAuthor ">Daniel  Jiménez</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Betts</span>, <span class="hlFld-ContribAuthor ">Eimear  McGlinchey</span>, <span class="hlFld-ContribAuthor ">David  Berron</span>, <span class="hlFld-ContribAuthor ">Antoinette  O’Connor</span>, <span class="hlFld-ContribAuthor ">Nick C.  Fox</span>, <span class="hlFld-ContribAuthor ">Joana B.  Pereira</span>, <span class="hlFld-ContribAuthor ">William  Jagust</span>, <span class="hlFld-ContribAuthor ">Stephen F.  Carter</span>, <span class="hlFld-ContribAuthor ">Ross W.  Paterson</span>, <span class="hlFld-ContribAuthor ">Michael  Schöll</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging biomarkers in neurodegeneration: current and future practices. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13195-020-00612-7" title="DOI URL">https://doi.org/10.1186/s13195-020-00612-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13195-020-00612-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13195-020-00612-7%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3DImaging%252Bbiomarkers%252Bin%252Bneurodegeneration%25253A%252Bcurrent%252Band%252Bfuture%252Bpractices%26aulast%3DYoung%26aufirst%3DPeter%2BN.%2BE.%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Leuzy</span>, <span class="hlFld-ContribAuthor ">Ruben  Smith</span>, <span class="hlFld-ContribAuthor ">Rik  Ossenkoppele</span>, <span class="hlFld-ContribAuthor ">Alexander  Santillo</span>, <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>, <span class="hlFld-ContribAuthor ">Gregory  Klein</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Jonas  Jögi</span>, <span class="hlFld-ContribAuthor ">Sebastian  Palmqvist</span>, <span class="hlFld-ContribAuthor ">Niklas  Mattsson-Carlgren</span>, <span class="hlFld-ContribAuthor ">Olof  Strandberg</span>, <span class="hlFld-ContribAuthor ">Erik  Stomrud</span>, <span class="hlFld-ContribAuthor ">Oskar  Hansson</span>. </span><span class="cited-content_cbyCitation_article-title">Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. </span><span class="cited-content_cbyCitation_journal-name">JAMA Neurology</span><span> <strong>2020,</strong> <em>77 </em>
                                    (8)
                                     , 955. <a href="https://doi.org/10.1001/jamaneurol.2020.0989" title="DOI URL">https://doi.org/10.1001/jamaneurol.2020.0989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1001/jamaneurol.2020.0989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1001%2Fjamaneurol.2020.0989%26sid%3Dliteratum%253Aachs%26jtitle%3DJAMA%2520Neurology%26atitle%3DDiagnostic%252BPerformance%252Bof%252BRO948%252BF%252B18%252BTau%252BPositron%252BEmission%252BTomography%252Bin%252Bthe%252BDifferentiation%252Bof%252BAlzheimer%252BDisease%252BFrom%252BOther%252BNeurodegenerative%252BDisorders%26aulast%3DLeuzy%26aufirst%3DAntoine%26date%3D2020%26volume%3D77%26issue%3D8%26spage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah K.  Yeo</span>, <span class="hlFld-ContribAuthor ">Yurii  Shepelytskyi</span>, <span class="hlFld-ContribAuthor ">Vira  Grynko</span>, <span class="hlFld-ContribAuthor ">Mitchell S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-β Detection. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3413. <a href="https://doi.org/10.3390/molecules25153413" title="DOI URL">https://doi.org/10.3390/molecules25153413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153413%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BImaging%252Bof%252BFluorinated%252BProbes%252Bfor%252BTau%252BProtein%252Band%252BAmyloid-%2525CE%2525B2%252BDetection%26aulast%3DYeo%26aufirst%3DSarah%2BK.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomohiro  Kaneta</span>. </span><span class="cited-content_cbyCitation_article-title">PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan. </span><span class="cited-content_cbyCitation_journal-name">Japanese Journal of Radiology</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 343-357. <a href="https://doi.org/10.1007/s11604-019-00901-8" title="DOI URL">https://doi.org/10.1007/s11604-019-00901-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11604-019-00901-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11604-019-00901-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJapanese%2520Journal%2520of%2520Radiology%26atitle%3DPET%252Band%252BSPECT%252Bimaging%252Bof%252Bthe%252Bbrain%25253A%252Ba%252Breview%252Bon%252Bthe%252Bcurrent%252Bstatus%252Bof%252Bnuclear%252Bmedicine%252Bin%252BJapan%26aulast%3DKaneta%26aufirst%3DTomohiro%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D4%26spage%3D343%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bright Chukwunwike  Uzuegbunam</span>, <span class="hlFld-ContribAuthor ">Damiano  Librizzi</span>, <span class="hlFld-ContribAuthor ">Behrooz  Hooshyar Yousefi</span>. </span><span class="cited-content_cbyCitation_article-title">PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 977. <a href="https://doi.org/10.3390/molecules25040977" title="DOI URL">https://doi.org/10.3390/molecules25040977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25040977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25040977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BRadiopharmaceuticals%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%252BDiagnosis%25252C%252Bthe%252BCurrent%252Band%252BFuture%252BLandscape%26aulast%3DUzuegbunam%26aufirst%3DBright%2BChukwunwike%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heiko  Kroth</span>, <span class="hlFld-ContribAuthor ">Felix  Oden</span>, <span class="hlFld-ContribAuthor ">Jerome  Molette</span>, <span class="hlFld-ContribAuthor ">Hanno  Schieferstein</span>, <span class="hlFld-ContribAuthor ">Francesca  Capotosti</span>, <span class="hlFld-ContribAuthor ">Andre  Mueller</span>, <span class="hlFld-ContribAuthor ">Mathias  Berndt</span>, <span class="hlFld-ContribAuthor ">Heribert  Schmitt-Willich</span>, <span class="hlFld-ContribAuthor ">Vincent  Darmency</span>, <span class="hlFld-ContribAuthor ">Emanuele  Gabellieri</span>, <span class="hlFld-ContribAuthor ">Cédric  Boudou</span>, <span class="hlFld-ContribAuthor ">Tanja  Juergens</span>, <span class="hlFld-ContribAuthor ">Yvan  Varisco</span>, <span class="hlFld-ContribAuthor ">Efthymia  Vokali</span>, <span class="hlFld-ContribAuthor ">David T.  Hickman</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Andrea  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Ludger  Dinkelborg</span>, <span class="hlFld-ContribAuthor ">Andreas  Muhs</span>, <span class="hlFld-ContribAuthor ">Andrew  Stephens</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2019,</strong> <em>46 </em>
                                    (10)
                                     , 2178-2189. <a href="https://doi.org/10.1007/s00259-019-04397-2" title="DOI URL">https://doi.org/10.1007/s00259-019-04397-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-019-04397-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-019-04397-2%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DDiscovery%252Band%252Bpreclinical%252Bcharacterization%252Bof%252B%25255B18F%25255DPI-2620%25252C%252Ba%252Bnext-generation%252Btau%252BPET%252Btracer%252Bfor%252Bthe%252Bassessment%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bother%252Btauopathies%26aulast%3DKroth%26aufirst%3DHeiko%26date%3D2019%26date%3D2019%26volume%3D46%26issue%3D10%26spage%3D2178%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Sanabria Bohórquez</span>, <span class="hlFld-ContribAuthor ">Jan  Marik</span>, <span class="hlFld-ContribAuthor ">Annie  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Jeff N.  Tinianow</span>, <span class="hlFld-ContribAuthor ">Herman S.  Gill</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">David  Alagille</span>, <span class="hlFld-ContribAuthor ">Gai  Ayalon</span>, <span class="hlFld-ContribAuthor ">Paul  Manser</span>, <span class="hlFld-ContribAuthor ">Thomas  Bengtsson</span>, <span class="hlFld-ContribAuthor ">Michael  Ward</span>, <span class="hlFld-ContribAuthor ">Simon-Peter  Williams</span>, <span class="hlFld-ContribAuthor ">Geoffrey A.  Kerchner</span>, <span class="hlFld-ContribAuthor ">John P.  Seibyl</span>, <span class="hlFld-ContribAuthor ">Kenneth  Marek</span>, <span class="hlFld-ContribAuthor ">Robby M.  Weimer</span>. </span><span class="cited-content_cbyCitation_article-title">[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2019,</strong> <em>46 </em>
                                    (10)
                                     , 2077-2089. <a href="https://doi.org/10.1007/s00259-019-04399-0" title="DOI URL">https://doi.org/10.1007/s00259-019-04399-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-019-04399-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-019-04399-0%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3D%25255B18F%25255DGTP1%252B%252528Genentech%252BTau%252BProbe%252B1%252529%25252C%252Ba%252Bradioligand%252Bfor%252Bdetecting%252Bneurofibrillary%252Btangle%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSanabria%2BBoh%25C3%25B3rquez%26aufirst%3DSandra%26date%3D2019%26date%3D2019%26volume%3D46%26issue%3D10%26spage%3D2077%26epage%3D2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Kaide</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Haruka  Tatsumi</span>, <span class="hlFld-ContribAuthor ">Shimpei  Iikuni</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakamoto</span>, <span class="hlFld-ContribAuthor ">Kaori  Togashi</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>. </span><span class="cited-content_cbyCitation_article-title">18F-labeled benzimidazopyridine derivatives for PET imaging of tau pathology in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3587-3594. <a href="https://doi.org/10.1016/j.bmc.2019.06.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D18F-labeled%252Bbenzimidazopyridine%252Bderivatives%252Bfor%252BPET%252Bimaging%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKaide%26aufirst%3DSho%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3587%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Leuzy</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Chiotis</span>, <span class="hlFld-ContribAuthor ">Laetitia  Lemoine</span>, <span class="hlFld-ContribAuthor ">Per-Göran  Gillberg</span>, <span class="hlFld-ContribAuthor ">Ove  Almkvist</span>, <span class="hlFld-ContribAuthor ">Elena  Rodriguez-Vieitez</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>. </span><span class="cited-content_cbyCitation_article-title">Tau PET imaging in neurodegenerative tauopathies—still a challenge. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 1112-1134. <a href="https://doi.org/10.1038/s41380-018-0342-8" title="DOI URL">https://doi.org/10.1038/s41380-018-0342-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41380-018-0342-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41380-018-0342-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DTau%252BPET%252Bimaging%252Bin%252Bneurodegenerative%252Btauopathies%2525E2%252580%252594still%252Ba%252Bchallenge%26aulast%3DLeuzy%26aufirst%3DAntoine%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D1112%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Paul  Edison</span>. </span><span class="cited-content_cbyCitation_article-title">Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Current Neurology and Neuroscience Reports</span><span> <strong>2019,</strong> <em>19 </em>
                                    (7)
                                     <a href="https://doi.org/10.1007/s11910-019-0962-7" title="DOI URL">https://doi.org/10.1007/s11910-019-0962-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11910-019-0962-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11910-019-0962-7%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neurology%2520and%2520Neuroscience%2520Reports%26atitle%3DTau%252BImaging%252Bin%252BNeurodegenerative%252BDiseases%252BUsing%252BPositron%252BEmission%252BTomography%26aulast%3DWang%26aufirst%3DYi%2BTing%26date%3D2019%26date%3D2019%26volume%3D19%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Schöll</span>, <span class="hlFld-ContribAuthor ">Anne  Maass</span>, <span class="hlFld-ContribAuthor ">Niklas  Mattsson</span>, <span class="hlFld-ContribAuthor ">Nicholas J.  Ashton</span>, <span class="hlFld-ContribAuthor ">Kaj  Blennow</span>, <span class="hlFld-ContribAuthor ">Henrik  Zetterberg</span>, <span class="hlFld-ContribAuthor ">William  Jagust</span>. </span><span class="cited-content_cbyCitation_article-title">Biomarkers for tau pathology. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Neuroscience</span><span> <strong>2019,</strong> <em>97 </em>, 18-33. <a href="https://doi.org/10.1016/j.mcn.2018.12.001" title="DOI URL">https://doi.org/10.1016/j.mcn.2018.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mcn.2018.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mcn.2018.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Neuroscience%26atitle%3DBiomarkers%252Bfor%252Btau%252Bpathology%26aulast%3DSch%25C3%25B6ll%26aufirst%3DMichael%26date%3D2019%26volume%3D97%26spage%3D18%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M Catarina  Silva</span>, <span class="hlFld-ContribAuthor ">Fleur M  Ferguson</span>, <span class="hlFld-ContribAuthor ">Quan  Cai</span>, <span class="hlFld-ContribAuthor ">Katherine A  Donovan</span>, <span class="hlFld-ContribAuthor ">Ghata  Nandi</span>, <span class="hlFld-ContribAuthor ">Debasis  Patnaik</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Tsang  Huang</span>, <span class="hlFld-ContribAuthor ">Diane E  Lucente</span>, <span class="hlFld-ContribAuthor ">Bradford C  Dickerson</span>, <span class="hlFld-ContribAuthor ">Timothy J  Mitchison</span>, <span class="hlFld-ContribAuthor ">Eric S  Fischer</span>, <span class="hlFld-ContribAuthor ">Nathanael S  Gray</span>, <span class="hlFld-ContribAuthor ">Stephen J  Haggarty</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2019,</strong> <em>8 </em><a href="https://doi.org/10.7554/eLife.45457" title="DOI URL">https://doi.org/10.7554/eLife.45457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.45457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.45457%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DTargeted%252Bdegradation%252Bof%252Baberrant%252Btau%252Bin%252Bfrontotemporal%252Bdementia%252Bpatient-derived%252Bneuronal%252Bcell%252Bmodels%26aulast%3DSilva%26aufirst%3DM%2BCatarina%26date%3D2019%26date%3D2019%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia E.  Cole</span>, <span class="hlFld-ContribAuthor ">Steven G.  Einstein</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Neuroimaging Biomarkers in CNS Drug Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 115-158. <a href="https://doi.org/10.1016/B978-0-12-803161-2.00009-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-803161-2.00009-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-803161-2.00009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-803161-2.00009-6%26sid%3Dliteratum%253Aachs%26atitle%3DApplications%252Bof%252BNeuroimaging%252BBiomarkers%252Bin%252BCNS%252BDrug%252BDevelopment%26aulast%3DCole%26aufirst%3DPatricia%2BE.%26date%3D2019%26spage%3D115%26epage%3D158%26pub%3DElsevier%26atitle%3DTranslational%252BMedicine%252Bin%252BCNS%252BDrug%252BDevelopment%26date%3D2019%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magisetty  Obulesu</span>. </span><span class="cited-content_cbyCitation_article-title">Early Diagnosis of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 7-12. <a href="https://doi.org/10.1016/B978-0-12-816412-9.00002-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-816412-9.00002-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816412-9.00002-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816412-9.00002-1%26sid%3Dliteratum%253Aachs%26atitle%3DEarly%252BDiagnosis%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DObulesu%26aufirst%3DMagisetty%26date%3D2019%26spage%3D7%26epage%3D12%26pub%3DElsevier%26atitle%3DAlzheimer%252527s%252BDisease%252BTheranostics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobey J.  Betthauser</span>. </span><span class="cited-content_cbyCitation_article-title">AD molecular: Imaging tau aggregates with positron emissions tomography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 107-138. <a href="https://doi.org/10.1016/bs.pmbts.2019.07.007" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2019.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2019.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2019.07.007%26sid%3Dliteratum%253Aachs%26atitle%3DAD%252Bmolecular%25253A%252BImaging%252Btau%252Baggregates%252Bwith%252Bpositron%252Bemissions%252Btomography%26aulast%3DBetthauser%26aufirst%3DTobey%2BJ.%26date%3D2019%26spage%3D107%26epage%3D138%26pub%3DElsevier%26atitle%3DBrain%252BImaging%26date%3D2019%26volume%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa C.  Wren</span>, <span class="hlFld-ContribAuthor ">Tammaryn  Lashley</span>, <span class="hlFld-ContribAuthor ">Erik  Årstad</span>, <span class="hlFld-ContribAuthor ">Kerstin  Sander</span>. </span><span class="cited-content_cbyCitation_article-title">Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2018,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-018-0535-z" title="DOI URL">https://doi.org/10.1186/s40478-018-0535-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-018-0535-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-018-0535-z%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DLarge%252Binter-%252Band%252Bintra-case%252Bvariability%252Bof%252Bfirst%252Bgeneration%252Btau%252BPET%252Bligand%252Bbinding%252Bin%252Bneurodegenerative%252Bdementias%26aulast%3DWren%26aufirst%3DMelissa%2BC.%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grazia  Femminella</span>, <span class="hlFld-ContribAuthor ">Tony  Thayanandan</span>, <span class="hlFld-ContribAuthor ">Valeria  Calsolaro</span>, <span class="hlFld-ContribAuthor ">Klara  Komici</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Rengo</span>, <span class="hlFld-ContribAuthor ">Graziamaria  Corbi</span>, <span class="hlFld-ContribAuthor ">Nicola  Ferrara</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging and Molecular Mechanisms of Alzheimer’s Disease: A Review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (12)
                                     , 3702. <a href="https://doi.org/10.3390/ijms19123702" title="DOI URL">https://doi.org/10.3390/ijms19123702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19123702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19123702%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DImaging%252Band%252BMolecular%252BMechanisms%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BA%252BReview%26aulast%3DFemminella%26aufirst%3DGrazia%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D12%26spage%3D3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, <span class="hlFld-ContribAuthor ">Robert A.  Comley</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Paul B.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Susan M.  Resnick</span>, <span class="hlFld-ContribAuthor ">Susanne  Ostrowitzki</span>, <span class="hlFld-ContribAuthor ">Cristina  Vozzi</span>, <span class="hlFld-ContribAuthor ">Frank  Boess</span>, <span class="hlFld-ContribAuthor ">Esther  Oh</span>, <span class="hlFld-ContribAuthor ">Constantine G.  Lyketsos</span>, <span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Luca  Gobbi</span>, <span class="hlFld-ContribAuthor ">Gregory  Klein</span>, <span class="hlFld-ContribAuthor ">Noble  George</span>, <span class="hlFld-ContribAuthor ">Lorena  Gapasin</span>, <span class="hlFld-ContribAuthor ">Kelly  Kitzmiller</span>, <span class="hlFld-ContribAuthor ">Josh  Roberts</span>, <span class="hlFld-ContribAuthor ">Jeff  Sevigny</span>, <span class="hlFld-ContribAuthor ">Ayon  Nandi</span>, <span class="hlFld-ContribAuthor ">James  Brasic</span>, <span class="hlFld-ContribAuthor ">Chakradhar  Mishra</span>, <span class="hlFld-ContribAuthor ">Madhav  Thambisetty</span>, <span class="hlFld-ContribAuthor ">Abhay  Moghekar</span>, <span class="hlFld-ContribAuthor ">Anil  Mathur</span>, <span class="hlFld-ContribAuthor ">Marilyn  Albert</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of 3 Novel Tau Radiopharmaceuticals,
              11
              C-RO-963,
              11
              C-RO-643, and
              18
              F-RO-948, in Healthy Controls and in Alzheimer Subjects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (12)
                                     , 1869-1876. <a href="https://doi.org/10.2967/jnumed.118.209916" title="DOI URL">https://doi.org/10.2967/jnumed.118.209916</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.209916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.209916%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DCharacterization%252Bof%252B3%252BNovel%252BTau%252BRadiopharmaceuticals%25252C%252B11%252BC-RO-963%25252C%252B11%252BC-RO-643%25252C%252Band%252B18%252BF-RO-948%25252C%252Bin%252BHealthy%252BControls%252Band%252Bin%252BAlzheimer%252BSubjects%26aulast%3DWong%26aufirst%3DDean%2BF.%26date%3D2018%26date%3D2018%26volume%3D59%26issue%3D12%26spage%3D1869%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Aiko  Ishiki</span>, <span class="hlFld-ContribAuthor ">Akio  Kikuchi</span>, <span class="hlFld-ContribAuthor ">Tadaho  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">The development and validation of tau PET tracers: current status and future directions. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Imaging</span><span> <strong>2018,</strong> <em>6 </em>
                                    (4)
                                     , 305-316. <a href="https://doi.org/10.1007/s40336-018-0290-y" title="DOI URL">https://doi.org/10.1007/s40336-018-0290-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40336-018-0290-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40336-018-0290-y%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Imaging%26atitle%3DThe%252Bdevelopment%252Band%252Bvalidation%252Bof%252Btau%252BPET%252Btracers%25253A%252Bcurrent%252Bstatus%252Band%252Bfuture%252Bdirections%26aulast%3DOkamura%26aufirst%3DNobuyuki%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D4%26spage%3D305%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor L.  Villemagne</span>, <span class="hlFld-ContribAuthor ">Vincent  Doré</span>, <span class="hlFld-ContribAuthor ">Samantha C.  Burnham</span>, <span class="hlFld-ContribAuthor ">Colin L.  Masters</span>, <span class="hlFld-ContribAuthor ">Christopher C.  Rowe</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Neurology</span><span> <strong>2018,</strong> <em>14 </em>
                                    (4)
                                     , 225-236. <a href="https://doi.org/10.1038/nrneurol.2018.9" title="DOI URL">https://doi.org/10.1038/nrneurol.2018.9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrneurol.2018.9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrneurol.2018.9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Neurology%26atitle%3DImaging%252Btau%252Band%252Bamyloid-%2525CE%2525B2%252Bproteinopathies%252Bin%252BAlzheimer%252Bdisease%252Band%252Bother%252Bconditions%26aulast%3DVillemagne%26aufirst%3DVictor%2BL.%26date%3D2018%26date%3D2018%26volume%3D14%26issue%3D4%26spage%3D225%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bjoern  Bartels</span>, <span class="hlFld-ContribAuthor ">Philipp  Cueni</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Matthias  Koerner</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a safe and scalable route towards a tau PET tracer precursor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (4)
                                     , 970-976. <a href="https://doi.org/10.1016/j.bmc.2017.10.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bsafe%252Band%252Bscalable%252Broute%252Btowards%252Ba%252Btau%252BPET%252Btracer%252Bprecursor%26aulast%3DBartels%26aufirst%3DBjoern%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D970%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor L.  Villemagne</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Tau Imaging:
              Der Stand der Dinge. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (2)
                                     , 175-176. <a href="https://doi.org/10.2967/jnumed.117.198325" title="DOI URL">https://doi.org/10.2967/jnumed.117.198325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.117.198325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.117.198325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DSelective%252BTau%252BImaging%25253A%252BDer%252BStand%252Bder%252BDinge%26aulast%3DVillemagne%26aufirst%3DVictor%2BL.%26date%3D2018%26date%3D2017%26volume%3D59%26issue%3D2%26spage%3D175%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Edison</span>. </span><span class="cited-content_cbyCitation_article-title">Tau Imaging in Preclinical Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 189-197. <a href="https://doi.org/10.1007/978-1-4939-7674-4_13" title="DOI URL">https://doi.org/10.1007/978-1-4939-7674-4_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-7674-4_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-7674-4_13%26sid%3Dliteratum%253Aachs%26atitle%3DTau%252BImaging%252Bin%252BPreclinical%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DEdison%26aufirst%3DPaul%26date%3D2018%26date%3D2018%26spage%3D189%26epage%3D197%26pub%3DSpringer%2520New%2520York%26atitle%3DBiomarkers%252Bfor%252BPreclinical%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPerneczky%26aufirst%3DRobert%26date%3D2018%26volume%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laetitia  Lemoine</span>, <span class="hlFld-ContribAuthor ">Per-Göran  Gillberg</span>, <span class="hlFld-ContribAuthor ">Marie  Svedberg</span>, <span class="hlFld-ContribAuthor ">Vladimir  Stepanov</span>, <span class="hlFld-ContribAuthor ">Zhisheng  Jia</span>, <span class="hlFld-ContribAuthor ">Jinghai  Huang</span>, <span class="hlFld-ContribAuthor ">Sangram  Nag</span>, <span class="hlFld-ContribAuthor ">He  Tian</span>, <span class="hlFld-ContribAuthor ">Bernardino  Ghetti</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains. </span><span class="cited-content_cbyCitation_journal-name">Alzheimer's Research & Therapy</span><span> <strong>2017,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13195-017-0325-z" title="DOI URL">https://doi.org/10.1186/s13195-017-0325-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13195-017-0325-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13195-017-0325-z%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%2527s%2520Research%2520%2526%2520Therapy%26atitle%3DComparative%252Bbinding%252Bproperties%252Bof%252Bthe%252Btau%252BPET%252Btracers%252BTHK5117%25252C%252BTHK5351%25252C%252BPBB3%25252C%252Band%252BT807%252Bin%252Bpostmortem%252BAlzheimer%252Bbrains%26aulast%3DLemoine%26aufirst%3DLaetitia%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of PET tracers for imaging of tau aggregates reported to have entered clinical evaluation studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Imidazo[1,2-<i>a</i>]pyridines <b>7</b> and <b>16</b>–<b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) For <b>12</b>, R<sub>1</sub> = NHMe: 40% aqueous MeNH<sub>2</sub>, 160 °C, 4 h, 75%. (b) For <b>7</b>, <b>18</b>: <b>14</b> or <b>15</b>, NaHCO<sub>3</sub>, MeOH or EtOH, reflux, 4–6 h, 22–35%. For <b>16</b>, <b>17</b>: <b>13</b>, acetone, 65 °C, 5 h, 44–90%. (c) NaH, DMF, 30 min, then MeI, rt, 18 h, 6%. (d) LiHMDS, THF, 0 °C, 25 min, then Boc<sub>2</sub>O, rt, 1.5 h, 66%. (e) NaH, DMF, rt, 15 min, then 1-bromo-2-fluoroethane, 50 °C, 1 h, 95%. (f) TFA, DCM, rt, 3 h, 93%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Imidazo[1,2-<i>a</i>]pyrimidines <b>8</b> and <b>29</b>–<b>37</b> and Imidazo[1,2-<i>c</i>]pyrimidine <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions. (a) <b>25</b>: NH<sub>2</sub>Me·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 2 h, 40%. <b>26</b>: NHMe<sub>2</sub>·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 1 h, 43%. <b>27</b>: NH<sub>2</sub><i>c</i>Pr, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C, 18 h, 55%. <b>28</b>: 4-(2-fluoroethyl)piperidine·HCl, K<sub>2</sub>CO<sub>3</sub>, NMP, 120 °C, 12 h, 78%. (b) <b>8</b> and <b>29</b>–<b>36</b>: α-Br-acetophenones, acetone, 60–65 °C, 5–18 h, 35–94%. Or <b>36</b>: α-Br-acetophenone, pTsOH, acetone, 65 °C, 12 h, 25%. (c) 1-Bromo-2-fluoroethane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 70 °C, 1 h, 55%. (d) (TsOCH<sub>2</sub>)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 50 °C, 2 h, 41%. (e) α-Br-acetophenone, EtOH, 80 °C, 8 h, 13%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrrolo[2,3-<i>b</i>:4,5-<i>c</i>′]dipyridines <b>9</b> and <b>49</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [Pd(OAc)<sub>2</sub>], PPh<sub>3</sub>, Et<sub>3</sub>N, DMF, 100 °C, 3 h, ∼90% purity, 63%. (b) K<sub>2</sub>CO<sub>3</sub>, 18-crown-6, DMF, 100 °C, 3 h, 63%. (c) NaH, DMF, 0 °C to rt, then Boc<sub>2</sub>O, DMF, 0 °C to rt, 18 h, 73%. (d) [PdCl<sub>2</sub>(dppf)]·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 17–18 h. <b>47</b>: 10%. <b>49</b>: 13%. (e) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 18 h, 88%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 9<i>H</i>-Pyrimido[4,5-<i>b</i>]indole <b>55</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOH, reflux, 3 h, 70%. (b) [Pd(OAc)<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>], NaOAc, DMA, microwave 130 °C, 4 h, 11%. (c) [PdCl<sub>2</sub>(dppf)]·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave 100 °C, 1 h, 20%.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 5<i>H</i>-Pyrido[4,3-<i>b</i>]indole <b>62</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BF<sub>3</sub>·Et<sub>2</sub>O, 120 °C, 16 h, 69% (mixture of regioisomers). (b) NaH, DMF, 0 °C to rt, 30 min, then TsCl, rt, 1 h, 21%. (c) [Pd<sub>2</sub>(dba)<sub>3</sub>]·CHCl<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, THF, 90 °C, 16 h, 76%. (d) NaOH, THF/H<sub>2</sub>O, 50 °C, 20 h, then NaOH, MeOH, reflux 6 h, 25%.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Representative Tritiations As Exemplified for the Preparation of [<sup>3</sup>H]<b>8</b>, [<sup>3</sup>H]<b>9</b>, and [<sup>3</sup>H]<b>37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [<sup>3</sup>H]MeONs, Cs<sub>2</sub>CO<sub>3</sub>, toluene, rt, 24 h. (b) [<sup>3</sup>H]H<sub>2</sub>, [Ir(COD)(PCy<sub>3</sub>)(Py)]PF<sub>6</sub>, DCM/DMF, rt, 4 h.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. In vitro autoradiography of the reference tracer [<sup>3</sup>H]<b>3</b> and all six test ligands (<b>7</b>–<b>9</b>, <b>22</b>, <b>34</b>, and <b>37</b>) in tritiated form using native cortical tissue sections from an AD Braak V patient (top row) and a healthy control subject (bottom row). The radioligand concentration was 3 nM for all compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Colocalization of tau mAb pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (A) and Aβ mAb BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (C) immunohistochemical staining with autoradiographical tracer binding (B) of [<sup>3</sup>H]<b>8</b>, as a representative example. Staining and binding experiments were performed on a single fresh-frozen tissue section from an AD Braak V cortical tissue block. The detail (D) shows the autoradiography superimposed with tau mAb (red) and Aβ mAb staining (green). The black radioactive binding signal colocalizes mainly with the tau mAb staining.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Colocalization of tau mAb pS422<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (A) and Aβ mAb BAP-2<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (C) immunohistochemical staining with microautoradiographical tracer binding (B) of [<sup>3</sup>H]<b>8</b>, as a representative example. Staining and binding experiments were performed on a single fresh-frozen tissue section from an AD Braak V cortical tissue block. The detail (D) shows the microautoradiographical signal superimposed with tau mAb staining (red). The black silver grain deposits (representing radioligand binding) colocalize with tau mAb staining, while areas of Aβ mAb staining (dotted circle in B) do not colocalize with microautoradiographical signals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Carbon-11 and Fluorine-18 Tracers<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) [<sup>11</sup>C]MeI, NaH, DMF, 80 °C, 3 min; (b) [<sup>11</sup>C]MeI, 6 N NaOH, DMSO, 80 °C, 3 min; (c) [<sup>18</sup>F]KF, Kryptofix 2.2.2, DMSO, microwave 50 W, 4 min; (d) [<sup>18</sup>F]KF, Kryptofix 2.2.2, DMSO, microwave 50 W, 80 s.</p></p></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/medium/jm-2017-00632k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time–activity curves of the whole gray matter of candidate radioligands as determined in a baboon PET study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-17/acs.jmedchem.7b00632/20170908/images/large/jm-2017-00632k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00632&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i87">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Buee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buee-Scherrer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span><span class="refDoi"> DOI: 10.1016/S0165-0173(00)00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0165-0173%2800%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10967355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=95-130&author=L.+Bueeauthor=T.+Bussiereauthor=V.+Buee-Scherrerauthor=A.+Delacourteauthor=P.+R.+Hof&title=Tau+protein+isoforms%2C+phosphorylation+and+role+in+neurodegenerative+disorders&doi=10.1016%2FS0165-0173%2800%2900019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span></div><div class="casAuthors">Buee, L.; Bussiere, T.; Buee-Scherrer, V.; Delacourte, A.; Hof, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-130</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 425 refs.  Tau proteins belong to the family of microtubule-assocd. proteins.  They are mainly expressed in neurons where they play an important role in the assembly of tubulin monomers into microtubules to constitute the neuronal microtubules network.  Microtubules are involved in maintaining the cell shape and serve as tracks for axonal transport.  Tau proteins also establish some links between microtubules and other cytoskeletal elements or proteins.  Tau proteins are translated from a single gene located on chromosome 17.  Their expression is developmentally regulated by an alternative splicing mechanism and six different isoforms exist in the human adult brain.  Tau proteins are the major constituents of intra-neuronal and glial fibrillar lesions described in Alzheimer's disease and numerous neurodegenerative disorders referred to as 'tauopathies'.  Mol. anal. has revealed that an abnormal phosphorylation might be one of the important events in the process leading to their aggregation.  Moreover, a specific set of pathol. tau proteins exhibiting a typical biochem. pattern, and a different regional and laminar distribution could characterize each of these disorders.  Finally, a direct correlation has been established between the progressive involvement of the neocortical areas and the increasing severity of dementia, suggesting that pathol. tau proteins are reliable marker of the neurodegenerative process.  The recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KNCSKfZ8_7Vg90H21EOLACvtfcHk0ljo01zprNPKtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D&md5=d51d14c9e8b56e9661db4ae4afc2c943</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DBuee%26aufirst%3DL.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DBuee-Scherrer%26aufirst%3DV.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DTau%2520protein%2520isoforms%252C%2520phosphorylation%2520and%2520role%2520in%2520neurodegenerative%2520disorders%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26spage%3D95%26epage%3D130%26doi%3D10.1016%2FS0165-0173%2800%2900019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">6446</span><span class="NLM_x">–</span> <span class="NLM_lpage">6457</span><span class="refDoi"> DOI: 10.1021/bi052530j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi052530j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6446-6457&author=M.+Von+Bergenauthor=S.+Barghornauthor=S.+A.+Muellerauthor=M.+Pickhardtauthor=J.+Biernatauthor=E.-M.+Mandelkowauthor=P.+Daviesauthor=U.+Aebiauthor=E.+Mandelkow&title=The+core+of+tau-paired+helical+filaments+studied+by+scanning+transmission+electron+microscopy+and+limited+proteolysis&doi=10.1021%2Fbi052530j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fbi052530j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi052530j%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DS.%2BA.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DAebi%26aufirst%3DU.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DThe%2520core%2520of%2520tau-paired%2520helical%2520filaments%2520studied%2520by%2520scanning%2520transmission%2520electron%2520microscopy%2520and%2520limited%2520proteolysis%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D6446%26epage%3D6457%26doi%3D10.1021%2Fbi052530j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2ebA3jff3JfaL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Alzheimer’s Association.</span><span> </span><span class="NLM_article-title">2015 Alzheimer’s disease facts and figures</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.jalz.2015.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25984581" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=332-384&author=Alzheimer%E2%80%99s+Association.&title=2015+Alzheimer%E2%80%99s+disease+facts+and+figures&doi=10.1016%2Fj.jalz.2015.02.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.02.003%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3D2015%2520Alzheimer%25E2%2580%2599s%2520disease%2520facts%2520and%2520figures%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D332%26epage%3D384%26doi%3D10.1016%2Fj.jalz.2015.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemuri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiste, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigand, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesnick, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankratz, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span><span class="refDoi"> DOI: 10.1016/S1474-4422(12)70291-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS1474-4422%2812%2970291-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23332364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=207-216&author=C.+R.+Jackauthor=D.+S.+Knopmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=M.+W.+Weinerauthor=P.+S.+Aisenauthor=L.+M.+Shawauthor=P.+Vemuriauthor=H.+J.+Wisteauthor=S.+D.+Weigandauthor=T.+G.+Lesnickauthor=V.+S.+Pankratzauthor=M.+C.+Donohueauthor=J.+Q.+Trojanowski&title=Tracking+pathophysiological+processes+in+Alzheimer%E2%80%99s+disease%3A+an+updated+hypothetical+model+of+dynamic+biomarkers&doi=10.1016%2FS1474-4422%2812%2970291-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers</span></div><div class="casAuthors">Jack, Clifford R.; Knopman, David S.; Jagust, William J.; Petersen, Ronald C.; Weiner, Michael W.; Aisen, Paul S.; Shaw, Leslie M.; Vemuri, Prashanthi; Wiste, Heather J.; Weigand, Stephen D.; Lesnick, Timothy G.; Pankratz, Vernon S.; Donohue, Michael C.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease (AD).  The model was received with interest because we described the temporal evolution of AD biomarkers in relation to each other and to the onset and progression of clin. symptoms.  Since then, evidence has accumulated that supports the major assumptions of this model.  Evidence has also appeared that challenges some of our assumptions, which has allowed us to modify our original model.  Refinements to our model include indexing of individuals by time rather than clin. symptom severity; incorporation of interindividual variability in cognitive impairment assocd. with progression of AD pathophysiol.; modifications of the specific temporal ordering of some biomarkers; and recognition that the two major proteinopathies underlying AD biomarker changes, amyloid β (Aβ) and tau, might be initiated independently in sporadic AD, in which we hypothesise that an incident Aβ pathophysiol. can accelerate antecedent limbic and brainstem tauopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgH6Mv-cXkY7Vg90H21EOLACvtfcHk0lg2mwkPTD0Q_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCht7o%253D&md5=0f7a94ec086d5287fef9f7a6995981df</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2812%2970291-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252812%252970291-0%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DWeiner%26aufirst%3DM.%2BW.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DShaw%26aufirst%3DL.%2BM.%26aulast%3DVemuri%26aufirst%3DP.%26aulast%3DWiste%26aufirst%3DH.%2BJ.%26aulast%3DWeigand%26aufirst%3DS.%2BD.%26aulast%3DLesnick%26aufirst%3DT.%2BG.%26aulast%3DPankratz%26aufirst%3DV.%2BS.%26aulast%3DDonohue%26aufirst%3DM.%2BC.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DTracking%2520pathophysiological%2520processes%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520updated%2520hypothetical%2520model%2520of%2520dynamic%2520biomarkers%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D207%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2812%2970291-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present, and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andr%C3%A9s&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present%2C+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future</span></div><div class="casAuthors">Ariza, Manuela; Kolb, Hartmuth C.; Moechars, Dieder; Rombouts, Frederik; Andres, Jose Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4365-4382</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population.  The good correlation of the d. and neocortical spread of neurofibrillary tangles (NFTs) with clin. AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomog. (PET).  Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD.  In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clin. development of tau PET radioligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr59qS3XVaWtrVg90H21EOLACvtfcHk0lg2mwkPTD0Q_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisF2ntrg%253D&md5=4d6974529735d3483482e5d7365440e0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Dani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span> </span><span class="NLM_article-title">Tau imaging in neurodegenerative diseases</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1150</span><span class="refDoi"> DOI: 10.1007/s00259-015-3231-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1007%2Fs00259-015-3231-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26572762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyhs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=1139-1150&author=M.+Daniauthor=D.+J.+Brooksauthor=P.+Edison&title=Tau+imaging+in+neurodegenerative+diseases&doi=10.1007%2Fs00259-015-3231-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging in neurodegenerative diseases</span></div><div class="casAuthors">Dani, M.; Brooks, D. J.; Edison, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1139-1150</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aggregated tau protein is a major neuropathol. substrate central to the pathophysiol. of neurodegenerative diseases such as Alzheimer's disease (AD), frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration and chronic traumatic encephalopathy.  In AD, it has been shown that the d. of hyperphosphorylated tau tangles correlates closely with neuronal dysfunction and cell death, unlike β-amyloid.  Until now, diagnostic and pathol. information about tau deposition has only been available from invasive techniques such as brain biopsy or autopsy.  The recent development of selective in-vivo tau PET imaging ligands including [18F]THK523, [18F]THK5117, [18F]THK5105 and [18F]THK5351, [18F]AV1451(T807) and [11C]PBB3 has provided information about the role of tau in the early phases of neurodegenerative diseases, and provided support for diagnosis, prognosis, and imaging biomarkers to track disease progression.  Moreover, the spatial and longitudinal relationship of tau distribution compared with β - amyloid and other pathologies in these diseases can be mapped.  In this review, we discuss the role of aggregated tau in tauopathies, the challenges posed in developing selective tau ligands as biomarkers, the state of development in tau tracers, and the new clin. information that has been uncovered, as well as the opportunities for improving diagnosis and designing clin. trials in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdgnXgdVuVrVg90H21EOLACvtfcHk0liEzwvcwtkk9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyhs7bO&md5=b6ec60c403b40d433dc45e1686e76c0b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3231-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3231-2%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DEdison%26aufirst%3DP.%26atitle%3DTau%2520imaging%2520in%2520neurodegenerative%2520diseases%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26spage%3D1139%26epage%3D1150%26doi%3D10.1007%2Fs00259-015-3231-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Rombouts, F. J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottelbergs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chupakhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleiren, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fierens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leenaerts, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariën, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te Riele, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintmolders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span> </span><span class="NLM_article-title">Discovery of N-(pyridin-4-yl)-1,5-naphthyridin-2-amines as potential tau pathology PET tracers for Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1291</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01173</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01173" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVansrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1272-1291&author=F.+J.+R.+Romboutsauthor=J.-I.+Andr%C3%A9sauthor=M.+Arizaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=A.+Bottelbergsauthor=L.+Chenauthor=V.+Chupakhinauthor=E.+Cleirenauthor=K.+Fierensauthor=A.+Fontanaauthor=X.+Langloisauthor=J.+E.+Leenaertsauthor=J.+Mari%C3%ABnauthor=C.+Mart%C3%ADnez+Lamencaauthor=R.+Salterauthor=M.+E.+Schmidtauthor=P.+Te+Rieleauthor=C.+Wintmoldersauthor=A.+A.+Trabancoauthor=W.+Zhangauthor=G.+Macdonaldauthor=D.+Moechars&title=Discovery+of+N-%28pyridin-4-yl%29-1%2C5-naphthyridin-2-amines+as+potential+tau+pathology+PET+tracers+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer's Disease</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Andres, Jose-Ignacio; Ariza, Manuela; Alonso, Jose Manuel; Austin, Nigel; Bottelbergs, Astrid; Chen, Lu; Chupakhin, Vladimir; Cleiren, Erna; Fierens, Katleen; Fontana, Alberto; Langlois, Xavier; Leenaerts, Joseph E.; Marien, Jonas; Martinez Lamenca, Carolina; Salter, Rhys; Schmidt, Mark E.; Te Riele, Paula; Wintmolders, Cindy; Trabanco, Andres A.; Zhang, Wei; Macdonald, Gregor; Moechars, Dieder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1272-1291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A mini-HTS on 4000 compds. selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quinolin-2-amine 10 as a novel potent binder to human AD aggregated tau with modest selectivity vs. aggregated β-amyloid (Aβ).  Initial medicinal chem. efforts identified key elements for potency and selectivity, as well as suitable positions for radiofluorination, leading to a first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicochem. properties.  Further optimization toward a more optimal pharmacokinetic profile led to the discovery of 1,5-naphthyridine 75, a potent and selective tau aggregate binder with potential as a tau PET tracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNbRcRYA-oCbVg90H21EOLACvtfcHk0liEzwvcwtkk9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVansrs%253D&md5=e32ac5db8fe1dffe3d616fc375db0f68</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01173%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBottelbergs%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChupakhin%26aufirst%3DV.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DFierens%26aufirst%3DK.%26aulast%3DFontana%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DLeenaerts%26aufirst%3DJ.%2BE.%26aulast%3DMari%25C3%25ABn%26aufirst%3DJ.%26aulast%3DMart%25C3%25ADnez%2BLamenca%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DTe%2BRiele%26aufirst%3DP.%26aulast%3DWintmolders%26aufirst%3DC.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520N-%2528pyridin-4-yl%2529-1%252C5-naphthyridin-2-amines%2520as%2520potential%2520tau%2520pathology%2520PET%2520tracers%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1272%26epage%3D1291%26doi%3D10.1021%2Facs.jmedchem.6b01173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span><span class="refDoi"> DOI: 10.2967/jnumed.113.136069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.113.136069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers&doi=10.2967%2Fjnumed.113.136069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.136069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.136069%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874%26doi%3D10.2967%2Fjnumed.113.136069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Shin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">The merits of FDDNP-PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.3233/JAD-2011-0008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-2011-0008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21971458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=135-145&issue=Suppl.+3&author=J.+Shinauthor=V.+Kepeauthor=J.+R.+Barrioauthor=G.+W.+Small&title=The+merits+of+FDDNP-PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2011-0008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Merits of FDDNP-PET Imaging in Alzheimer's Disease</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Shin, Jonghan; Kepe, Vladimir; Barrio, Jorge R.; Small, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  2-(1-{6-[(2-[Fluorine-18]fluoroethyl)(methyl)amino]-2-naphthyl}-ethylidene)malononitrile (FDDNP) is the first positron emission tomog. (PET) mol. imaging probe to visualize Alzheimer's disease (AD) pathol. in living humans.  The most unique features of FDDNP are that (1) it is the only currently available radiotracer to image neurofibrillary tangles, beside amyloid aggregates, in living humans; and (2) it is also the only radiotracer to visualize AD pathol. in the hippocampal region of living humans.  In this article, we discuss FDDNP's unique ability to image tau pathol. in living humans.  Emphasizing tau pathol. imaging capability using FDDNP in AD, as well as other tauopathies, is timely and beneficial considering that (1) post mortem histopathol. studies using human specimens have consistently demonstrated that neurofibrillary tangles, compared with amyloid plaques, are better correlated with the disease severity and neuronal death; and (2) recently reported clin. trial failures of disease-modifying drugs in development, based on the amyloid-cascade hypothesis, suggest that some of the basic assumptions of AD causality warrant reassessment and redirection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmfShnsgqf7Vg90H21EOLACvtfcHk0liEzwvcwtkk9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J&md5=3f18072cd1d9516c234e493d2fc500ec</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-0008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-0008%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DThe%2520merits%2520of%2520FDDNP-PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26issue%3DSuppl.%25203%26spage%3D135%26epage%3D145%26doi%3D10.3233%2FJAD-2011-0008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Shoghi-Jadid, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agdeppa, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1097/00019442-200201000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1097%2F00019442-200201000-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11790632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FntF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=24-35&author=K.+Shoghi-Jadidauthor=G.+W.+Smallauthor=E.+D.+Agdeppaauthor=V.+Kepeauthor=L.+M.+Ercoliauthor=P.+Siddarthauthor=S.+Readauthor=N.+Satyamurthyauthor=A.+Petricauthor=S.-C.+Huangauthor=J.+R.+Barrio&title=Localization+of+neurofibrillary+tangles+and+beta-amyloid+plaques+in+the+brains+of+living+patients+with+Alzheimer+disease&doi=10.1097%2F00019442-200201000-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease</span></div><div class="casAuthors">Shoghi-Jadid Kooresh; Small Gary W; Agdeppa Eric D; Kepe Vladimir; Ercoli Linda M; Siddarth Prabha; Read Stephen; Satyamurthy Nagichettiar; Petric Andrej; Huang Sung-Cheng; Barrio Jorge R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-35</span>
        ISSN:<span class="NLM_cas:issn">1064-7481</span>.
    </div><div class="casAbstract">The authors used 2-(1-(6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl)ethylidene)malononitrile ([18F]FDDNP), a hydrophobic radiofluorinated derivative of 2-(1-[6-(dimethylamino)-2-naphthyl]ethylidene)malononitrile (DDNP), in conjunction with positron emission tomography to determine the localization and load of neurofibrillary tangles (NFTs) and beta-amyloid senile plaques (APs) in the brains of living Alzheimer disease (AD) patients.  Previous work illustrated the in vitro binding characteristics of [18F]FDDNP to synthetic beta-amyloid(1-40) fibrils and to NFTs and APs in human AD brain specimens.  In the present study, greater accumulation and slower clearance was observed in AP- and NFT-dense brain areas and correlated with lower memory performance scores.  The relative residence time of the probe in brain regions affected by AD was significantly greater in patients with AD (n=9) than in control subjects (n=7; p=0.0007).  This noninvasive technique for monitoring AP and NFT development is expected to facilitate diagnostic assessment of patients with AD and assist in response-monitoring during experimental treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDj7JxSapyzs25P7XSLhESfW6udTcc2eZZzjNkIc9gTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FntF2ltw%253D%253D&md5=a6454002bae6d60ff1cef57a0fc85c55</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1097%2F00019442-200201000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00019442-200201000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DShoghi-Jadid%26aufirst%3DK.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DAgdeppa%26aufirst%3DE.%2BD.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DRead%26aufirst%3DS.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DLocalization%2520of%2520neurofibrillary%2520tangles%2520and%2520beta-amyloid%2520plaques%2520in%2520the%2520brains%2520of%2520living%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2002%26volume%3D10%26spage%3D24%26epage%3D35%26doi%3D10.1097%2F00019442-200201000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eZZzjNkIc9gTbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0lh8J6TA6reh6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.,  Sr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navitsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaerf, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1093/brain/aww334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1093%2Fbrain%2Faww334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=28077397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC1c7kslCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2017&pages=748-763&author=M.+J.+Pontecorvoauthor=M.+D.+Devousauthor=M.+Navitskyauthor=M.+Luauthor=S.+Sallowayauthor=F.+W.+Schaerfauthor=D.+Jenningsauthor=A.+K.+Aroraauthor=A.+McGeehanauthor=N.+C.+Limauthor=H.+Xiongauthor=A.+D.+Joshiauthor=A.+Siderowfauthor=M.+A.+Mintun&title=Relationships+between+flortaucipir+PET+tau+binding+and+amyloid+burden%2C+clinical+diagnosis%2C+age+and+cognition&doi=10.1093%2Fbrain%2Faww334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition</span></div><div class="casAuthors">Pontecorvo Michael J; Devous Michael D Sr; Navitsky Michael; Lu Ming; Arora Anupa K; McGeehan Anne; Lim Nathaniel C; Xiong Hui; Joshi Abhinay D; Siderowf Andrew; Mintun Mark A; Salloway Stephen; Schaerf Frederick W; Jennings Danna</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">748-763</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The advent of tau-targeted positron emission tomography tracers such as flortaucipir (18F-AV-1451, also known as 18F-T807) have made it possible to investigate the sequence of development of tau and amyloid-β in relationship to age, and to the development of cognitive impairment due to Alzheimer's disease.  In this study, flortaucipir tau and florbetapir amyloid positron emission tomography were obtained for 217 subjects including 16 young and 58 older cognitively normal subjects, 95 subjects with mild cognitive impairment (Mini-Mental State Examination 24-30) and 48 subjects with clinically-defined possible or probable Alzheimer's disease (Mini-Mental State Examination >10).  Images were evaluated visually and quantitatively by regional and voxel-based cortical to cerebellar standard uptake value ratios.  For amyloid positron emission tomography positive (Aβ+) subjects, flortaucipir neocortical standard uptake value ratio was significantly higher with more advanced clinical stage (Alzheimer's disease > mild cognitive impairment > older cognitively normal) and was significantly elevated for Aβ+ mild cognitive impairment and Alzheimer's disease subjects relative to the respective Aβ- subjects.  In contrast, florbetapir Aβ- older cognitively normal subjects showed an increase in flortaucipir standard uptake value ratios in mesial temporal lobe regions (amygdala, hippocampus/choroid plexus region of interest) compared to younger cognitively normal subjects, but no increased standard uptake value ratios in neocortical regions.  Analysis of covariance with planned contrasts showed no differences in regional or composite posterior neocortical flortaucipir standard uptake value ratio as a function of diagnostic group among Aβ- older cognitively normal or clinically diagnosed Alzheimer's disease or mild cognitive impairment subjects.  The pattern of flortaucipir distribution among Aβ+ subjects was reminiscent of the cross-sectional distribution of tau reported in post-mortem pathology studies, in that the most commonly affected regions were the inferior and lateral temporal lobes, the same regions where the first signs of increased retention appeared in Aβ+ cognitively normal subjects.  However, there was large variability in extent/density of flortaucipir tau binding among Aβ+ subjects.  Although high neocortical flortaucipir retention was consistently associated with an Aβ+ florbetapir positron emission tomography scan, not all Aβ+ subjects had elevated flortaucipir standard uptake value ratios.  Finally, within the Aβ+ group, increasing levels of flortaucipir tau binding were associated with increased cognitive impairment, as assessed by Mini-Mental State Examination and Alzheimer's Disease Assessment Scale.  These results suggest development of tau beyond the mesial temporal lobe is associated with, and may be dependent on, amyloid accumulation.  Further, the results are consistent with the hypothesis that cortical tau is associated with cognitive impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIkDeaqfdY7MvLc4ARHEmzfW6udTcc2ebMyd6rYHnrq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7kslCjtA%253D%253D&md5=b83b958e22c18fbc5dd63b42e4fa9072</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faww334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faww334%26sid%3Dliteratum%253Aachs%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DNavitsky%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSchaerf%26aufirst%3DF.%2BW.%26aulast%3DJennings%26aufirst%3DD.%26aulast%3DArora%26aufirst%3DA.%2BK.%26aulast%3DMcGeehan%26aufirst%3DA.%26aulast%3DLim%26aufirst%3DN.%2BC.%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DRelationships%2520between%2520flortaucipir%2520PET%2520tau%2520binding%2520and%2520amyloid%2520burden%252C%2520clinical%2520diagnosis%252C%2520age%2520and%2520cognition%26jtitle%3DBrain%26date%3D2017%26volume%3D140%26spage%3D748%26epage%3D763%26doi%3D10.1093%2Fbrain%2Faww334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+K.+Szardeningsauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2ebMyd6rYHnrq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span><span class="refDoi"> DOI: 10.3233/JAD-2012-120712</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies&doi=10.3233%2FJAD-2012-120712"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang, Wei; Arteaga, Janna; Cashion, Daniel K.; Chen, Gang; Gangadharmath, Umesh; Gomez, Luis F.; Kasi, Dhanalakshmi; Lam, Chung; Liang, Qianwa; Liu, Changhui; Mocharla, Vani P.; Mu, Fanrong; Sinha, Anjana; Szardenings, A. Katrin; Wang, Eric; Walsh, Joseph C.; Xia, Chunfang; Yu, Chul; Zhao, Tieming; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-612</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathol. hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a no. of amyloid-β positron emission tomog. (PET) tracers currently in different stages of clin. development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compds. utilizing a unique screening process.  A competitive autoradiog. assay was set up to test compds. for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compd. [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclin. in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCPcTCD2ucRLVg90H21EOLACvtfcHk0liCY6L9JiQ8YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI&md5=f9b40fa67928e2cbaa876fbaef62ff70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612%26doi%3D10.3233%2FJAD-2012-120712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26541774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">18F-THK5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Tago, Tetsuro; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">208-214</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Imaging of neurofibrillary pathol. in the brain helps in diagnosing dementia, tracking disease progression, and evaluating the therapeutic efficacy of antidementia drugs.  The radiotracers used in this imaging must be highly sensitive and specific for tau protein fibrils in the human brain.  We developed a novel tau PET tracer, 18F-THK5351, through compd. optimization of arylquinoline derivs.  Methods: The in vitro binding properties, pharmacokinetics, and safety of 18F-THK5351 were investigated, and a clin. study on Alzheimer disease (AD) patients was performed.  Results:18F-THK5351 demonstrated higher binding affinity for hippocampal homogenates from AD brains and faster dissocn. from white-matter tissue than did 18F-THK5117.  The THK5351 binding amt. correlated with the amt. of tau deposits in human brain samples.  Autoradiog. of brain sections revealed that THK5351 bound to neurofibrillary tangles selectively and with a higher signal-to-background ratio than did THK5117.  THK5351 exhibited favorable pharmacokinetics and no defluorination in mice.  In first-in-human PET studies in AD patients, 18F-THK5351 demonstrated faster kinetics, higher contrast, and lower retention in subcortical white matter than 18F-THK5117.  Conclusion:18F-THK5351 is a useful PET tracer for the early detection of neurofibrillary pathol. in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_bH5nh_KBLVg90H21EOLACvtfcHk0liCY6L9JiQ8YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltVKguw%253D%253D&md5=f488c442abb7ca31d5b66fbe60afd14e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1108</span><span class="refDoi"> DOI: 10.1016/j.neuron.2013.07.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.neuron.2013.07.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24050400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1094-1108&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.-R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.+Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.-K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+a+tauopathy+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls&doi=10.1016%2Fj.neuron.2013.07.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls</span></div><div class="casAuthors">Maruyama, Masahiro; Shimada, Hitoshi; Suhara, Tetsuya; Shinotoh, Hitoshi; Ji, Bin; Maeda, Jun; Zhang, Ming-Rong; Trojanowski, John Q.; Lee, Virginia M.-Y.; Ono, Maiko; Masamoto, Kazuto; Takano, Harumasa; Sahara, Naruhiko; Iwata, Nobuhisa; Okamura, Nobuyuki; Furumoto, Shozo; Kudo, Yukitsuka; Chang, Qing; Saido, Takaomi C.; Takashima, Akihiko; Lewis, Jada; Jang, Ming-Kuei; Aoki, Ichio; Ito, Hiroshi; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1094-1108</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Accumulation of intracellular tau fibrils has been the focus of research on the mechanisms of neurodegeneration in Alzheimer's disease (AD) and related tauopathies.  Here, we have developed a class of tau ligands, phenyl/pyridinyl-butadienyl-benzothiazoles/benzothiazoliums (PBBs), for visualizing diverse tau inclusions in brains of living patients with AD or non-AD tauopathies and animal models of these disorders.  In vivo optical and positron emission tomog. (PET) imaging of a transgenic mouse model demonstrated sensitive detection of tau inclusions by PBBs.  A pyridinated PBB, [11C]PBB3, was next applied in a clin. PET study, and its robust signal in the AD hippocampus wherein tau pathol. is enriched contrasted strikingly with that of a senile plaque radioligand, [11C]Pittsburgh Compd.-B ([11C]PIB). [11C]PBB3-PET data were also consistent with the spreading of tau pathol. with AD progression.  Furthermore, increased [11C]PBB3 signals were found in a corticobasal syndrome patient neg. for [11C]PIB-PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD931Df6cdi7Vg90H21EOLACvtfcHk0liCY6L9JiQ8YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOks7nL&md5=7f1092519ce6b0f9c33a67e5364ba7b6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2013.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2013.07.037%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.%2BY.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520a%2520tauopathy%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1094%26epage%3D1108%26doi%3D10.1016%2Fj.neuron.2013.07.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wood, H.</span><span> </span><span class="NLM_article-title">Alzheimer disease: [<sup>11</sup>C]PBB3 - a new PET ligand that identifies tau pathology in the brains of patients with AD</span> <span class="citation_source-journal">Nat. Rev. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="refDoi"> DOI: 10.1038/nrneurol.2013.216</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrneurol.2013.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24145369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FosV2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=599&author=H.+Wood&title=Alzheimer+disease%3A+%5B11C%5DPBB3+-+a+new+PET+ligand+that+identifies+tau+pathology+in+the+brains+of+patients+with+AD&doi=10.1038%2Fnrneurol.2013.216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: [11C]PBB3--a new PET ligand that identifies tau pathology in the brains of patients with AD</span></div><div class="casAuthors">Wood Heather</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">599</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2eJd9xPq30d1QT_1O5WBYfW6udTcc2ebRHxxUupNPgbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FosV2nsw%253D%253D&md5=ef3553346355cd9ef7c28d46fb0d8d01</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2013.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2013.216%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DH.%26atitle%3DAlzheimer%2520disease%253A%2520%255B11C%255DPBB3%2520-%2520a%2520new%2520PET%2520ligand%2520that%2520identifies%2520tau%2520pathology%2520in%2520the%2520brains%2520of%2520patients%2520with%2520AD%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2013%26volume%3D9%26spage%3D599%26doi%3D10.1038%2Fnrneurol.2013.216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obrien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-(fluoro-<sup>18</sup>F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([<sup>18</sup>F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4778</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4778-4789&author=A.+M.+Waljiauthor=E.+D.+Hostetlerauthor=H.+Selnickauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=M.+Holahanauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=J.+Liauthor=J.+Balsellsauthor=J.+A.+Obrienauthor=S.+Melquistauthor=A.+Sorianoauthor=X.+Zhangauthor=A.+Ogawaauthor=S.+Xuauthor=E.+M.+Joshiauthor=J.+Della+Roccaauthor=F.+J.+Hessauthor=J.+Schachterauthor=D.+Heskauthor=D.+Schenkauthor=A.+Struykauthor=K.+Babaogluauthor=T.+G.+Lohithauthor=Y.+Wangauthor=K.+Yangauthor=J.+Fuauthor=J.+L.+Evelhochauthor=P.+J.+Coleman&title=Discovery+of+6-%28fluoro-18F%29-3-%281H-pyrrolo%5B2%2C3-c%5Dpyridin-1-yl%29isoquinolin-5-amine+%28%5B18F%5D-MK-6240%29%3A+a+positron+emission+tomography+%28PET%29+imaging+agent+for+quantification+of+neurofibrillary+tangles+%28NFTs%29&doi=10.1021%2Facs.jmedchem.6b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)</span></div><div class="casAuthors">Walji, Abbas M.; Hostetler, Eric D.; Selnick, Harold; Zeng, Zhizhen; Miller, Patricia; Bennacef, Idriss; Salinas, Cristian; Connolly, Brett; Gantert, Liza; Holahan, Marie; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Li, Jing; Balsells, Jaume; OBrien, Julie A.; Melquist, Stacey; Soriano, Aileen; Zhang, Xiaoping; Ogawa, Aimie; Xu, Serena; Joshi, Elizabeth; Della Rocca, Joseph; Hess, Fred J.; Schachter, Joel; Hesk, David; Schenk, David; Struyk, Arie; Babaoglu, Kerim; Lohith, Talakad G.; Wang, Yaode; Yang, Kun; Fu, Jianmin; Evelhoch, Jeffrey L.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4778-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathol. hallmark of several neurodegenerative diseases including Alzheimer's disease.  In vivo detection of NFTs using PET imaging represents a unique opportunity to develop a pharmacodynamic tool to accelerate the discovery of new disease modifying therapeutics targeting tau pathol.  Herein, we present the discovery of 6-(fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine, 6 ([18F]-MK-6240), as a novel PET tracer for detecting NFTs. 6 exhibits high specificity and selectivity for binding to NFTs, with suitable physicochem. properties and in vivo pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTkJBwXYLQ4LVg90H21EOLACvtfcHk0lhkOiRkQNG-yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D&md5=7155752a95bc279765280108b794a758</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00166%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DObrien%26aufirst%3DJ.%2BA.%26aulast%3DMelquist%26aufirst%3DS.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DE.%2BM.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DStruyk%26aufirst%3DA.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25206-%2528fluoro-18F%2529-3-%25281H-pyrrolo%255B2%252C3-c%255Dpyridin-1-yl%2529isoquinolin-5-amine%2520%2528%255B18F%255D-MK-6240%2529%253A%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520agent%2520for%2520quantification%2520of%2520neurofibrillary%2520tangles%2520%2528NFTs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4778%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.6b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span> </span><span class="NLM_article-title">Preclinical characterization of [<sup>18</sup>F]-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1599</span><span class="NLM_x">–</span> <span class="NLM_lpage">1606</span><span class="refDoi"> DOI: 10.2967/jnumed.115.171678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.115.171678" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1599-1606&author=E.+D.+Hostetlerauthor=A.+M.+Waljiauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=H.+Haleyauthor=M.+Holahanauthor=M.+Purcellauthor=K.+Riffelauthor=T.+G.+Lohithauthor=P.+Colemanauthor=A.+Sorianoauthor=A.+Ogawaauthor=S.+Xuauthor=X.+Zhangauthor=E.+Joshiauthor=J.+Della+Roccaauthor=D.+Heskauthor=D.+J.+Schenkauthor=J.+L.+Evelhoch&title=Preclinical+characterization+of+%5B18F%5D-MK-6240%2C+a+promising+PET+tracer+for+in+vivo+quantification+of+human+neurofibrillary+tangles&doi=10.2967%2Fjnumed.115.171678"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.171678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.171678%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHaley%26aufirst%3DH.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DColeman%26aufirst%3DP.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DJoshi%26aufirst%3DE.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%2BJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DPreclinical%2520characterization%2520of%2520%255B18F%255D-MK-6240%252C%2520a%2520promising%2520PET%2520tracer%2520for%2520in%2520vivo%2520quantification%2520of%2520human%2520neurofibrillary%2520tangles%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1599%26epage%3D1606%26doi%3D10.2967%2Fjnumed.115.171678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of imidazo[1,2-<i>a</i>]pyridin-7-amines as imaging tools</span>. WO2015044095 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+imidazo%5B1%2C2-a%5Dpyridin-7-amines+as+imaging+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520imidazo%255B1%252C2-a%255Dpyridin-7-amines%2520as%2520imaging%2520tools%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of 2-phenylimidazo[1,2-<i>a</i>]pyrimidines as imaging agents for diagnosis of Alzheimer’s disease</span>. WO2014187762 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+2-phenylimidazo%5B1%2C2-a%5Dpyrimidines+as+imaging+agents+for+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%25202-phenylimidazo%255B1%252C2-a%255Dpyrimidines%2520as%2520imaging%2520agents%2520for%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koerner, M.; Muri, D.</span><span> </span><span class="NLM_article-title">Preparation of diazacarbazole derivatives as tau PET ligands</span>. WO2015052105 A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Gobbi&author=H.+Knust&author=M.+Koerner&author=D.+Muri&title=Preparation+of+diazacarbazole+derivatives+as+tau+PET+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DPreparation%2520of%2520diazacarbazole%2520derivatives%2520as%2520tau%2520PET%2520ligands%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span><span class="refDoi"> DOI: 10.1371/journal.pbio.1001080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid&doi=10.1371%2Fjournal.pbio.1001080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0liT2yELFCRJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080%26doi%3D10.1371%2Fjournal.pbio.1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Childers, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynn, D. G.</span><span> </span><span class="NLM_article-title">Templating molecular arrays in Amyloid’s cross-β grooves</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">10165</span><span class="NLM_x">–</span> <span class="NLM_lpage">10172</span><span class="refDoi"> DOI: 10.1021/ja902332s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja902332s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvFWktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=10165-10172&author=W.+S.+Childersauthor=A.+K.+Mehtaauthor=K.+Luauthor=D.+G.+Lynn&title=Templating+molecular+arrays+in+Amyloid%E2%80%99s+cross-%CE%B2+grooves&doi=10.1021%2Fja902332s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Templating Molecular Arrays in Amyloid's Cross-β Grooves</span></div><div class="casAuthors">Childers, W. Seth; Mehta, Anil K.; Lu, Kun; Lynn, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">10165-10172</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloid fibers, independent of primary amino acid sequence, share a common cross-β structure and bind the histochem. dye Congo Red (CR).  Despite extensive use of CR in amyloid diagnostics, remarkably little is known about the specific and characteristic binding interactions.  Fibril insoly., morphol. inhomogeneity, and multiple possible ligand binding sites all conspire to limit characterization.  Here, the authors have exploited the structure of cross-β nanotubes, which limit the no. of potential binding sites, to directly interrogate cross-β laminate grooves.  CR bound to cross-β nanotubes displays the hallmark apple-green interference color, a broad red-shifted low energy transition, and a Kd of 1.9±0.5 μM.  Oriented electron diffraction and linear dichroism defines the orientation of CR as parallel to the amyloid long axis and colinear with laminate grooves.  The broad red-shifted UV signature of CR bound to amyloid can be explained by semiempirical quantum calcns. that support the existence of a precise network of J- and H-CR aggregates, illuminating the ability of the amyloid to organize mols. into extended arrays that underlie the remarkable diagnostic potential of CR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPa_oIWRaGCrVg90H21EOLACvtfcHk0liT2yELFCRJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvFWktLs%253D&md5=246cba3b95997fa83e8b605a1e088bdf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja902332s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902332s%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BS.%26aulast%3DMehta%26aufirst%3DA.%2BK.%26aulast%3DLu%26aufirst%3DK.%26aulast%3DLynn%26aufirst%3DD.%2BG.%26atitle%3DTemplating%2520molecular%2520arrays%2520in%2520Amyloid%25E2%2580%2599s%2520cross-%25CE%25B2%2520grooves%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D10165%26epage%3D10172%26doi%3D10.1021%2Fja902332s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Schuetz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soragni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornemann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguzzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, B. H.</span><span> </span><span class="NLM_article-title">The amyloid-congo red interface at atomic resolution</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5956</span><span class="NLM_x">–</span> <span class="NLM_lpage">5960</span><span class="refDoi"> DOI: 10.1002/anie.201008276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fanie.201008276" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=5956-5960&author=A.+K.+Schuetzauthor=A.+Soragniauthor=S.+Hornemannauthor=A.+Aguzziauthor=M.+Ernstauthor=A.+Boeckmannauthor=B.+H.+Meier&title=The+amyloid-congo+red+interface+at+atomic+resolution&doi=10.1002%2Fanie.201008276"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201008276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201008276%26sid%3Dliteratum%253Aachs%26aulast%3DSchuetz%26aufirst%3DA.%2BK.%26aulast%3DSoragni%26aufirst%3DA.%26aulast%3DHornemann%26aufirst%3DS.%26aulast%3DAguzzi%26aufirst%3DA.%26aulast%3DErnst%26aufirst%3DM.%26aulast%3DBoeckmann%26aufirst%3DA.%26aulast%3DMeier%26aufirst%3DB.%2BH.%26atitle%3DThe%2520amyloid-congo%2520red%2520interface%2520at%2520atomic%2520resolution%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D5956%26epage%3D5960%26doi%3D10.1002%2Fanie.201008276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span><span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgv3JQptQZnww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martarello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span> </span><span class="NLM_article-title">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.drudis.2014.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25173703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1936-1944&author=M.+Honerauthor=L.+Gobbiauthor=L.+Martarelloauthor=R.+A.+Comley&title=Radioligand+development+for+molecular+imaging+of+the+central+nervous+system+with+positron+emission+tomography&doi=10.1016%2Fj.drudis.2014.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span></div><div class="casAuthors">Honer, Michael; Gobbi, Luca; Martarello, Laurent; Comley, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1936-1944</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) is routinely used to support the development of drugs to treat neurol. and psychiatric disorders.  PET radioligands must not only be selective for the target of interest but must also possess a range of physicochem. and pharmacol. characteristics that allow them to be radiolabeled with short-lived positron-emitting isotopes, safely administered to humans, and for the degree of target binding to be quantified in vivo.  We review the ligand development process, including target selection, radioligand discovery (in vitro and preclin. evaluation), radiochem. and evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOrjEdZ64wLVg90H21EOLACvtfcHk0lgv3JQptQZnww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE&md5=9ae3bb3030cdc3a701be1df568190371</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DMartarello%26aufirst%3DL.%26aulast%3DComley%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520development%2520for%2520molecular%2520imaging%2520of%2520the%2520central%2520nervous%2520system%2520with%2520positron%2520emission%2520tomography%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1936%26epage%3D1944%26doi%3D10.1016%2Fj.drudis.2014.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">Considerations in the development of reversibly binding PET radioligands for brain imaging</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1869</span><span class="refDoi"> DOI: 10.2174/0929867323666160418114826</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2174%2F0929867323666160418114826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=27087244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFGqsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1818-1869&author=V.+W.+Pike&title=Considerations+in+the+development+of+reversibly+binding+PET+radioligands+for+brain+imaging&doi=10.2174%2F0929867323666160418114826"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1818-1869</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The development of reversibly binding radioligands for imaging brain proteins in vivo, such as enzymes, neurotransmitter transporters, receptors and ion channels, with positron emission tomog. (PET) is keenly sought for biomedical studies of neuropsychiatric disorders and for drug discovery and development, but is recognized as being highly challenging at the medicinal chem. level.  This article aims to compile and discuss the main considerations to be taken into account by chemists embarking on programs of radioligand development for PET imaging of brain protein targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmdw3kTJmoxLVg90H21EOLACvtfcHk0lhzpWhcMVfWEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFGqsrnI&md5=410265974a2a4569dea72376dcf6a8a1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F0929867323666160418114826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867323666160418114826%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DConsiderations%2520in%2520the%2520development%2520of%2520reversibly%2520binding%2520PET%2520radioligands%2520for%2520brain%2520imaging%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2016%26volume%3D23%26spage%3D1818%26epage%3D1869%26doi%3D10.2174%2F0929867323666160418114826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhang, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Synthesis of pyrimido[4,5-<i>b</i>]indoles and benzo[4,5]furo[2,3-<i>d</i>]pyrimidines via palladium-catalyzed intramolecular arylation</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">8235</span><span class="NLM_x">–</span> <span class="NLM_lpage">8239</span><span class="refDoi"> DOI: 10.1016/S0040-4039(02)02036-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0040-4039%2802%2902036-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD38XotVylurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=8235-8239&author=Y.-M.+Zhangauthor=T.+Razlerauthor=P.+F.+Jackson&title=Synthesis+of+pyrimido%5B4%2C5-b%5Dindoles+and+benzo%5B4%2C5%5Dfuro%5B2%2C3-d%5Dpyrimidines+via+palladium-catalyzed+intramolecular+arylation&doi=10.1016%2FS0040-4039%2802%2902036-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines via palladium-catalyzed intramolecular arylation</span></div><div class="casAuthors">Zhang, Yue-Mei; Razler, Thomas; Jackson, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">8235-8239</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Various pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines were synthesized via a palladium-catalyzed intramol. arylation of pyrimidine substrates.  Thus, 4-aryloxy- or 4-anilino-5-iodopyrimidines, e.g. I, were treated with Pd(OAc)2(PPh3)2 and base in DMF to give the regioselective cyclized heterocycles, e.g. II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwaJ2_1zmIu7Vg90H21EOLACvtfcHk0lhzpWhcMVfWEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotVylurg%253D&md5=21958a59ec9365c318f188899fc3a049</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2802%2902036-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252802%252902036-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-M.%26aulast%3DRazler%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DSynthesis%2520of%2520pyrimido%255B4%252C5-b%255Dindoles%2520and%2520benzo%255B4%252C5%255Dfuro%255B2%252C3-d%255Dpyrimidines%2520via%2520palladium-catalyzed%2520intramolecular%2520arylation%26jtitle%3DTetrahedron%2520Lett.%26date%3D2002%26volume%3D43%26spage%3D8235%26epage%3D8239%26doi%3D10.1016%2FS0040-4039%2802%2902036-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+high+throughput+screening%3A+parallel+artificial+membrane+permeation+assay+in+the+description+of+passive+absorption+processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0ljYFT4DjyykBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520high%2520throughput%2520screening%253A%2520parallel%2520artificial%2520membrane%2520permeation%2520assay%2520in%2520the%2520description%2520of%2520passive%2520absorption%2520processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Assmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seelig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaentzlin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span> </span><span class="NLM_article-title">Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1016/j.ejps.2015.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.ejps.2015.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=26341407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGgs77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2015&pages=27-35&author=F.+Assmusauthor=A.+Seeligauthor=L.+Gobbiauthor=E.+Borroniauthor=P.+Glaentzlinauthor=H.+Fischer&title=Label-free+assay+for+the+assessment+of+nonspecific+binding+of+positron+emission+tomography+tracer+candidates&doi=10.1016%2Fj.ejps.2015.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates</span></div><div class="casAuthors">Assmus, Frauke; Seelig, Anna; Gobbi, Luca; Borroni, Edilio; Glaentzlin, Patricia; Fischer, Holger</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) is a valuable non-invasive technique for the visualization of drug tissue distribution and receptor occupancy at the target site in living animals and men.  Many potential PET tracers, however, fail due to an unfavorably high non-specific binding (NSB) to non-target proteins and phospholipid membranes which compromises the sensitivity of PET.  Hence, there is a high demand to assess the extent of NSB as early as possible in the PET tracer development process, preferentially before ligands are radiolabeled and elaborate imaging studies are performed.  The purpose of this study was to establish a novel Lipid Membrane Binding Assay (LIMBA) for assessing the tendency of potential tracers to bind non-specifically to brain tissue.  The assay works with unlabeled compds. and allows the medium-throughput measurement of brain tissue/water distribution coeffs., logDbrain (pH 7.4), at minimal expense of animal tissue.  To validate LIMBA, logDbrain (pH 7.4) values were measured and compared with NSB ests. derived from in vivo PET studies in human brain (n = 10 tracers, literature data), and in vitro autoradiog. studies in rat and mouse brain slices (n = 30 tritiated radioligands).  Good agreement between logDbrain (pH 7.4) and the vol. of distribution in brain of non-specifically bound tracer in PET was achieved, pertaining to compds. classified as non-substrates of P-glycoprotein (R2 ≥ 0.88).  The ability of LIMBA for the prediction of NSB was further supported by the strong correlation between logDbrain (pH 7.4) and NSB in brain autoradiog. (R2 ≥ 0.76), whereas octanol/water distribution coeffs., logDoct (pH 7.4) were less predictive.  In conclusion, LIMBA provides a fast and reliable tool for identifying compds. with unfavorably high NSB in brain tissue.  The data may be used in conjunction with other parameters like target affinity, d. and membrane permeability for the selection of most promising compds. to be further investigated in vivo as potential novel PET tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQSBHKYXu7F7Vg90H21EOLACvtfcHk0ljYFT4DjyykBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGgs77O&md5=1b6fee87a0f08c9640b09cf3813c8362</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2015.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2015.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DAssmus%26aufirst%3DF.%26aulast%3DSeelig%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DGlaentzlin%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26atitle%3DLabel-free%2520assay%2520for%2520the%2520assessment%2520of%2520nonspecific%2520binding%2520of%2520positron%2520emission%2520tomography%2520tracer%2520candidates%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D79%26spage%3D27%26epage%3D35%26doi%3D10.1016%2Fj.ejps.2015.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Belli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assmus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Sánchez, R.</span><span> </span><span class="NLM_article-title">Estimation of drug binding to brain tissue: methodology and in vivo application of a distribution assay in brain polar lipids</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4529</span><span class="NLM_x">–</span> <span class="NLM_lpage">4541</span><span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00717</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00717" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSlsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4529-4541&author=S.+Belliauthor=F.+Assmusauthor=B.+Wagnerauthor=M.+Honerauthor=H.+Fischerauthor=F.+Schulerauthor=R.+Alvarez-S%C3%A1nchez&title=Estimation+of+drug+binding+to+brain+tissue%3A+methodology+and+in+vivo+application+of+a+distribution+assay+in+brain+polar+lipids&doi=10.1021%2Facs.molpharmaceut.5b00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Estimation of Drug Binding to Brain Tissue: Methodology and in Vivo Application of a Distribution Assay in Brain Polar Lipids</span></div><div class="casAuthors">Belli, Sara; Assmus, Frauke; Wagner, Bjoern; Honer, Michael; Fischer, Holger; Schuler, Franz; Alvarez-Sanchez, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4529-4541</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The unbound drug concn.-effect relationship in brain is a key aspect in CNS drug discovery and development.  In this work, we describe an in vitro high-throughput distribution assay between an aq. buffer and a microemulsion of porcine brain polar lipids (BPL).  The derived distribution coeff. LogDBPL was applied to the prediction of unbound drug concns. in brain (Cu,b) and nonspecific binding to brain tissue.  The in vivo relevance of the new assay was assessed for a large set of proprietary drug candidates and CNS drugs by (1) comparing obsd. compd. concns. in rat CSF with Cu,b calcd. using the LogDBPL assay in combination with total drug brain concns., (2) comparing Cu,b derived from LogDBPL and total drug brain concns. to Cu,b estd. using in vitro P-glycoprotein efflux ratio data and unbound drug plasma levels, and (3) comparing tissue nonspecific binding data from human brain autoradiog. studies for 17 PET tracer candidates to distribution in BPL.  In summary, the LogDBPL assay provides a predicted drug fraction unbound in brain tissue that is nearly identical to brain homogenate equil. dialysis with an estn. of in vivo Cu,b that is superior to LogD in octanol.  LogDBPL complements the approach for predicting Cu,b based on in vitro P-glycoprotein efflux ratio and in vivo unbound plasma concn. and stands as a fast and cost-effective tool for nonspecific brain binding optimization of PET ligand candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHszf6IElNwbVg90H21EOLACvtfcHk0lh1QqTEzSQD_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSlsLfL&md5=085bdd5622cd74cd11ee4050e3637416</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00717%26sid%3Dliteratum%253Aachs%26aulast%3DBelli%26aufirst%3DS.%26aulast%3DAssmus%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DAlvarez-S%25C3%25A1nchez%26aufirst%3DR.%26atitle%3DEstimation%2520of%2520drug%2520binding%2520to%2520brain%2520tissue%253A%2520methodology%2520and%2520in%2520vivo%2520application%2520of%2520a%2520distribution%2520assay%2520in%2520brain%2520polar%2520lipids%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4529%26epage%3D4541%26doi%3D10.1021%2Facs.molpharmaceut.5b00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span> </span><span class="NLM_article-title">The role of ligand efficiency metrics in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span><span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keseruauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+role+of+ligand+efficiency+metrics+in+drug+discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lh1QqTEzSQD_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520role%2520of%2520ligand%2520efficiency%2520metrics%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0ljesojk18cGng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Maurer, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBartolo, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tess, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span><span class="refDoi"> DOI: 10.1124/dmd.104.001222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1124%2Fdmd.104.001222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=15502010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=175-181&author=T.+S.+Maurerauthor=D.+B.+DeBartoloauthor=D.+A.+Tessauthor=D.+O.+Scott&title=Relationship+between+exposure+and+nonspecific+binding+of+thirty-three+central+nervous+system+drugs+in+mice&doi=10.1124%2Fdmd.104.001222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</span></div><div class="casAuthors">Maurer, Tristan S.; DeBartolo, Demetria B.; Tess, David A.; Scott, Dennis O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">175-181</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Unbound fractions in mouse brain and plasma were detd. for 31 structurally diverse central nervous system (CNS) drugs and two active metabolites.  Three comparisons were made between in vitro binding and in vivo exposure data, namely: (1) mouse brain-to-plasma exposure vs. unbound plasma-to-unbound brain fraction ratio (fuplasma/fubrain), (2) cerebrospinal fluid-to-brain exposure vs. unbound brain fraction (fubrain), and (3) cerebrospinal fluid-to-plasma exposure vs. unbound plasma fraction (fuplasma).  Unbound fraction data were within 3-fold of in vivo exposure ratios for the majority of the drugs examd. (i.e., 22 of 33), indicating a predominately free equil. across the blood-brain and blood-CSF barriers.  Some degree of distributional impairment at either the blood-CSF or the blood-brain barrier was indicated for 8 of the 11 remaining drugs (i.e., carbamazepine, midazolam, phenytoin, sulpiride, thiopental, risperidone, 9-hydroxyrisperidone, and zolpidem).  In several cases, the indicated distributional impairment is consistent with other independent literature reports for these drugs.  Through the use of this approach, it appears that most CNS-active agents freely equilibrate across the blood-brain and blood-CSF barriers such that unbound drug concns. in brain approx. those in the plasma.  However, these results also support the intuitive concept that distributional impairment does not necessarily preclude CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH6imduXukj7Vg90H21EOLACvtfcHk0ljesojk18cGng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlentA%253D%253D&md5=27e70989846ff3eeb4fa4a7d8c6e73b5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.001222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.001222%26sid%3Dliteratum%253Aachs%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26aulast%3DDeBartolo%26aufirst%3DD.%2BB.%26aulast%3DTess%26aufirst%3DD.%2BA.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DRelationship%2520between%2520exposure%2520and%2520nonspecific%2520binding%2520of%2520thirty-three%2520central%2520nervous%2520system%2520drugs%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2005%26volume%3D33%26spage%3D175%26epage%3D181%26doi%3D10.1124%2Fdmd.104.001222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez-Sánchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrecht, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavé, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, S.</span><span> </span><span class="NLM_article-title">PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation</span> <span class="citation_source-journal">Biochem. Pharmacol. (Amsterdam, Neth.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1684</span><span class="NLM_x">–</span> <span class="NLM_lpage">1699</span><span class="refDoi"> DOI: 10.1016/j.bcp.2013.02.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2Fj.bcp.2013.02.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlKrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2013&pages=1684-1699&author=A.+Carusoauthor=R.+Alvarez-S%C3%A1nchezauthor=A.+Hillebrechtauthor=A.+Poirierauthor=F.+Schulerauthor=T.+Lav%C3%A9author=C.+Funkauthor=S.+Belli&title=PK%2FPD+assessment+in+CNS+drug+discovery%3A+Prediction+of+CSF+concentration+in+rodents+for+P-glycoprotein+substrates+and+application+to+in+vivo+potency+estimation&doi=10.1016%2Fj.bcp.2013.02.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimation</span></div><div class="casAuthors">Caruso, Antonello; Alvarez-Sanchez, Ruben; Hillebrecht, Alexander; Poirier, Agnes; Schuler, Franz; Lave, Thierry; Funk, Christoph; Belli, Sara</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1684-1699</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The unbound drug concn. in brain parenchyma is considered to be the relevant driver for interaction with central nervous system (CNS) biol. targets.  Drug levels in cerebrospinal fluid (C_CSF) are frequently used surrogates for the unbound concns. in brain.  For drugs actively transported across the blood-brain barrier (BBB), C_CSF differs from unbound plasma concn. (Cu_p) to an extent that is commonly unknown.  In this study, the relationship between CSF-to-unbound plasma drug partitioning in rats and the mouse Pgp (Mdr1a) efflux ratio (ER) obtained from in vitro transcellular studies has been investigated for a set of 61 CNS compds. exhibiting substantial diversity in chem. structure and physico-chem. properties.  In order to understand the in vitro-in vivo extrapolation of Pgp efflux, a mechanistic model was derived relating in vivo CNS distribution kinetics to in vitro active transport.  The model was applied to predict C_CSF from Cu_p and ER data for 19 proprietary Roche CNS drug candidates.  The calcd. CSF concns. were correlated with CNS pharmacodynamic responses obsd. in rodent models.  The correlation between in vitro and in vivo potency for different pharmacol. endpoints indicated that the predicted C_CSF is a valuable surrogate of the concn. at the target site.  Overall, C_CSF proved superior description of PK/PD data than unbound plasma or total brain concn. for Mdr1a substrates.  Predicted C_CSF can be used as a default approach to understand the PK/PD relationships in CNS efficacy models and can support the extrapolation of efficacious brain exposure for new drug candidates from rodent to man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruK6k0mONiBbVg90H21EOLACvtfcHk0ljk79RSKPsorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlKrs70%253D&md5=76fec0e52a881f894ed01836bba27db6</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.02.021%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DAlvarez-S%25C3%25A1nchez%26aufirst%3DR.%26aulast%3DHillebrecht%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DLav%25C3%25A9%26aufirst%3DT.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DBelli%26aufirst%3DS.%26atitle%3DPK%252FPD%2520assessment%2520in%2520CNS%2520drug%2520discovery%253A%2520Prediction%2520of%2520CSF%2520concentration%2520in%2520rodents%2520for%2520P-glycoprotein%2520substrates%2520and%2520application%2520to%2520in%2520vivo%2520potency%2520estimation%26jtitle%3DBiochem.%2520Pharmacol.%2520%2528Amsterdam%252C%2520Neth.%2529%26date%3D2013%26volume%3D85%26spage%3D1684%26epage%3D1699%26doi%3D10.1016%2Fj.bcp.2013.02.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfaltz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muri, D.</span><span> </span><span class="NLM_article-title">Iridium-catalyzed H/D exchange: ligand complexes with improved efficiency and scope</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">11496</span><span class="NLM_x">–</span> <span class="NLM_lpage">11504</span><span class="refDoi"> DOI: 10.1002/chem.201402078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fchem.201402078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25043104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=11496-11504&author=M.+Parmentierauthor=T.+Hartungauthor=A.+Pfaltzauthor=D.+Muri&title=Iridium-catalyzed+H%2FD+exchange%3A+ligand+complexes+with+improved+efficiency+and+scope&doi=10.1002%2Fchem.201402078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Iridium-catalyzed H/D exchange: Ligand complexes with improved efficiency and scope</span></div><div class="casAuthors">Parmentier, Michael; Hartung, Thomas; Pfaltz, Andreas; Muri, Dieter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11496-11504</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Ir complexes with N,P-ligands, highly active catalysts for asym. double bond redn., were tested for their hydrogen isotope exchange (HIE) capabilities.  Electron-rich ligands, contg. dicyclohexylphosphines or phosphinites, were identified as excellent ligands for efficient D incorporation.  Substrates with strong directing groups, i.e., pyridines, ketones, and amides, as well as weak ligating units, such as nitro, sulfone, and sulfonamide, could be labeled efficiently.  With the addn. of B(C6F5)3 to the reaction mixt., also highly deactivating nitrile substituents were well tolerated in the reaction.  Based on the excellent results obtained with the chiral ThrePhox ligand, a structurally simpler, achiral ligand was developed.  The Ir complex contg. this ligand, proved to be a powerful catalyst for HIE reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDCnTLLu2rx7Vg90H21EOLACvtfcHk0ljk79RSKPsorQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtbfN&md5=7217e035dd35d013a169f64c608ad6c6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fchem.201402078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201402078%26sid%3Dliteratum%253Aachs%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DPfaltz%26aufirst%3DA.%26aulast%3DMuri%26aufirst%3DD.%26atitle%3DIridium-catalyzed%2520H%252FD%2520exchange%253A%2520ligand%2520complexes%2520with%2520improved%2520efficiency%2520and%2520scope%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D11496%26epage%3D11504%26doi%3D10.1002%2Fchem.201402078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Collin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göpfert, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oroszlan-Szovik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span> </span><span class="NLM_article-title">Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">2834</span><span class="NLM_x">–</span> <span class="NLM_lpage">2846</span><span class="refDoi"> DOI: 10.1093/brain/awu213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1093%2Fbrain%2Fawu213" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=2834-2846&author=L.+Collinauthor=B.+Bohrmannauthor=U.+G%C3%B6pfertauthor=K.+Oroszlan-Szovikauthor=L.+Ozmenauthor=F.+Gr%C3%BCninger&title=Neuronal+uptake+of+tau%2FpS422+antibody+and+reduced+progression+of+tau+pathology+in+a+mouse+model+of+Alzheimer%E2%80%98s+disease&doi=10.1093%2Fbrain%2Fawu213"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawu213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawu213%26sid%3Dliteratum%253Aachs%26aulast%3DCollin%26aufirst%3DL.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DG%25C3%25B6pfert%26aufirst%3DU.%26aulast%3DOroszlan-Szovik%26aufirst%3DK.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26atitle%3DNeuronal%2520uptake%2520of%2520tau%252FpS422%2520antibody%2520and%2520reduced%2520progression%2520of%2520tau%2520pathology%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2598s%2520disease%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D2834%26epage%3D2846%26doi%3D10.1093%2Fbrain%2Fawu213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Rüfenacht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güntert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducret, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span> </span><span class="NLM_article-title">Quantification of the Aβ peptide in Alzheimer’s plaques by laser dissection microscopy combined with mass spectrometry</span> <span class="citation_source-journal">J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1002/jms.739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjms.739" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=193-201&author=P.+R%C3%BCfenachtauthor=A.+G%C3%BCntertauthor=B.+Bohrmannauthor=A.+Ducretauthor=H.+D%C3%B6beli&title=Quantification+of+the+A%CE%B2+peptide+in+Alzheimer%E2%80%99s+plaques+by+laser+dissection+microscopy+combined+with+mass+spectrometry&doi=10.1002%2Fjms.739"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fjms.739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjms.739%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25BCfenacht%26aufirst%3DP.%26aulast%3DG%25C3%25BCntert%26aufirst%3DA.%26aulast%3DBohrmann%26aufirst%3DB.%26aulast%3DDucret%26aufirst%3DA.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26atitle%3DQuantification%2520of%2520the%2520A%25CE%25B2%2520peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520plaques%2520by%2520laser%2520dissection%2520microscopy%2520combined%2520with%2520mass%2520spectrometry%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2005%26volume%3D40%26spage%3D193%26epage%3D201%26doi%3D10.1002%2Fjms.739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ambler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priestle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wathey, B.</span><span> </span><span class="NLM_article-title">Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: ion-dipole interactions with lysine 60G</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1322</span><span class="refDoi"> DOI: 10.1016/S0960-894X(99)00172-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0960-894X%2899%2900172-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1317-1322&author=J.+Amblerauthor=L.+Brownauthor=X.-L.+Cockcroftauthor=M.+Gr%C3%BCtterauthor=J.+Haylerauthor=D.+Janusauthor=D.+Jonesauthor=P.+Kaneauthor=K.+Menearauthor=J.+Priestleauthor=G.+Smithauthor=M.+Talbotauthor=C.+V.+Walkerauthor=B.+Wathey&title=Optimisation+of+the+P2+pharmacophore+in+a+series+of+thrombin+inhibitors%3A+ion-dipole+interactions+with+lysine+60G&doi=10.1016%2FS0960-894X%2899%2900172-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900172-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900172-9%26sid%3Dliteratum%253Aachs%26aulast%3DAmbler%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCockcroft%26aufirst%3DX.-L.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%26aulast%3DHayler%26aufirst%3DJ.%26aulast%3DJanus%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DKane%26aufirst%3DP.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DPriestle%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DTalbot%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DC.%2BV.%26aulast%3DWathey%26aufirst%3DB.%26atitle%3DOptimisation%2520of%2520the%2520P2%2520pharmacophore%2520in%2520a%2520series%2520of%2520thrombin%2520inhibitors%253A%2520ion-dipole%2520interactions%2520with%2520lysine%252060G%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1317%26epage%3D1322%26doi%3D10.1016%2FS0960-894X%2899%2900172-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">A microwave radiosynthesis of the 4-[<sup>18</sup>F]-fluorobenzyltriphenylphosphonium ion</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span><span class="refDoi"> DOI: 10.1002/jlcr.3241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjlcr.3241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25329827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVyksL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=695-698&author=H.+T.+Ravertauthor=D.+P.+Holtauthor=R.+F.+Dannals&title=A+microwave+radiosynthesis+of+the+4-%5B18F%5D-fluorobenzyltriphenylphosphonium+ion&doi=10.1002%2Fjlcr.3241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A microwave radiosynthesis of the 4-[18F]-fluorobenzyltriphenylphosphonium ion</span></div><div class="casAuthors">Ravert, Hayden T.; Holt, Daniel P.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">695-698</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The 4-[18F]-fluorobenzyltriphenylphosphonium cation was synthesized by a series of microwave reactions from no carrier added [18F]-fluoride.  The microwave procedure reduced the quantity of reagents used and synthesis time when compared with the original synthesis.  In addn., problematic solid phase extn., sodium borohydride redn. by column and inconsistent yields with excessive ppt. formation during the bromination step were eliminated.  The 4-[18F]-fluorobenzyltriphenylphosphonium cation was produced radiochem. pure in 8.3% yield with a specific radioactivity of 534.5 ± 371.4 GBq/μmole at end of synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhzK5ukWRUerVg90H21EOLACvtfcHk0ljhTMXd82lXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVyksL3L&md5=5a91df498aff829a16c645635c91b694</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3241%26sid%3Dliteratum%253Aachs%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DA%2520microwave%2520radiosynthesis%2520of%2520the%25204-%255B18F%255D-fluorobenzyltriphenylphosphonium%2520ion%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D695%26epage%3D698%26doi%3D10.1002%2Fjlcr.3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span> </span><span class="NLM_article-title">Synthesis and quality control of [<sup>18</sup>F]T807 for tau PET imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span><span class="refDoi"> DOI: 10.1002/jlcr.3425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1002%2Fjlcr.3425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=27427174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFynsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=411-415&author=D.+P.+Holtauthor=H.+T.+Ravertauthor=R.+F.+Dannals&title=Synthesis+and+quality+control+of+%5B18F%5DT807+for+tau+PET+imaging&doi=10.1002%2Fjlcr.3425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and quality control of [18F]T807 for tau PET imaging</span></div><div class="casAuthors">Holt, Daniel P.; Ravert, Hayden T.; Dannals, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The detailed synthesis and quality control of [18F]T807, radiotracer for tau protein aggregate imaging, are described.  The radiotracer synthesis was accomplished in an av. of 48 min with an av. specific activity at end-of-synthesis of over 4.4 TBq/μmole (120 Ci/μmole) and an av. radiochem. yield of 32%.  Compliance with all std. US Pharmacopeia (chapter 823) acceptance tests was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQIDxNpZoHcrVg90H21EOLACvtfcHk0lhvWNKoejPHDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFynsbvK&md5=d328495eeb9fd3421373523558a1f331</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3425%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26atitle%3DSynthesis%2520and%2520quality%2520control%2520of%2520%255B18F%255DT807%2520for%2520tau%2520PET%2520imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2016%26volume%3D59%26spage%3D411%26epage%3D415%26doi%3D10.1002%2Fjlcr.3425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lazari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farhoud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maraglia, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dam, R. M.</span><span> </span><span class="NLM_article-title">Fully automated production of diverse <sup>18</sup>F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification</span> <span class="citation_source-journal">J. Nucl. Med. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span><span class="refDoi"> DOI: 10.2967/jnmt.114.140392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnmt.114.140392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=25033883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BC2cbjt1GmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=203-210&author=M.+Lazariauthor=J.+Collinsauthor=B.+Shenauthor=M.+Farhoudauthor=D.+Yehauthor=B.+Maragliaauthor=F.+T.+Chinauthor=D.+A.+Nathansonauthor=M.+Mooreauthor=R.+M.+van+Dam&title=Fully+automated+production+of+diverse+18F-labeled+PET+tracers+on+the+ELIXYS+multireactor+radiosynthesizer+without+hardware+modification&doi=10.2967%2Fjnmt.114.140392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Fully automated production of diverse 18F-labeled PET tracers on the ELIXYS multireactor radiosynthesizer without hardware modification</span></div><div class="casAuthors">Lazari Mark; van Dam R Michael; Collins Jeffrey; Shen Bin; Chin Frederick T; Farhoud Mohammed; Yeh Daniel; Nathanson David A; Maraglia Brandon; Moore Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine technology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Fully automated radiosynthesizers are continuing to be developed to meet the growing need for the reliable production of PET tracers made under current good manufacturing practice guidelines.  There is a current trend toward supporting kitlike disposable cassettes that come preconfigured for particular tracers, thus eliminating the need for cleaning protocols between syntheses and enabling quick transitions to synthesizing other tracers.  Though ideal for production, these systems are often limited for the development of novel tracers because of pressure, temperature, and chemical compatibility considerations.  This study demonstrated the versatile use of the ELIXYS fully automated radiosynthesizer to adapt and produce 8 different (18)F-labeled PET tracers of varying complexity.  METHODS:  Three-reactor syntheses of 2-deoxy-2-(18)F-fluoro-β-d-arabinofuranosylcytosine (d-(18)F-FAC), 2-deoxy-2-(18)F-fluoro-5-methyl-β-l-arabinofuranosyluracil (l-(18)F-FMAU), and 2-deoxy-2-(18)F-fluoro-5-ethyl-β-d-arabinofuranosyluracil (d-(18)F-FEAU) along with the 1-reactor syntheses of d-(18)F-FEAU, (18)F-FDG, 3-deoxy-3-(18)F-fluoro-l-thymidine ((18)F-FLT), (18)F-fallypride, 9-(4-(18)F-fluoro-3-hydroxymethylbutyl)-guanine ((18)F-FHBG), and N-succinimidyl-4-(18)F-fluorobenzoate ((18)F-SFB), were all produced using ELIXYS without the need for any hardware modifications or reconfiguration.  Synthesis protocols were adapted and slightly modified from those in the literature but were not fully optimized.  Furthermore, (18)F-FLT, (18)F-FDG, and (18)F-fallypride were produced sequentially on the same day and used for preclinical imaging of A431 tumor-bearing severe combined immunodeficient mice and wild-type BALB/c mice.  To assess future translation to the clinical setting, several batches of tracers were subjected to a full set of quality control tests.  RESULTS:  All tracers were produced with radiochemical yields comparable to those in the literature. (18)F-FLT, (18)F-FDG, and (18)F-fallypride were successfully used to image the mice, with results consistent with those reported in the literature.  All tracers that were subjected to clinical quality control tests passed.  CONCLUSION:  The ELIXYS radiosynthesizer facilitates rapid tracer development and is capable of producing multiple (18)F-labeled PET tracers suitable for clinical applications using the same hardware setup.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSynwpW7YKkXftos8R3JUhXfW6udTcc2eb0j-Y3_PguT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbjt1GmsQ%253D%253D&md5=a12a8567a5d0c3305de139266f929e64</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.2967%2Fjnmt.114.140392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnmt.114.140392%26sid%3Dliteratum%253Aachs%26aulast%3DLazari%26aufirst%3DM.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DShen%26aufirst%3DB.%26aulast%3DFarhoud%26aufirst%3DM.%26aulast%3DYeh%26aufirst%3DD.%26aulast%3DMaraglia%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DF.%2BT.%26aulast%3DNathanson%26aufirst%3DD.%2BA.%26aulast%3DMoore%26aufirst%3DM.%26aulast%3Dvan%2BDam%26aufirst%3DR.%2BM.%26atitle%3DFully%2520automated%2520production%2520of%2520diverse%252018F-labeled%2520PET%2520tracers%2520on%2520the%2520ELIXYS%2520multireactor%2520radiosynthesizer%2520without%2520hardware%2520modification%26jtitle%3DJ.%2520Nucl.%2520Med.%2520Technol.%26date%3D2014%26volume%3D42%26spage%3D203%26epage%3D210%26doi%3D10.2967%2Fjnmt.114.140392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgA0uiyuog6kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camborde, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newport, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruth, T. J.</span><span> </span><span class="NLM_article-title">The influence of measurement uncertainties on the evaluation of the distribution volume ratio and binding potential in rat studies on a microPET R4: a phantom study</span> <span class="citation_source-journal">Phys. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2859</span><span class="NLM_x">–</span> <span class="NLM_lpage">2869</span><span class="refDoi"> DOI: 10.1088/0031-9155/50/12/009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1088%2F0031-9155%2F50%2F12%2F009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=15930607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A280%3ADC%252BD2M3os1Wmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2005&pages=2859-2869&author=V.+Sossiauthor=M.-L.+Cambordeauthor=G.+Tropiniauthor=D.+Newportauthor=A.+Rahmimauthor=D.+J.+Doudetauthor=T.+J.+Ruth&title=The+influence+of+measurement+uncertainties+on+the+evaluation+of+the+distribution+volume+ratio+and+binding+potential+in+rat+studies+on+a+microPET+R4%3A+a+phantom+study&doi=10.1088%2F0031-9155%2F50%2F12%2F009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of measurement uncertainties on the evaluation of the distribution volume ratio and binding potential in rat studies on a microPET R4: a phantom study</span></div><div class="casAuthors">Sossi Vesna; Camborde Marie-Laure; Tropini Giorgia; Newport Danny; Rahmim Arman; Doudet Doris J; Ruth Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Physics in medicine and biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2859-69</span>
        ISSN:<span class="NLM_cas:issn">0031-9155</span>.
    </div><div class="casAbstract">In small animal positron emission tomography (PET) imaging, the injectable radiotracer dose is often limited by the tracer mass which, together with the tracer kinetics and scanner sensitivity, dictates the statistical quality of the time activity curves (TACs) used to extract biological parameters.  We investigated the effect of measurement uncertainty on the determination of the distribution volume ratio (DVR) and binding potential (BP) as estimated using the tissue input Logan (DVR(L), BP(L)) and the ratio (DVRr, BPr) methods for two tracers, with the Concorde microPET R4 camera.  Parameters' coefficients of variation (COV) were estimated from a combination of rat and phantom data.  For 11C-dihydrotetrabenazine, the COV was 11% for the BP(L) and 13.4% for the BPr when using TACs obtained from individual regions of interest (ROIs) and segmented attenuation correction.  The COVs were reduced to 7.5% (BP(L)) and 8.6% (BPr) when the striatal and cerebellar TACs were estimated as averages of 3 and 2 ROIs respectively.  Results obtained for 11C-methylphenidate (MP) yielded approximately 30% higher COVs.  With measured attenuation correction, the COVs were on average 100% higher.  The presented method can be used to examine the contribution of a variety of imaging conditions to the uncertainty of biologically meaningful parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1I2Gy_ZBe_LjnyZkbE8yXfW6udTcc2eYw_6lmCMwhl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3os1Wmug%253D%253D&md5=7d1302ffb08f61bba8e363e980f64e06</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1088%2F0031-9155%2F50%2F12%2F009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1088%252F0031-9155%252F50%252F12%252F009%26sid%3Dliteratum%253Aachs%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DCamborde%26aufirst%3DM.-L.%26aulast%3DTropini%26aufirst%3DG.%26aulast%3DNewport%26aufirst%3DD.%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DDoudet%26aufirst%3DD.%2BJ.%26aulast%3DRuth%26aufirst%3DT.%2BJ.%26atitle%3DThe%2520influence%2520of%2520measurement%2520uncertainties%2520on%2520the%2520evaluation%2520of%2520the%2520distribution%2520volume%2520ratio%2520and%2520binding%2520potential%2520in%2520rat%2520studies%2520on%2520a%2520microPET%2520R4%253A%2520a%2520phantom%2520study%26jtitle%3DPhys.%2520Med.%2520Biol.%26date%3D2005%26volume%3D50%26spage%3D2859%26epage%3D2869%26doi%3D10.1088%2F0031-9155%2F50%2F12%2F009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Column-switching HPLC for the analysis of plasma in PET imaging studies</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1016/S0969-8051(00)00125-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0969-8051%2800%2900125-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11056380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVWlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2000&pages=627-630&author=J.+Hiltonauthor=F.+Yokoiauthor=R.+F.+Dannalsauthor=H.+T.+Ravertauthor=Z.+Szaboauthor=D.+F.+Wong&title=Column-switching+HPLC+for+the+analysis+of+plasma+in+PET+imaging+studies&doi=10.1016%2FS0969-8051%2800%2900125-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Column-switching HPLC for the analysis of plasma in PET imaging studies</span></div><div class="casAuthors">Hilton, John; Yokoi, Fuji; Dannals, Robert F.; Ravert, Hayden T.; Szabo, Zsolt; Wong, Dean F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-630</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A column-switch high performance liq. chromatog. method for the anal. of 4 mL of plasma is described with six examples of chromatog. of [11C]-labeled positron-emission tomog. imaging agents.  Complete extn. of all but the most polar metabolites by the reverse phase capture column is achieved by disruption of plasma protein binding by 8 M urea.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC_vdT2H7syLVg90H21EOLACvtfcHk0lim88bpUftJ9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVWlurs%253D&md5=9e1f15e3bbe689845e351d38e24a1288</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900125-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900125-6%26sid%3Dliteratum%253Aachs%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DSzabo%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DColumn-switching%2520HPLC%2520for%2520the%2520analysis%2520of%2520plasma%2520in%2520PET%2520imaging%2520studies%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2000%26volume%3D27%26spage%3D627%26epage%3D630%26doi%3D10.1016%2FS0969-8051%2800%2900125-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Gillings, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falborg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marthi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Kinetics of the metabolism of four PET radioligands in living minipigs</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span><span class="refDoi"> DOI: 10.1016/S0969-8051(00)00187-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.1016%2FS0969-8051%2800%2900187-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=11182570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1yjsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=97-104&author=N.+M.+Gillingsauthor=D.+Benderauthor=L.+Falborgauthor=K.+Marthiauthor=O.+L.+Munkauthor=P.+Cumming&title=Kinetics+of+the+metabolism+of+four+PET+radioligands+in+living+minipigs&doi=10.1016%2FS0969-8051%2800%2900187-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of the metabolism of four PET radioligands in living minipigs</span></div><div class="casAuthors">Gillings, N. M.; Bender, D.; Falborg, L.; Marthi, K.; Munk, O. L.; Cumming, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-104</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Most radioligands are substantially metabolized in peripheral organs during the course of positron emission tomog. (PET) recordings.  Accurate detn. of plasma concns. of unmetabolized radioligands is often important for quantification of data from PET studies.  The fractions of untransformed radioligand and radioactive metabolites in plasma exts. must then be measured.  Temporal changes in these fractions are influenced by the rate const. of appearance of total radioactive metabolites in plasma (apparent rate const. of metab. in plasma, k0) and the net rate const. of elimination of all radioactive metabolites from plasma (k-1).  In order to clarify the relationship between radioligand fractions and rate consts., plasma samples collected from Gottingen minipigs during PET recordings using four different binding site ligands were analyzed by radio high performance liq. chromatog.  The calcd. plasma concns. of parent compds. and their radioactive metabolites were used to calc. k0 and k-1 for 11C-labeled NNC 112, NS 2214, PK 11195 and raclopride in minipigs using a novel application of the tissue-slope intercept plot.  In general, the apparent rate const. of metab. in plasma was found to be greater in the minipig than in man.  The reported kinetic anal. enables the apparent metab. of PET radioligands in plasma to be quantified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsETsfL5MYObVg90H21EOLACvtfcHk0lim88bpUftJ9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1yjsLk%253D&md5=4eff34b5a54444942954b538b2d0e18d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2800%2900187-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252800%252900187-6%26sid%3Dliteratum%253Aachs%26aulast%3DGillings%26aufirst%3DN.%2BM.%26aulast%3DBender%26aufirst%3DD.%26aulast%3DFalborg%26aufirst%3DL.%26aulast%3DMarthi%26aufirst%3DK.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DKinetics%2520of%2520the%2520metabolism%2520of%2520four%2520PET%2520radioligands%2520in%2520living%2520minipigs%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D97%26epage%3D104%26doi%3D10.1016%2FS0969-8051%2800%2900187-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A. G.</span><span> </span><span class="NLM_article-title">PET imaging of nicotinic acetylcholine receptors in baboons with <sup>18</sup>F-AZAN, a radioligand with improved brain kinetics</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span><span class="refDoi"> DOI: 10.2967/jnumed.111.092338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;key=10.2967%2Fjnumed.111.092338" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=121-129&author=H.+Kuwabaraauthor=D.+F.+Wongauthor=Y.+Gaoauthor=H.+Valentineauthor=D.+P.+Holtauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=A.+G.+Horti&title=PET+imaging+of+nicotinic+acetylcholine+receptors+in+baboons+with+18F-AZAN%2C+a+radioligand+with+improved+brain+kinetics&doi=10.2967%2Fjnumed.111.092338"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.092338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.092338%26sid%3Dliteratum%253Aachs%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DValentine%26aufirst%3DH.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DHorti%26aufirst%3DA.%2BG.%26atitle%3DPET%2520imaging%2520of%2520nicotinic%2520acetylcholine%2520receptors%2520in%2520baboons%2520with%252018F-AZAN%252C%2520a%2520radioligand%2520with%2520improved%2520brain%2520kinetics%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D121%26epage%3D129%26doi%3D10.2967%2Fjnumed.111.092338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i82"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00632">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_43531"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00632">10.1021/acs.jmedchem.7b00632</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Radiochemical synthesis procedure for [<sup>3</sup>H]<b>3</b>, radioactivity and ultraviolet chromatograms of [<sup>11</sup>C]<b>7</b>, [<sup>11</sup>C]<b>8</b>, [<sup>18</sup>F]<b>9</b>, [<sup>11</sup>C]<b>34</b>, and [<sup>18</sup>F]<b>37</b>, experimental details on the determination of drug distribution coefficients in octanol (log <i>D</i>), of brain lipids/water distribution coefficient (LIMBA log <i>D</i><sub>brain</sub>), and of high throughput passive membrane permeability assay (PAMPA) values, protocols for the single dose pharmacokinetics studies in mouse, the determination of P-gp-mediated drug transport, and the determination of drug binding to plasma proteins (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_001.pdf">jm7b00632_si_001.pdf (1.18 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00632/suppl_file/jm7b00632_si_002.csv">jm7b00632_si_002.csv (1.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00632&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00632%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00632" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679945e39a773cee","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
